<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Front Pharmacol</journal-id><journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id><journal-title-group><journal-title>Frontiers in Pharmacology</journal-title></journal-title-group><issn pub-type="epub">1663-9812</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6856223</article-id><article-id pub-id-type="doi">10.3389/fphar.2019.01207</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pharmacology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mohammadi Pour</surname><given-names>Pardis</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fakhri</surname><given-names>Sajad</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/773594"/></contrib><contrib contrib-type="author"><name><surname>Asgary</surname><given-names>Sedigheh</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/519281"/></contrib><contrib contrib-type="author"><name><surname>Farzaei</surname><given-names>Mohammad Hosein</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/791030"/></contrib><contrib contrib-type="author"><name><surname>Echeverr&#x000ed;a</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref><xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/439467"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup><institution>Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences</institution>, <addr-line>Isfahan</addr-line>, <country>Iran</country></aff><aff id="aff2">
<sup>2</sup><institution>Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences</institution>, <addr-line>Kermanshah</addr-line>, <country>Iran</country></aff><aff id="aff3">
<sup>3</sup><institution>Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences</institution>, <addr-line>Isfahan</addr-line>, <country>Iran</country></aff><aff id="aff4">
<sup>4</sup><institution>Departamento de Ciencias del Ambiente, Facultad de Qu&#x000ed;mica y Biolog&#x000ed;a, Universidad de Santiago de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Banasri Hazra, Jadavpur University, India</p></fn><fn fn-type="edited-by"><p>Reviewed by: Santhi Gorantla, University of Nebraska Medical Center, United States; Mingze Qin, Shenyang Pharmaceutical University, China</p></fn><corresp id="fn001">*Correspondence: Mohammad Hosein Farzaei, <email xlink:href="mailto:mh.farzaei@gmail.com" xlink:type="simple">mh.farzaei@gmail.com</email>; Javier Echeverria, <email xlink:href="mailto:javier.echeverriam@usach.cl" xlink:type="simple">javier.echeverriam@usach.cl</email>
</corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology</p></fn></author-notes><pub-date pub-type="epub"><day>08</day><month>11</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>10</volume><elocation-id>1207</elocation-id><history><date date-type="received"><day>16</day><month>7</month><year>2019</year></date><date date-type="accepted"><day>19</day><month>9</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Mohammadi Pour, Fakhri, Asgary, Farzaei and Echeverr&#x000ed;a</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Mohammadi Pour, Fakhri, Asgary, Farzaei and Echeverr&#x000ed;a</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>As the leading cause of death worldwide, viruses significantly affect global health. Despite the rapid progress in human healthcare, there are few viricidal and antiviral therapies that are efficient enough. The rapid emergence of resistance, and high costs, as well as the related side effects of synthetic antiviral drugs, raise the need to identify novel, effective, and safe alternatives against viral diseases. Nature has been of the most exceptional help and source of inspiration for developing novel multi-target antiviral compounds, affecting several steps of the viral life cycle and host proteins. For that matter and due to safety and efficacy limitations, as well as high resistance rate of conventional therapies, hundreds of natural molecules are preferred over the synthetic drugs. Besides, natural antiviral agents have shown acceptable antiviral value in both preclinical and clinical trials.This is the first review regarding molecular and cellular pathways of the virus life cycle, treatment strategies, and therapeutic targets of several viral diseases with a particular focus on anthocyanins as promising natural compounds for significant antiviral enhancements. Clinical applications and the need to develop nano-formulation of anthocyanins in drug delivery systems are also considered.</p></abstract><kwd-group><kwd>anthocyanins</kwd><kwd>natural compounds</kwd><kwd>antiviral</kwd><kwd>viral diseases</kwd><kwd>signaling pathways</kwd><kwd>therapeutic targets</kwd></kwd-group><counts><fig-count count="4"/><table-count count="3"/><equation-count count="0"/><ref-count count="271"/><page-count count="23"/><word-count count="11810"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>As unique obligate pathogens mostly dependent on live organisms, viruses are becoming a leading cause of death in life-threatening diseases (<xref rid="B10" ref-type="bibr">Becker et al., 2006</xref>). Due to their simplest form of an encapsidated nucleic acid and their ability to borrow molecular equipment from host cells to complete their replication cycle, viruses have a few targets for antiviral agents (<xref rid="B204" ref-type="bibr">Schneider et al., 2014</xref>).</p><p>In spite of tremendous advancements in antiviral drugs, there are several problems with the existing antiviral treatments, including safety and efficacy limitations, as well as their high costs (<xref rid="B183" ref-type="bibr">Perrin and Telenti, 1998</xref>; <xref rid="B197" ref-type="bibr">Revuelta-Herrero et al., 2018</xref>). The catastrophic rise in viral infections and related mortality urged a growing need to provide safe and effective drugs to treat viral diseases. It has yet remained a challenge due to the small number of targets in viruses, the rapid evolution of viral genes, the rapid emergence of drug-resistant pathways, and the appearance of new viral strains through mutations (<xref rid="B150" ref-type="bibr">Martins et al., 2016</xref>). Furthermore, considering the increasing threat of viral diseases, the emphasis is always on the need to identify suitable alternative therapies targeting different steps in the viral replication cycle (<xref rid="B183" ref-type="bibr">Perrin and Telenti, 1998</xref>; <xref rid="B63" ref-type="bibr">Gogineni et al., 2015</xref>). Recent developments in the investigation of novel cellular and molecular mechanisms of virus invasion and replication have provided alternative or additional innovative and effective therapeutic strategies. There are several natural compounds already with proven antiviral value in preventing and/or attenuating viral diseases or that are waiting to be evaluated for therapeutic applications. Anthocyanins are believed to display an array of beneficial actions on human health and well-being. Due to our increasing understanding and awareness of the potential beneficial human health effects, research on anthocyanins has recently intensified. A growing number of studies have recently shown the diverse beneficial effects of anthocyanins in vegetables and fruits, including the anti-cancer, anti-diabetes, ant-aging, anti-allergy, cardioprotection, anti-mutagenesis, and antimicrobial effects (<xref rid="B62" ref-type="bibr">Ghosh, 2005</xref>). Anthocyanins also constitute a flavonoids subfamily with neuroprotective, anti-inflammatory, and anti-oxidative properties (<xref rid="B3" ref-type="bibr">Amin et al., 2017</xref>). Besides, considering the inhibitory effects of anthocyanins on different pathways involved in virus life cycle, they would be hopeful antiviral therapies. Several other biological and pharmacological effects of anthocyanins are incessantly being investigated.</p><p>This is the first review regarding the current antiviral approaches and alternative, natural antiviral compounds while tackling particular attention to anthocyanins. We also focused our attention on the need to develop nanoformulation to improve the anthocyanin delivery system.</p></sec><sec id="s2"><title>Current Therapeutic Approaches for Viral Diseases and Their Restrictions</title><p>Antiviral drugs can be categorized into the inhibitors of fusion, uncoating, nucleic acid synthesis, integration, protease, and release (<xref rid="B187" ref-type="bibr">Pommier et al., 2005</xref>; <xref rid="B5" ref-type="bibr">Antonelli and Turriziani, 2012</xref>).</p><p>The interaction between the virus and the host cell membrane or receptor(s) is the first phase of the viral life cycle called fusion/entry. Fusion/entry inhibitors have been more provided for human immunodeficiency virus (HIV) treatment (<xref rid="B216" ref-type="bibr">Soriano et al., 2009</xref>; <xref rid="B223" ref-type="bibr">Tilton and Doms, 2010</xref>; <xref rid="B57" ref-type="bibr">Fumakia et al., 2016</xref>) and respiratory syncytial virus (RSV) prevention (<xref rid="B81" ref-type="bibr">Hu and Robinson, 2010</xref>; <xref rid="B124" ref-type="bibr">Lanari et al., 2010</xref>; <xref rid="B245" ref-type="bibr">Welliver, 2010</xref>). Targeting chemokine receptors (<xref rid="B107" ref-type="bibr">Kindberg et al., 2008</xref>; <xref rid="B139" ref-type="bibr">Lim and Murphy, 2011</xref>) and glycoprotein (GP)-receptor interactions (<xref rid="B4" ref-type="bibr">Antoine et al., 2013</xref>), as critical co-transporters of entry phase, are also of the most attractive candidates to inhibit viral entry/fusion. A novel lipopeptide known as myrcludex B also blocks taurocholate co-transporting polypeptide (NTCP); the co-receptor which is crucial for either hepatitis B virus (HBV) and hepatitis D virus (HDV) entry into hepatocytes (<xref rid="B227" ref-type="bibr">Uhl et al., 2014</xref>).</p><p>The low pH of the endosome activates M2 proton channels following virus entry to acidify the viral interior and weaken the electrostatic interaction to allow viral uncoating (<xref rid="B185" ref-type="bibr">Pinto et al., 1992</xref>). Uncoating inhibitors have been used more against the influenza virus (InfV) by inhibiting the function of the M2 ion channel (<xref rid="B33" ref-type="bibr">Davies et al., 1964</xref>; <xref rid="B148" ref-type="bibr">Martin and Heleniust, 1991</xref>). However, the emergence of resistance to these drugs has been detected, which raises concerns regarding their widespread use (<xref rid="B67" ref-type="bibr">Guan and Chen, 2005</xref>).</p><p>Following uncoating, nucleic acid synthesis is the third step of the viral life cycle, which is mediated by viral enzymes, including RNA polymerase, DNA polymerase, and reverse transcriptase. So, these enzymes have been considered as alternative targets in many viral infections such as HBV (<xref rid="B38" ref-type="bibr">De Clercq, 2015</xref>), herpes simplex virus-1/2 (HSV-1/2) and HIV-1. There are more targets and, also, more drugs against HIV in comparison to other viruses. Viral polymerase inhibitors are classified into nucleotide reverse transcriptase inhibitors (NtRTIs), nucleoside reverse transcriptase inhibitors (NRTIs), and non-nucleoside reverse transcriptase inhibitors (NNRTIs) (<xref rid="B157" ref-type="bibr">Miller and Miller, 1982</xref>; <xref rid="B51" ref-type="bibr">Elion, 1993</xref>; <xref rid="B37" ref-type="bibr">De Clercq, 2009</xref>). A serious problem with the use of a nucleic acid synthesis inhibitor is the frequently-developed drug-resistance (<xref rid="B161" ref-type="bibr">Montaner et al., 2010</xref>). Despite a rapid mutation for the first-generation NNRTIs (e.g., nevirapine, efavirenz, delavirdine) as the efficacy limitation agent (<xref rid="B34" ref-type="bibr">de B&#x000e9;thune, 2010</xref>), the second generation NNRTIs (e.g., etravirine, rilpivirine) possess a flexible structure and overcome common NNRTI resistance-associated mutations (<xref rid="B203" ref-type="bibr">Schiller and Youssef-Bessler, 2009</xref>; <xref rid="B1" ref-type="bibr">Adams et al., 2010</xref>). Altogether, most antiretroviral therapies did not eradicate the viral infection. Instead, they limited the immune recovery and their long-term use results in resistance and toxicity (<xref rid="B179" ref-type="bibr">Pantaleo, 1997</xref>; <xref rid="B180" ref-type="bibr">Pantaleo and Perrin, 1998</xref>; <xref rid="B183" ref-type="bibr">Perrin and Telenti, 1998</xref>; <xref rid="B222" ref-type="bibr">Telenti and Paolo Rizzardi, 2000</xref>). Therefore, new antiviral classes with new targets are urgently needed.</p><p>Inhibitors that specifically target integration have also been approved for the treatment of HIV infection. Since integrase is a necessary enzyme for the replication step involving the integration of host cell DNA to the viral genome, it has become a validated target for developing anti-HIV agents (<xref rid="B76" ref-type="bibr">Hazuda et al., 2000</xref>; <xref rid="B187" ref-type="bibr">Pommier et al., 2005</xref>; <xref rid="B5" ref-type="bibr">Antonelli and Turriziani, 2012</xref>). New integrase inhibitors targeting Gag, as an antiviral target, indicated auspicious effects both in preclinical and clinical trials (<xref rid="B159" ref-type="bibr">Min et al., 1999b</xref>; <xref rid="B187" ref-type="bibr">Pommier et al., 2005</xref>; <xref rid="B66" ref-type="bibr">Grinsztejn et al., 2007</xref>).</p><p>Viral proteases also signify an appropriate target for the development of novel antiviral agents against HIV and hepatitis C virus (HCV) infections (<xref rid="B52" ref-type="bibr">Eron Jr, 2000</xref>). Furthermore, the genome of HCV owns an open reading frame (ORF) encoding a single long polyprotein, which is processed either by virus-encoded proteases or host cellular peptidases (<xref rid="B233" ref-type="bibr">Vassilaki et al., 2008</xref>).</p><p>Nowadays, using a combination therapy of protease inhibitors with reverse transcriptase inhibitors, called highly active antiretroviral therapy (HAART), significantly enhanced the clinical outcome, reduced mortality, and morbidity, and greatly improved the life expectancy in HIV-1-infected individuals. HAART cannot eradicate the virus from HIV-infected cases. Drug-resistant, long-term use toxicity, and related high-cost limit the use of HAART in infected individuals (<xref rid="B211" ref-type="bibr">Simon et al., 2006</xref>). These all raise the need for novel medicinal agents (<xref rid="B109" ref-type="bibr">Kitazato et al., 2007</xref>).</p><p>The release of new viruses from the host cell is the final step of the virus infection cycle. Some drugs inhibit this phase through acting on the viral protein involved in such a process, which have been approved for the treatment of InfV infection (<xref rid="B75" ref-type="bibr">Hayden et al., 1997</xref>; <xref rid="B68" ref-type="bibr">Gubareva et al., 2000</xref>). The haemagglutinin of InfV A and B viruses bind to receptors with neuraminic acid (<xref rid="B68" ref-type="bibr">Gubareva et al., 2000</xref>). The neuraminidase (NA) enzymatic activity promotes the release of viruses by removing neuraminic acids from oligosaccharide chains of receptors (<xref rid="B26" ref-type="bibr">Colman, 1994</xref>). In addition to previously introduced M2 ion channel inhibitors, neuraminidase inhibitors (NAIs) are another class of anti-InfV drugs currently available (<xref rid="B36" ref-type="bibr">De Clercq, 2006</xref>). Most of the antiviral agents not only inhibit viral replication but also alter cellular metabolism, which creates the toxicity.</p><p>From the antiviral drugs restrictions point of view, there is no suitable vaccine or therapeutic option for many viral infections. Conventional antiviral drugs are limited by the inadequate response, the rapid development of resistance, and adverse effects. It is well established that using even standard and the same doses of antiviral drugs may result in different inter-individual serum concentrations and clinical outcomes, the reasons for which may be multifactorial including differences in concomitant medications, underlying diseases, treatment compliance, genetic factors, and gender-related metabolism. This noticeably influences the antiviral efficacy, consequent resistant variants, and the toxicity incidence. Drug hypersensitivity reactions, which vary in clinical manifestations, severity, and frequency, are among other adverse effects of a few antiviral drugs (<xref rid="B225" ref-type="bibr">Tozzi, 2010</xref>; <xref rid="B19" ref-type="bibr">Chaponda and Pirmohamed, 2011</xref>) (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>). Altogether, the best antiviral agents would include those more effective, having less resistance and which pose low toxicity. Therefore, the development of innovative and novel therapeutic and preventive strategies for viral infections is of particular importance. Further research is necessary to increase our knowledge about antiviral drugs adverse effects, to discover unknown mechanisms of novel therapies and to develop new antiviral agent (e.g. plant-derived) with innovative pharmacological mechanisms.</p><fig id="f1" position="float"><label>Figure 1</label><caption><p>Targeting host proteins and several steps of the viral life cycle by current therapeutic and alternative natural products (in red). HIV, human immunodeficiency viruses; RSV, respiratory syncytial virus; HBV, hepatitis B virus; HSV-1/2, herpes simplex virus-1/2, NtRTIs, nucleotide reverse transcriptase inhibitors; NRTIs, nucleoside reverse transcriptase inhibitors; and NNRTIs, non-nucleoside reverse transcriptase inhibitors; NAIs, neuraminidase inhibitors; PGC-1&#x003b1;, peroxisome proliferator-activated receptor gamma coactivator 1-alpha.</p></caption><graphic xlink:href="fphar-10-01207-g001"/></fig></sec><sec id="s3"><title>New Targets to Combat Viral Infections: Host Proteins, Nucleic Acids, and Antibodies</title><p>In addition to previously described viral targets, new classes of antiviral drugs targeting host factors involved in virus replication, virus-cell interactions, and the immune response have been introduced.</p><p>Targeting some host proteins participating in the replication of viruses positively modulate the viral infection, and their inhibition has recently shown new insights into antiviral drugs development (<xref rid="B84" ref-type="bibr">Huthoff and Towers, 2008</xref>). Although not all of these proteins have been identified, recent advances in clinical studies indicated additional targets to combat viral infection. Targeting the host cell factors involved in the HIV-1 replication might be one way to overcome the resistance of HIV-1 to antiviral drugs (<xref rid="B176" ref-type="bibr">Opar, 2007</xref>). While drugs directed to viral proteins act against specific viral infections, those targeting host proteins have a wide range of antiviral effects (<xref rid="B5" ref-type="bibr">Antonelli and Turriziani, 2012</xref>). Binding the HIV envelope protein gp120 to the CD4 receptor on host cells is followed by engagement of specific chemokine receptors (CXCR4 and CCR5) as co-receptors of host cells for fusion and their antagonists considered as HIV-fusion inhibitor (<xref rid="B176" ref-type="bibr">Opar, 2007</xref>; <xref rid="B107" ref-type="bibr">Kindberg et al., 2008</xref>; <xref rid="B139" ref-type="bibr">Lim and Murphy, 2011</xref>). Zinc-finger nucleases, a powerful tool to edit the human genome, has also been considered as another approach making cells virtually resistant to HIV infection through knockout of CXCR4 or CCR5 receptors (<xref rid="B78" ref-type="bibr">Holt et al., 2010</xref>; <xref rid="B191" ref-type="bibr">Rahman et al., 2011</xref>; <xref rid="B262" ref-type="bibr">Yuan et al., 2012</xref>).</p><p>Blocking the replication through inhibiting the host tyrosine kinase (<xref rid="B194" ref-type="bibr">Reeves et al., 2005</xref>), and inhibiting ErbB1, a cellular growth factor, also strongly inhibited the replication of poxviruses and vaccinia virus, respectively (<xref rid="B257" ref-type="bibr">Yang et al., 2005</xref>).</p><p>The current studies also confirmed the role of host immune modulators toward antiviral effects, as the agonist of toll-like receptor-3 or 7 (TLR-3 or 7), showed the potential antiviral effects (<xref rid="B156" ref-type="bibr">Miller et al., 2008</xref>). Inhibitors of IL8 and targeting IL12, IL2, interferon-gamma (IFN&#x003b3;) and tumor necrosis factor-&#x003b1; (TNF-&#x003b1;) are other possible immune-modulators used to combat some viral infections (<xref rid="B118" ref-type="bibr">Koumbi, 2015</xref>). It is now well known that several other therapeutic targets can improve the clinical outcome of our current standard treatment, such as programmed death 1 (PD-1), cytotoxic T-lymphocyte antigen 4 (CTLA-4), T-cell immunoglobulin and mucin domain-containing molecule 3 (TIM-3) (<xref rid="B104" ref-type="bibr">Khan et al., 2019</xref>), which all regulate the state of T-cell exhaustion (<xref rid="B69" ref-type="bibr">Hakim et al., 2014</xref>).</p><p>Therapeutic antibodies have also shown promising effects against viral infections, including RSV, HIV, avian InfV, and rabies viruses (<xref rid="B21" ref-type="bibr">Chen and Dimitrov, 2012</xref>).</p><p>Nowadays, ribozymes, aptamers, and RNA interference (RNAi), specifically small interfering RNAs (siRNAs) are of other nucleic acid-based antiviral therapies to target HIV, HCV, HBV, Marburg virus, Ebola virus and influenza viral genes (<xref rid="B266" ref-type="bibr">Zeller and Kumar, 2011</xref>). Besides, several other classes of immune modulators and antiviral agents are still under investigation (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>).</p><p>As novel cellular targets of licensed antiviral drugs, DNA terminase, helicase, and primase have a promising future. Letermovir has shown prophylactic effects against HCV in phase 2 and 3 of a clinical trial, by influencing the synthesis of the viral terminase complex (<xref rid="B120" ref-type="bibr">Kropeit et al., 2017</xref>). It did not demonstrate cross-resistance with other antiviral drugs, but did demonstrate a promising efficacy against cidofovir, foscarnet, and ganciclovir-resistance viruses (<xref rid="B154" ref-type="bibr">Melendez and Razonable, 2015</xref>). The primary inhibitors of terminase, benzimidazole derivatives (<xref rid="B232" ref-type="bibr">Valiente&#x02010;Echeverr&#x000ed;a et al., 2015</xref>), were initially introduced and developed as anticancer drugs. The efficacy of these derivatives on CMV replication did not comprise the DNA synthesis inhibition on viruses but led to virions production, which had a left-end-truncated genome inside their capsid (<xref rid="B153" ref-type="bibr">McVoy and Nixon, 2005</xref>). The results showed that benzimidazole derivatives inhibited the replication of CMV at the final steps of viral DNA synthesis (<xref rid="B17" ref-type="bibr">Champier et al., 2008</xref>). The other new licensed antiviral drugs have affected the DDX3 (Asp-Glu-Ala-Asp(DEAD)-box polypeptide 3), that is a member of ATP-dependent RNA helicases. DDX3 plays various roles in RNA metabolism, such as transcription, translation, nuclear export, and stress granules assembly. Moreover, the evidence showed that DDX3 is a part of the innate immunity response against viral infections. It is interesting to note that some RNA viruses, such as HCV and HIV-1, use DDX3 to perform different replication cycles stages. Therefore, it appears that viruses have progressed to use DDX3&#x02019;s boxes to coincide with threatening, so the innate immune response (<xref rid="B232" ref-type="bibr">Valiente&#x02010;Echeverr&#x000ed;a et al., 2015</xref>) and targeting helicase could be a novel strategy to combat viral diseases. One of the other new classes of antiviral drugs with the potential to treat HSV infections is the helicase-primase inhibitors (<xref rid="B110" ref-type="bibr">Kleymann et al., 2002</xref>), through affecting the non-structural protein-3 helicase (NS3h) and 5B (NS5B) RNA-dependent RNA polymerase, which are necessary for RNA replication of viruses. The helicase-primase complex is also the target of prilelivir and amenamevir with antiviral activities against HSV-1 and HSV-2 (<xref rid="B110" ref-type="bibr">Kleymann et al., 2002</xref>). This class of antiviral drugs also showed a potential efficacy against varicella-zoster virus (VZV) (<xref rid="B23" ref-type="bibr">Chono et al., 2010</xref>). Altogether, these proteins are unique targets for the discovery and development of direct-acting antivirals (<xref rid="B258" ref-type="bibr">Yang et al., 2017</xref>).</p></sec><sec id="s4"><title>The Contribution of Ethnopharmacology to the Development of Antiviral Drugs</title><p>In the past few years, some natural products and synthetic compounds had potential <italic>in vitro</italic> and <italic>in vivo</italic> antiviral activities. Among them, only a few have been approved for clinical use by western health (<xref rid="B239" ref-type="bibr">Vlietinck and Berghe, 1991</xref>). However, some agents have been in drug development, including both preclinical and clinical assessment, and have led to more prospects for discovering new antiviral agents with promising future. Among these antiviral substances, some are natural compounds which were isolated from medicinal plants used in complementary and traditional medicine, such as polysaccharides (<xref rid="B189" ref-type="bibr">Premanathan et al., 1999</xref>), polyphenols (<xref rid="B215" ref-type="bibr">Sokmen et al., 2005</xref>), flavonoids (<xref rid="B236" ref-type="bibr">Veckenstedt et al., 1978</xref>), anthocyanins (<xref rid="B209" ref-type="bibr">Sim&#x000f5;es et al., 2010</xref>), phenyl carboxylic acids (<xref rid="B123" ref-type="bibr">Kulkarni and Sanghai, 2014</xref>), terpenes (<xref rid="B250" ref-type="bibr">Wright et al., 1993</xref>), alkaloids (<xref rid="B178" ref-type="bibr">&#x000d6;z&#x000e7;elik et al., 2011</xref>), phenolic compounds (<xref rid="B178" ref-type="bibr">&#x000d6;z&#x000e7;elik et al., 2011</xref>), depsides (<xref rid="B73" ref-type="bibr">Hassan et al., 2019</xref>) and amino acids (<xref rid="B70" ref-type="bibr">Han et al., 1998</xref>). The number of secondary metabolites showed a unique antiviral mechanism of action and have a promising future for clinical research (<xref rid="B239" ref-type="bibr">Vlietinck and Berghe, 1991</xref>). There are some methods in the selection of plants for the assessment of antiviral activity, including mass screening of collected randomized plants; ethnomedical usage, available literature, and chemotaxonomical methods (<xref rid="B239" ref-type="bibr">Vlietinck and Berghe, 1991</xref>). Altogether, the plant kingdom is one of the best sources of new antiviral agents.</p></sec><sec id="s5"><title>Role of Natural Products for the Prevention and Treatment of Viral Diseases</title><p>For years, natural medicines have been used for the treatment and prophylactic of several viral infections (<xref rid="B113" ref-type="bibr">Koehn and Carter, 2005</xref>; <xref rid="B109" ref-type="bibr">Kitazato et al., 2007</xref>; <xref rid="B169" ref-type="bibr">Newman and Cragg, 2007</xref>). Many of the natural compounds, in particular biologically active small molecular, act as multi-target agents of high biochemical specificity and chemical diversity with lower cost and more covering mechanisms. They all help to find novel antiviral lead-compounds and lead-structures. Therefore, traditional and alternative medicinal plants offer novel promising antiviral effects.</p><p>Considerable advancement has been made in the use of several natural plant-derived products for the treatment of HIV infection. It has been previously shown that terpenoids, coumarins and flavonoids possess promising activities for the prevention and attenuation of the HIV infection. Flavonoids have been found to inhibit fusion (<xref rid="B134" ref-type="bibr">Li et al., 2000</xref>), integration (<xref rid="B130" ref-type="bibr">Lee et al., 2003</xref>), and reverse transcription (<xref rid="B108" ref-type="bibr">Kitamura et al., 1998</xref>). Inhibiting protease (<xref rid="B158" ref-type="bibr">Min et al., 1999a</xref>; <xref rid="B159" ref-type="bibr">Min et al., 1999b</xref>), reverse transcriptase (<xref rid="B200" ref-type="bibr">Rukachaisirikul et al., 2003</xref>), replication (<xref rid="B268" ref-type="bibr">Zhang et al., 2003</xref>), and maturation (<xref rid="B261" ref-type="bibr">Yu et al., 2007</xref>) are among anti-HIV mechanisms of some terpenoids. Coumarins also inhibit reverse transcriptase to show their anti-HIV effect. More recently, a tricyclic coumarin has been shown to suppress nuclear factor-kappa B (NF-&#x0043a;B) activation and, thereby, inhibited HIV replication <italic>in vitro</italic> (<xref rid="B122" ref-type="bibr">Kudo et al., 2013</xref>).</p><p>To date, flavonoids (<xref rid="B155" ref-type="bibr">Miki et al., 2007</xref>), polyphenols (<xref rid="B215" ref-type="bibr">Sokmen et al., 2005</xref>), alkaloids (<xref rid="B208" ref-type="bibr">Serkedjieva and Velcheva, 2003</xref>), anthocyanins (<xref rid="B119" ref-type="bibr">Krawitz et al., 2011</xref>), chalcones (<xref rid="B32" ref-type="bibr">Dao et al., 2011</xref>), xanthones (<xref rid="B31" ref-type="bibr">Dao et al., 2012</xref>), and homoisoflavonoids (<xref rid="B94" ref-type="bibr">Jeong et al., 2012</xref>) have also been introduced as anti-influenza agents predominantly inhibiting the NA enzyme (<xref rid="B242" ref-type="bibr">Wang et al., 2006</xref>).</p><p>Extensive reports have been conducted on the anti-HBV effects of natural products. A polyphenol, isochlorogenic acid (<xref rid="B71" ref-type="bibr">Hao et al., 2012</xref>), dehydrocheilanthifoline and some other amide alkaloids have been reported to show anti-HBV effects (<xref rid="B95" ref-type="bibr">Jiang et al., 2013</xref>; <xref rid="B267" ref-type="bibr">Zeng et al., 2013</xref>). Curcumin, as a polyphenol, down-regulated the coactivator of HBV transcription, peroxisome proliferator-activated receptor-gamma coactivator 1-&#x003b1; (PGC-1&#x003b1;), and thereby inhibited HBV gene replication and expression (<xref rid="B192" ref-type="bibr">Rechtman et al., 2010</xref>).</p><p>The medicinal herbs also showed noteworthy <italic>in vitro</italic> inhibitory activity by inhibiting protease to combat HCV (<xref rid="B83" ref-type="bibr">Hussein et al., 2000</xref>). Recent reports on natural products highlighted the flavonoid antiviral activity against HCV in different steps of its life cycle. Ladanein blocked the entry phase and quercetin, luteolin, and apigenin inhibited the replication phase. Honokiol, as a lignan, inhibited either entry or replication phases of HCV (<xref rid="B14" ref-type="bibr">Calland et al., 2012</xref>). Silymarin also inhibited HCV in different stages, including fusion, assembly (as naringenin blocked this phase) and transmission (<xref rid="B14" ref-type="bibr">Calland et al., 2012</xref>). It also displayed immunomodulatory and anti-inflammatory effects, contributed to its hepatoprotective effects (<xref rid="B163" ref-type="bibr">Morishima et al., 2010</xref>). The <italic>Sophora</italic> alkaloids also showed the antiviral potential to inhibit liver fibrosis, reduce the destruction of liver cells, inhibit viral replication, and promote the bile flow (<xref rid="B143" ref-type="bibr">Liu et al., 2003</xref>).</p><p>It is also crucial to identify novel anti-HSV lead-compounds with new mechanisms of action. Among natural entities, anthraquinone (<xref rid="B39" ref-type="bibr">De Logu et al., 2000</xref>), terpenoids, polyphenols, phenolics, flavonoids [e.g. houttuynoids (<xref rid="B80" ref-type="bibr">Houttuynoids, 2012</xref>)], proanthocyanidins (<xref rid="B30" ref-type="bibr">Danaher et al., 2011</xref>), geraniin (<xref rid="B255" ref-type="bibr">Yang et al., 2007a</xref>), hippomanin (<xref rid="B256" ref-type="bibr">Yang et al., 2007b</xref>), and excoecarianin (<xref rid="B22" ref-type="bibr">Cheng et al., 2011</xref>) have also shown promising anti-viral activities against HSV (<xref rid="B103" ref-type="bibr">Khan et al., 2005</xref>).</p><p>Chebulagic acid and punicalagin as tannins demonstrated an entry-inhibitor effect to HSV-1 (<xref rid="B18" ref-type="bibr">Chang et al., 2004</xref>). These hydrolyzable tannins inhibited viral entry phase, including attachment and penetration, thereby showing anti-RSV effects (<xref rid="B140" ref-type="bibr">Lin et al., 2013</xref>). New antiviral chromone glycosides (Uncinoside A) (<xref rid="B145" ref-type="bibr">Ma et al., 2003</xref>), biflavonoid (Genkwanol) (<xref rid="B82" ref-type="bibr">Huang et al., 2010</xref>), and flavone (<xref rid="B243" ref-type="bibr">Wang et al., 2012</xref>) protected against RSV with an unclear mechanism and resveratrol by reducing RSV-induced Inflammation through down-regulation of IFN&#x003b3; levels (<xref rid="B265" ref-type="bibr">Zang et al., 2011</xref>). <xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref> also displays the mechanistic pathways which are blocked by natural products.</p></sec><sec id="s6"><title>Anthocyanins</title><p>Anthocyanins belong to the most conspicuous structural class of glycosylated polyphenol, which produce anthocyanidins in the underlying conditions (<xref rid="B16" ref-type="bibr">Castaneda-Ovando et al., 2009</xref>), and show an unlimited range of colors, associated with their specific structures (<xref rid="B79" ref-type="bibr">Holton and Cornish, 1995</xref>). These structures are associated with the color of plant organs such as leaves, flowers, and fruits (<xref rid="B186" ref-type="bibr">Pojer et al., 2013</xref>). The importance of anthocyanins is related to their multiple functions within plants. The presence of anthocyanins in petals is connected to attracting the pollinators, while the anthocyanin presence in seeds and fruits may lead to dispersal of the seed. The other importance of anthocyanins in plants is their use as feeding deterrents and protectants against UV irradiation- induced damage (<xref rid="B79" ref-type="bibr">Holton and Cornish, 1995</xref>).</p><sec id="s6_1"><title>Chemical Structures</title><p>Anthocyanidins as aglycones consisting of a benzyl ring (A) connected to a heterocyclic ring with oxygen function (C), which is also connected to a third benzyl ring (B). Part C with three carbon bridges is connected to parts A and B (<xref ref-type="fig" rid="f2">
<bold>Figure 2</bold>
</xref>) (<xref rid="B213" ref-type="bibr">Smeriglio et al., 2016</xref>).</p><fig id="f2" position="float"><label>Figure 2</label><caption><p>General anthocyanin&#x02019;s structure.</p></caption><graphic xlink:href="fphar-10-01207-g002"/></fig><p>Glycosidic bonds are formed at 3 or 5 positions or both, and produce the monosaccharides, including glucose, galactose, rhamnose, and arabinose, as well as di-saccharides, and tri-saccharides, which could possess acylated side chains with aliphatic or cinnamic acids (<xref ref-type="fig" rid="f3">
<bold>Figure 3</bold>
</xref>) (<xref rid="B64" ref-type="bibr">Goto, 1987</xref>).</p><fig id="f3" position="float"><label>Figure 3</label><caption><p>Number, position, and substituents of anthocyanins.</p></caption><graphic xlink:href="fphar-10-01207-g003"/></fig><p>This is the cause of the structural diversity of anthocyanins with the difference in stability and color. The fundamental differences would be the total number and position of OH groups, nature, number, and position of connected sugars, the carboxylates in aliphatic chain or aromatic forms or acylated groups linked to the sugar in the structures, and the position and place of these connections (<xref rid="B64" ref-type="bibr">Goto, 1987</xref>) (<xref rid="T1" ref-type="table">
<bold>Table 1</bold>
</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Name, substituents, color, and the plant that anthocyanins were isolated.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" rowspan="1" colspan="1">Compound </th><th valign="top" rowspan="1" colspan="1">R<sub>1</sub>
</th><th valign="top" rowspan="1" colspan="1">R<sub>2</sub>
</th><th valign="top" rowspan="1" colspan="1">R<sub>3</sub>
</th><th valign="top" rowspan="1" colspan="1">R<sub>4</sub>
</th><th valign="top" rowspan="1" colspan="1">R<sub>5</sub>
</th><th valign="top" rowspan="1" colspan="1">R<sub>6</sub>
</th><th valign="top" rowspan="1" colspan="1">R<sub>7</sub>
</th><th valign="top" rowspan="1" colspan="1">Color </th><th valign="top" rowspan="1" colspan="1">Plant</th><th valign="top" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td valign="top" rowspan="1" colspan="1">Apigeninidin</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">
<italic>Sorghum caudatum</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B117" ref-type="bibr">Kouda-Bonafos et al., 1994</xref>)
</td></tr><tr><td valign="top" rowspan="1" colspan="1">Arrabidin</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">
<italic>Arrabidaea chica</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B249" ref-type="bibr">Wouters et al., 2005</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Aurantinidin</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">
<italic>Alstroemeria</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B221" ref-type="bibr">Tatsuzawa et al., 2003</xref>)
</td></tr><tr><td valign="top" rowspan="1" colspan="1">Capensinin</td><td valign="top" rowspan="1" colspan="1">
<italic>O</italic>-rhamnose</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">
<italic>Plumbago</italic> and <italic>Ceratostigma</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B72" ref-type="bibr">Harborne, 1967</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Carajurin</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">Ome</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">
<italic>Arrabidaea chica</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B249" ref-type="bibr">Wouters et al., 2005</xref>)
</td></tr><tr><td valign="top" rowspan="1" colspan="1">cyanidin-3-<italic>O</italic>-glucoside</td><td valign="top" rowspan="1" colspan="1">
<italic>O</italic>-glucoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">Orange-red</td><td valign="top" rowspan="1" colspan="1">Purple rice and pomegranate</td><td valign="top" rowspan="1" colspan="1">
<xref rid="B43" ref-type="bibr">Diaz-Mula et al., 2019</xref>; <xref rid="B248" ref-type="bibr">Wongwichai et al., 2019</xref>)
</td></tr><tr><td valign="top" rowspan="1" colspan="1">Cyanidin-coumaroyl-hexoside</td><td valign="top" rowspan="1" colspan="1">coumaroyl-hexoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">cyanidin 3-rutinoside</td><td valign="top" rowspan="1" colspan="1">rutinoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">
<italic>Prunus spinosa</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B132" ref-type="bibr">Leichtweis et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Delphinidin-3-<italic>O</italic>-glucoside</td><td valign="top" rowspan="1" colspan="1">
<italic>O</italic>-glucoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">Blue-red</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Delphinidin-coumaroyl-hexoside</td><td valign="top" rowspan="1" colspan="1">coumaroyl-hexoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)
</td></tr><tr><td valign="top" rowspan="1" colspan="1">Delphinidin-caffeoyl-hexoside</td><td valign="top" rowspan="1" colspan="1">caffeoyl-hexoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Delphinidin-acetyl-hexoside</td><td valign="top" rowspan="1" colspan="1">acetyl-hexoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)
</td></tr><tr><td valign="top" rowspan="1" colspan="1">Europinidin</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">Blue-red</td><td valign="top" rowspan="1" colspan="1">
<italic>Plumbago europea</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B72" ref-type="bibr">Harborne, 1967</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Hirsutidin</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">Blue-red</td><td valign="top" rowspan="1" colspan="1">
<italic>Catharanthus roseus</italic> and <italic>Primula sp</italic>.</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B88" ref-type="bibr">Iwashina, 2000</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">3&#x02032;-Hydroxyarrabidin</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">
<italic>Arrabidaea chica</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B249" ref-type="bibr">Wouters et al., 2005</xref>)
</td></tr><tr><td valign="top" rowspan="1" colspan="1">6-Hydroxycyanidin</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">Red</td><td valign="top" rowspan="1" colspan="1">
<italic>Alstroemeria</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B201" ref-type="bibr">Saito et al., 1985</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">6-Hydroxydelphinidin</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">Blue-red</td><td valign="top" rowspan="1" colspan="1">
<italic>Alstroemeria</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B174" ref-type="bibr">N&#x000f8;rbaek et al., 1996</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">6-Hydroxyplargonidin</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">
<italic>Alstroemeria</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B221" ref-type="bibr">Tatsuzawa et al., 2003</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Malvidin-3-<italic>O</italic>-glucoside</td><td valign="top" rowspan="1" colspan="1">
<italic>O</italic>-glucoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">Blue-red</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Malvidin-caffeoyl-hexoside</td><td valign="top" rowspan="1" colspan="1">caffeoyl-hexoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)
</td></tr><tr><td valign="top" rowspan="1" colspan="1">Malvidin-cumaroyl-hexoside</td><td valign="top" rowspan="1" colspan="1">cumaroyl-hexoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Malvidin-acetyl-hexoside</td><td valign="top" rowspan="1" colspan="1">acetyl-hexoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">5-Methylcyanidin</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">Orange-red</td><td valign="top" rowspan="1" colspan="1">cashew apple</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B35" ref-type="bibr">de Britoa et al., 2007</xref>)
</td></tr><tr><td valign="top" rowspan="1" colspan="1">Pelargonidin 3-<italic>O</italic>-rutinoside</td><td valign="top" rowspan="1" colspan="1">
<italic>O</italic>-rutinoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Gentian</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B45" ref-type="bibr">Diretto et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Pelargonidin 3-<italic>O</italic>-(6-<italic>p</italic>-coumaroyl) glucoside</td><td valign="top" rowspan="1" colspan="1">
<italic>O</italic>-(6-<italic>p</italic>-coumaroyl)glucoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Gentian</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B45" ref-type="bibr">Diretto et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Pelargonidin 3-<italic>O</italic>-glucoside</td><td valign="top" rowspan="1" colspan="1">
<italic>O</italic>-glucoside</td><td valign="top" rowspan="1" colspan="1">OH </td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Gentian</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B45" ref-type="bibr">Diretto et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Pelargonidin 3-<italic>O</italic>-rutinoside-5-<italic>O</italic>-&#x003b2;-D-glucoside</td><td valign="top" rowspan="1" colspan="1">
<italic>O</italic>-rutinoside</td><td valign="top" rowspan="1" colspan="1">
<italic>O</italic>-&#x003b2;-D-glucoside</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Gentian</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B45" ref-type="bibr">Diretto et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Pelargonidin 3,5-<italic>O</italic>-diglucoside</td><td valign="top" rowspan="1" colspan="1">
<italic>O</italic>-diglucoside</td><td valign="top" rowspan="1" colspan="1">
<italic>O</italic>-diglucoside</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Gentian</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B45" ref-type="bibr">Diretto et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">peonidin-3-<italic>O</italic>-glucoside</td><td valign="top" rowspan="1" colspan="1">
<italic>O</italic>-glucoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Purple rice and Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>; <xref rid="B248" ref-type="bibr">Wongwichai et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Peonidin-coumaroyl-hexoside</td><td valign="top" rowspan="1" colspan="1">coumaroyl-hexoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Peonidin-caffeoyl-hexoside</td><td valign="top" rowspan="1" colspan="1">caffeoyl-hexoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Peonidin-acetyl-hexoside</td><td valign="top" rowspan="1" colspan="1">acetyl-hexoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">peonidin 3-rutinoside</td><td valign="top" rowspan="1" colspan="1">rutinoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">
<italic>Prunus spinosa</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B132" ref-type="bibr">Leichtweis et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Peonidin -3-(6&#x02033;-caffeoyl-6?- feruolylsophoroside)-5-glucose</td><td valign="top" rowspan="1" colspan="1">-(6&#x02033;-caffeoyl-6?- feruolylsophoroside)</td><td valign="top" rowspan="1" colspan="1">glucose</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Sweet Potato</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B237" ref-type="bibr">Vishnu et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Petunidin-3-<italic>O</italic>-glucoside</td><td valign="top" rowspan="1" colspan="1">
<italic>O</italic>-glucoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">Blue-red</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Petunidin-coumaroyl-hexoside</td><td valign="top" rowspan="1" colspan="1">coumaroyl-hexoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Petunidin-caffeoyl-hexoside</td><td valign="top" rowspan="1" colspan="1">caffeoyl-hexoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Petunidin-acetyl-hexoside</td><td valign="top" rowspan="1" colspan="1">acetyl-hexoside</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">Grape</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">Colombo et al., 2019</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Pulchellidin</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">Blue-red</td><td valign="top" rowspan="1" colspan="1">
<italic>Plumbago pulchella</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B88" ref-type="bibr">Iwashina, 2000</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Riccionidin A</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">N.R.</td><td valign="top" rowspan="1" colspan="1">
<italic>Ricciocarpos natans</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B88" ref-type="bibr">Iwashina, 2000</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Rosinidin</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OMe</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">Red</td><td valign="top" rowspan="1" colspan="1">
<italic>Primula rosea</italic>
</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B88" ref-type="bibr">Iwashina, 2000</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Tricetinidin</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">H</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">OH</td><td valign="top" rowspan="1" colspan="1">Red</td><td valign="top" rowspan="1" colspan="1">black tea</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B88" ref-type="bibr">Iwashina, 2000</xref>)</td></tr></tbody></table></table-wrap><p>The sugar residues of anthocyanin may be acylated by caffeic, sinapic, <italic>p</italic>-coumaric, and ferulic acids, and occasionally by acetic acid, malonic acid or <italic>p</italic>-hydroxybenzoic acid. The position of the C-3 in sugar is sometimes substituted by acyl (<xref rid="B13" ref-type="bibr">Brouillard, 1982</xref>; <xref rid="B64" ref-type="bibr">Goto, 1987</xref>). The most crucial characteristic of anthocyanins is their color changes against pH variation (<xref rid="B64" ref-type="bibr">Goto, 1987</xref>). The acidic pH of anthocyanins causes the following principal equilibrium types, including the quinonoidal base, which captures proton and produces the flavylium cation with a resonating system, picking up H<sub>2</sub>O and leading the reaction for producing the anhydrobase or carbinol, and the chalcone types (<xref rid="B195" ref-type="bibr">Rein, 2005</xref>; <xref rid="B219" ref-type="bibr">Swaminathan et al., 2014</xref>) (<xref ref-type="fig" rid="f4">
<bold>Figure 4</bold>
</xref>). The stability of anthocyanins depends on major parameters like oxygen, chemical structure, pH, light, solvents, concentration, processing and storage temperature, the presence of proteins, enzymes, metallic ions, flavonoids, and presentment of ascorbic acid preserve from sugars and oxidation (<xref rid="B195" ref-type="bibr">Rein, 2005</xref>).</p><fig id="f4" position="float"><label>Figure 4</label><caption><p>The substitution pattern of flavylium cation forming the naturally-occurring anthocyanidins which are known today.</p></caption><graphic xlink:href="fphar-10-01207-g004"/></fig></sec><sec id="s6_2"><title>Biological Activities and Health Benefits of Anthocyanins</title><p>Anthocyanins are indeed among the critical supplements that improve human health (<xref rid="B259" ref-type="bibr">Yeung et al., 2018</xref>) and play a functional antioxidant activity through free-radical scavenging, decreasing ROS and lipid peroxidation (<xref rid="B240" ref-type="bibr">Wang et al., 1999</xref>; <xref rid="B138" ref-type="bibr">Lila, 2004</xref>). Anthocyanins supply a cardioprotective effect <italic>via</italic> increasing the postischemic coronary flow, inhibiting of the cholesteryl ester transfer and consequently regulating the serum level of LDL and HDL (<xref rid="B190" ref-type="bibr">Qin et al., 2009</xref>), as well as the occurrence and period of reperfusion arrhythmias (<xref rid="B190" ref-type="bibr">Qin et al., 2009</xref>; <xref rid="B186" ref-type="bibr">Pojer et al., 2013</xref>). Anthocyanin-rich formula inhibited H<sub>2</sub>O<sub>2</sub>- and TNF-&#x003b1;-induced vascular endothelial growth factor release (<xref rid="B9" ref-type="bibr">Bagchi et al., 2004</xref>), and activated both caspase-dependent and independent pathways (<xref rid="B193" ref-type="bibr">Reddivari et al., 2007</xref>), thereby exerting its anti-angiogenic and anticarcinogenic activities.</p><p>Anthocyanins also improved the visual function through the inhibition of transitory myopia, improving the blood flow of retin, enhancing dark adaptation, and decreasing eye fatigue in glaucoma disease (<xref rid="B226" ref-type="bibr">Tsuda, 2012</xref>). From the neuroprotective point of view, anthocyanins improved the brain function through enhancement of the memory and motor performances (<xref rid="B226" ref-type="bibr">Tsuda, 2012</xref>), enabling the cunctation of the onset of age-related neurodegenerative dysfunction (<xref rid="B186" ref-type="bibr">Pojer et al., 2013</xref>). Anthocyanins also displayed anti-obesity and anti-diabetic activity (increasing the insulin secretion) (<xref rid="B93" ref-type="bibr">Jayaprakasam et al., 2005</xref>), anti&#x02010;inflammatory activity (through modification of inflammatory cytokines and mediators including IL-1, IL-6, IL-10, TNF-a, NF-kB, inducible nitric oxide synthase and COX-2)(<xref rid="B12" ref-type="bibr">Bowen-Forbes et al., 2010</xref>; <xref rid="B214" ref-type="bibr">Sodagari et al., 2015</xref>) and bacteriostatic activity (<xref rid="B24" ref-type="bibr">Cisowska et al., 2011</xref>). Previously, anthocyanins were shown to have pharmacological and nutraceutical activities and also played a key role in human nutrition that improves both physical and mental health.</p></sec><sec id="s6_3"><title>Anthocyanin Enriched Plant and Fruits With Antiviral Effect</title><p>The antiviral activity of anthocyanins is considered to be one of their pharmacological properties, which indicates their importance in health and hygiene. Furthermore, the antiviral effects of anthocyanin-enriched plants and fruits have so far been reported (<xref rid="T2" ref-type="table">
<bold>Table 2</bold>
</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>The antiviral activity of anthocyanins-enriched plants and purified anthocyanins with their pharmacological activity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" rowspan="1" colspan="1">Antiviral activity against</th><th valign="top" rowspan="1" colspan="1">Active compounds </th><th valign="top" rowspan="1" colspan="1">Plant material </th><th valign="top" rowspan="1" colspan="1">Mechanism of action</th><th valign="top" rowspan="1" colspan="1">Ref </th></tr><tr><th valign="top" colspan="5" rowspan="1">Anthocyanins-enriched plants</th></tr></thead><tbody><tr><td valign="top" rowspan="1" colspan="1">InfV A and B </td><td valign="top" rowspan="1" colspan="1">3-<italic>O</italic>-&#x003b1;-L-rhamnopyranosyl-&#x003b2;-D-glucopyranosyl-cyanidin, 3-<italic>O</italic>-&#x003b2;-D-glucopyranosyl-cyanidin, 3-<italic>O</italic>-&#x003b1;-L-rhamnopyranosyl-&#x003b2;-D-glucopyranosyl-delphinidin, and 3-<italic>O</italic>-&#x003b2;-D-glucopyranosyl-delphinidin</td><td valign="top" rowspan="1" colspan="1">
<italic>Ribes nigrum</italic>
</td><td valign="top" rowspan="1" colspan="1">Inhibited virus adsorption to cells and also virus release from infected cells</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B111" ref-type="bibr">Knox et al., 2001</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">InfV A and B</td><td valign="top" rowspan="1" colspan="1">Pelanin, pelargonidin, pelargonidin 3-<italic>p</italic>-coumaroylglucose- 5-glucose, pelargonidin 3-<italic>p</italic>-coumaroylglucose- 5-malonylglucose</td><td valign="top" rowspan="1" colspan="1">
<italic>Solanum tuberosum</italic>
</td><td valign="top" rowspan="1" colspan="1">The structure of the anthocyanin pigment, their additive or synergistic effects and other coexisting constituents in the tuber.</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B74" ref-type="bibr">Hayashi et al., 2003</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">InfV</td><td valign="top" rowspan="1" colspan="1">Cyanidin-3-sambubiocide</td><td valign="top" rowspan="1" colspan="1">
<italic>Sambucus nigra </italic>
</td><td valign="top" rowspan="1" colspan="1">Binding to 430-cavity near the neuraminidase residues to regulate neuraminidase resistance. </td><td valign="top" rowspan="1" colspan="1">(<xref rid="B218" ref-type="bibr">Swaminathan et al., 2013</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">HSV-1 </td><td valign="top" rowspan="1" colspan="1">Delphinidin-3-rutinoside</td><td valign="top" rowspan="1" colspan="1">
<italic>Solanum melongena</italic>
</td><td valign="top" rowspan="1" colspan="1">Inhibite the HSV-1 replication, reduce viral proteins expression, and reduce NOX4 expression</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B42" ref-type="bibr">Di Sotto et al., 2018</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">HSV-1 </td><td valign="top" rowspan="1" colspan="1">Total anthocyanins </td><td valign="top" rowspan="1" colspan="1">
<italic>Fragaria x ananassa </italic>
</td><td valign="top" rowspan="1" colspan="1">Increase the anthocyanins content and decrease the detected anti-HSV-1 activity</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B210" ref-type="bibr">Sim&#x000f5;es et al., 2012</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">RV</td><td valign="top" rowspan="1" colspan="1">Anthocyanin-related substance</td><td valign="top" rowspan="1" colspan="1">
<italic>Vigna angularis </italic>
</td><td valign="top" rowspan="1" colspan="1">Effect on the early phase of the infection cycle</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B100" ref-type="bibr">Kawai and Fujita, 2007</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">InfV A and CV-B1</td><td valign="top" rowspan="1" colspan="1">Total anthocyanins</td><td valign="top" rowspan="1" colspan="1">
<italic>Fragaria vesca, Rubus idaeus, Vaccinium myrtillis, and V. vitis-idaea </italic>
</td><td valign="top" rowspan="1" colspan="1">Inhibit the replication of viruses</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B172" ref-type="bibr">Nikolaeva-Glomb et al., 2014</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">InfV A and B</td><td valign="top" rowspan="1" colspan="1">Cyanidin-3-rutinoside</td><td valign="top" rowspan="1" colspan="1">
<italic>Morus alba</italic>
</td><td valign="top" rowspan="1" colspan="1">Inhibite the attachment phase or internalization and intervene with the ROS-mediated cell damage caused by InfV Infection</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B105" ref-type="bibr">Kim and Chung, 2018</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Adenovirus 36</td><td valign="top" rowspan="1" colspan="1">Kuromanin chloride and total extract</td><td valign="top" rowspan="1" colspan="1">
<italic>Morus alba</italic>
</td><td valign="top" rowspan="1" colspan="1">Inhibits viral replication </td><td valign="top" rowspan="1" colspan="1">(<xref rid="B164" ref-type="bibr">Na et al., 2014</xref>) </td></tr><tr><td valign="top" rowspan="1" colspan="1">BT2, T4 and simian rotavirus SA-11</td><td valign="top" rowspan="1" colspan="1">Total anthocyanins</td><td valign="top" rowspan="1" colspan="1">
<italic>Vaccinium macrocarpon</italic>
</td><td valign="top" rowspan="1" colspan="1">Inhibited the viral adsorption of phage T4 and the replication of rotavirus </td><td valign="top" rowspan="1" colspan="1">(<xref rid="B141" ref-type="bibr">Lipson et al., 2007</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">HAV, FCV-F9 and MNV-1</td><td valign="top" rowspan="1" colspan="1">Total anthocyanins</td><td valign="top" rowspan="1" colspan="1">
<italic>Vitis vinifera</italic>
</td><td valign="top" rowspan="1" colspan="1">Inhibite the viral adsorption and have less effect on replication </td><td valign="top" rowspan="1" colspan="1">(<xref rid="B97" ref-type="bibr">Joshi et al., 2015</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">InfV A, InfV B and avian InfV.</td><td valign="top" rowspan="1" colspan="1">cyanidin-3-arabinoside and cyanidin-3-galactoside</td><td valign="top" rowspan="1" colspan="1">
<italic>Theobroma cacao</italic>
</td><td valign="top" rowspan="1" colspan="1">Increase the NK cell activity, enhance the immune system responses and prepare more potent protection</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B170" ref-type="bibr">Niemenak et al., 2006</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">InfV A</td><td valign="top" rowspan="1" colspan="1">Total anthocyanins</td><td valign="top" rowspan="1" colspan="1">
<italic>Lycium barbarum </italic>
</td><td valign="top" rowspan="1" colspan="1">Attenuate the inflammatory cytokines in the lungs and raise T cells mediated function by producing IL-2</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B196" ref-type="bibr">Ren et al., 2012</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">InfV subtypes A/Vama/5/003 and A/Vama/3/003.</td><td valign="top" rowspan="1" colspan="1">Total anthocyanins</td><td valign="top" rowspan="1" colspan="1">
<italic>Aronia melanocarpa</italic>
</td><td valign="top" rowspan="1" colspan="1">Inhibit the reproduction of InfV in its initial phase</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B231" ref-type="bibr">Valcheva-Kuzmanova et al., 2003</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">Adenovirus and HIV-1 IIIB</td><td valign="top" rowspan="1" colspan="1">Total anthocyanins</td><td valign="top" rowspan="1" colspan="1">
<italic>Punica granatum</italic>
</td><td valign="top" rowspan="1" colspan="1">Bind irreversibly or strongly to the binding site of CD4 on gp120</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B168" ref-type="bibr">Neurath et al., 2004</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">HSV-1, HSV-2, and ACV<sup>res</sup>
</td><td valign="top" rowspan="1" colspan="1">Total anthocyanins</td><td valign="top" rowspan="1" colspan="1">
<italic>Lamiaceae family</italic>
</td><td valign="top" rowspan="1" colspan="1">Inhibit the virus adsorption stage and have no effect on the replication stage</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B173" ref-type="bibr">Nolkemper et al., 2006</xref>)</td></tr><tr><td valign="top" colspan="5" rowspan="1">
<bold>Purified antiviral anthocyanin</bold>
</td></tr><tr><td valign="top" rowspan="1" colspan="1">HCV</td><td valign="top" colspan="2" rowspan="1">Delphinidin</td><td valign="top" rowspan="1" colspan="1">Inhibit the attachment stage </td><td valign="top" rowspan="1" colspan="1">(<xref rid="B15" ref-type="bibr">Calland et al., 2015</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">InfV</td><td valign="top" colspan="2" rowspan="1">Cyanidin-3-sambubiocide</td><td valign="top" rowspan="1" colspan="1">Regulate neuraminidase resistance</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B99" ref-type="bibr">Kannan and Kolandaivel, 2018</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">WNV, DENV, and ZIKV</td><td valign="top" colspan="2" rowspan="1">Delphinidin, and cyanidin </td><td valign="top" rowspan="1" colspan="1">Inhibit the attachment, adsorption and entrance stages and a have direct activity on virus particles</td><td valign="top" rowspan="1" colspan="1">(<xref rid="B234" ref-type="bibr">V&#x000e1;zquez-Calvo et al., 2017</xref>)</td></tr><tr><td valign="top" rowspan="1" colspan="1">InfV neuraminidase</td><td valign="top" colspan="2" rowspan="1">Pelargonidin, cyanidin and delphinidin</td><td valign="top" rowspan="1" colspan="1">Depend on OH substituent each compound with more number of OH substituent, bond strongly and have a more inhibitory activity </td><td valign="top" rowspan="1" colspan="1">(<xref rid="B219" ref-type="bibr">Swaminathan et al., 2014</xref>)</td></tr></tbody></table></table-wrap><sec id="s6_3_1"><title><italic>Ribes nigrum</italic> L.</title><p>Some functional anthocyanins such 3-<italic>O</italic>-rutinosides and 3-<italic>O</italic>-glucosides of malvidin, pelargonidin, peonidin, petunidin, delphinidin, cyanidin, and cyanidin 3-<italic>O</italic>-arabinoside have been isolated from the extract of blackcurrant berries (<italic>Ribes nigrum</italic> L.) (<xref rid="B212" ref-type="bibr">Slimestad and Solheim, 2002</xref>). Knox et al. studied the effect of <italic>R. nigrum</italic> extract against the InfV A and B and showed four anthocyanins-containing fractions with potent antiviral activity. According to the results, one of the fractions contained 3-<italic>O</italic>-&#x003b1;-L-rhamnopyranosyl-&#x003b2;-D-glucopyranosyl-cyanidin and 3-<italic>O</italic>-&#x003b2;-D-glucopyranosyl-cyanidin anthocyanins, and the second contained 3-<italic>O</italic>-&#x003b1;-L-rhamnopyranosyl-&#x003b2;-D-glucopyranosyl-delphinidin and 3-<italic>O</italic>-&#x003b2;-D-glucopyranosyl-delphinidin. Both fractions displayed strong antiviral activity against the InfV A and B. The second fraction anthocyanins prevented viral attachment and entry to cells, as well as their release from the infected cells (<xref rid="B111" ref-type="bibr">Knox et al., 2001</xref>). <italic>R. nigrum</italic> extracts also inhibited InfV adsorption on the cell surface (<xref rid="B87" ref-type="bibr">Ikuta et al., 2013</xref>), interference with virus internalization (<xref rid="B50" ref-type="bibr">Ehrhardt et al., 2013</xref>) and completely suppressed the growth of InfV A <italic>in vitro</italic> (<xref rid="B112" ref-type="bibr">Knox et al., 2003</xref>). As Ikuta et al. reported, a low concentration of blackcurrant inhibited the replication while a high one inhibited adsorption of InfV A and B onto the cell surface (<xref rid="B86" ref-type="bibr">Ikuta et al., 2012</xref>). Altogether, the blackcurrant extracts displayed auspicious anti-InfV effects through different mechanisms. This extract might be a hopeful source for the drug discovery and development of new antiviral agents to struggle against InfV infections.</p></sec><sec id="s6_3_2"><title><italic>Solanum</italic> spp.</title><p>As red potatoes, <italic>Solanum stenotomum</italic> and <italic>S. tuberosum</italic> were surveyed potential sources for natural red colorants, especially anthocyanins and contained pelargonidin-3-rutinoside-5-glucoside acylated with <italic>p</italic>-coumaric acid as major anthocyanins (<xref rid="B198" ref-type="bibr">Rodriguez&#x02010;Saona et al., 1998</xref>). Only the anthocyanins of red-fleshed potato were observed to possess antiviral effects till now (<xref rid="B270" ref-type="bibr">Zhao et al., 2009</xref>). Hayashi et al. investigated the activity of red-fleshed potato anthocyanins against the InfV A and B viruses. According to the results, the purified <italic>Solanum</italic> sp. anthocyanin, pelanin, pelargonidin, pelargonidin 3-<italic>p</italic>-coumaroylglucose-5-malonylglucose, and pelargonidin 3-<italic>p</italic>-coumaroylglucose-5-glucose were effective against the InfV B virus. They also reported that the inhibitory impact of anthocyanins against InfV A and B viruses arose from their molecular structure, synergistic effects, and coexisting components of tuber (<xref rid="B74" ref-type="bibr">Hayashi et al., 2003</xref>; <xref rid="B270" ref-type="bibr">Zhao et al., 2009</xref>). Valadares et al. investigated the antiviral effect of <italic>S. paniculatum</italic> against murine encephalomyocarditis virus (EMCv), human herpes virus type 1 (HHV-1), and vaccinia virus strains Western Reserve (VACV-WR). According to the results, the extract of <italic>S. paniculatum</italic> inhibited the replication of HHV-1, but exhibited no effect on VACV-WR and EMCv (<xref rid="B230" ref-type="bibr">Valadares et al., 2009</xref>). Javid et al. also studied the anti HCV activity of chloroform extract of <italic>S. nigrum</italic> seeds (SNS). As reported by the authors, the chloroform extract of SNS reduced the expression or function of HCV NS3 protease in a dose-dependent manner. Furthermore, NS3 may have extra effects involved in interference with host cell functions, like inhibition of protein kinase A-mediated signal transduction or cell transformation. Besides, the antiviral activity of SNS is a target for therapeutic development of new antiviral compounds for acute and chronic HCV, where NS3- mediated processing of the polyprotein is essential for HCV RNA replication and maturation (<xref rid="B92" ref-type="bibr">Javed et al., 2011</xref>). Therefore, the antiviral effects of <italic>Solanum</italic> sp. anthocyanins are believed to belong to the synergistic or additive effect of them with other coexisting pigments, which inhibit the replication and decrease the expression of protease for RNA replication and maturation. Therefore, this species is a conspicuous source of antiviral agents and could become a structure template for the development of new antiviral therapy.</p></sec><sec id="s6_3_3"><title>
<italic>Fragaria &#x000d7; ananassa</italic> (Duchesne ex Weston) Duchesne ex Rozier - Strawberries</title><p>An analysis of the anthocyanins of strawberry varieties reported by Garcia&#x02010;Viguera et al. introduced cyanidin 3-glucoside, pelargonidin 3-glucoside, pelargonidin 3-rutinoside in fresh and frozen fruit (<xref rid="B58" ref-type="bibr">Garcia&#x02010;Viguera et al., 1998</xref>). In the 1970s, researchers reported the antiviral activity of strawberry fruit juice against coxsackievirus B5, poliovirus type 1 and echovirus 7 (<xref rid="B116" ref-type="bibr">Konowalchuk and Speirs, 1976</xref>). Carvalho et al. studied five strawberry cultivars and quantified their total anthocyanins content (TA). The extracts were evaluated for in vitro anti-HSV activity. They showed that aromas and camarosa cultivars had the highest TA, but camino real cultivar presented the lowest TA. The two first cultivars also showed the most activity against the herpes virus, while the camino real cultivar had the lowest activity. Finally, the authors suggested a relationship between the amount of anthocyanins and the detected anti-HSV for the strawberry&#x02019;s cultivars (<xref rid="B210" ref-type="bibr">Sim&#x000f5;es et al., 2012</xref>). In another research study by Willig et al., the anti-HSV-1 activity of strawberry&#x02019;s anthocyanins were examined. They revealed that the concentrations equal to or greater than 20&#x000b5;g/ml of strawberry&#x02019;s anthocyanins completely inhibited HSV-1 (<xref rid="B246" ref-type="bibr">Willig, 2013</xref>). In summary, strawberry anthocyanins are effective prophylactic agents to treat or tackle HSV-1.</p></sec><sec id="s6_3_4"><title>
<italic>Vigna angularis</italic> (Willd.) Ohwi &#x00026; H.Ohashi</title><p>The isolation and structural elucidation of anthocyanin from the <italic>Vigna angularis</italic> (red bean) have shown cyanin as a major anthocyanin of this species of edible legumes (<xref rid="B260" ref-type="bibr">Yoshida et al., 1996</xref>). Kawai et al. studied different extracts of <italic>V. angularis</italic>, which among exudate fluids and aqueous extract, respectively, indicated potent and little antiviral activities against rabies virus (RV). According to the findings, the anthocyanins fractions were involved in the antiviral activity of <italic>V. angularis</italic>, which were affected by maceration conditions, and the anthocyanin-deficient white bean did not show antiviral effects into the exudate fluids. Moreover, the antiviral activity was still observed after heating for 10 min. Further studies on the antiviral activity of the extract affect preliminary adsorption phase and the preliminary phase of viral replication. The antiviral activity of <italic>V. angularis</italic> was not only restricted to RV, but the HSV and InfV were affected as well (<xref rid="B100" ref-type="bibr">Kawai and Fujita, 2007</xref>). This implicated the possible application of Adzuki bean (small red bean) exudate fluids for post-exposure treatment of rabid dog-bite injuries accompanied by vaccination.</p></sec><sec id="s6_3_5"><title>Wilberries</title><p>Cyanidin, peonidin, pelargonidin, delphinidin, petunidin and malvidin glycosides as a wide variety of anthocyanins were isolated and quantified in the 24 wild and cultivated berry fruit species using high-performance liquid chromatography-diode array detector (HPLC-DAD) (<xref rid="B235" ref-type="bibr">Veberic et al., 2015</xref>). In spite of noticeable antimicrobial effects of wild berries, their antiviral capacity has not been well assessed (<xref rid="B116" ref-type="bibr">Konowalchuk and Speirs, 1976</xref>). In their study, Glomb et al. examined the methanol extract of wild berries (raspberry and strawberry of the Rosaceae, and lingonberry and bilberry of the Ericaceae family) against the representatives of Orthomyxo-, Paramyxo- and Picorna-viridae. The antiviral effects of methanolic extract, anthocyanin and non-anthocyanin fractions were evaluated on Picornaviridae [e.g., coxsackievirus B1 (CV-B1) and poliovirus type 1 (PV-1)], Paramyxoviridae (e.g. human respiratory syncytial virus A2 (HRSV-A2)), and Orthomyxoviridae such as InfV A. According to the results, the methanolic extracts of all types of berries inhibited the replication of InfV A and CV-B1. The total extract of strawberry and bilberry inhibited the highest degree of CV-B1 replication. Lingonberry, strawberry, and bilberry extracts also inhibited the InfV A virus. All of the anthocyanins fractions of wild berries had a potent effect and inhibited the replication of InfV A; however, they did not show any significant activity against the other tested viruses (<xref rid="B172" ref-type="bibr">Nikolaeva-Glomb et al., 2014</xref>). A straight relationship was perceived between the antiviral activity of berry extracts and total polyphenol content (<xref rid="B206" ref-type="bibr">Sekizawa et al., 2013</xref>). Searches demonstrated that components of berry fruits might inhibit replication of the virus even directly and indirectly, first by blocking surface gps of InfV and second by stimulating the organism immune system (<xref rid="B65" ref-type="bibr">Gramza-Micha&#x00142;owska et al., 2017</xref>). Considering the attained results, wildberry is an auspicious source of anthocyanins to combat viral infections.</p></sec><sec id="s6_3_6"><title>
<italic>Rubus coreanus</italic> Miq.</title><p>The outcomes of HPLC-PDA-MS/MS analysis of the anthocyanins extracted from <italic>Rubus coreanus</italic> (Bokbunja, black raspberry) exhibited the presence of some anthocyanin structures, which were tentatively identified as cyanidin 3-<italic>O</italic>-xylosylrutinoside, 3-<italic>O</italic>-sambubioside, cyanidin 3-<italic>O</italic>-rutinoside, delphinidin 3-<italic>O</italic>-rutinoside, delphinidin 3-<italic>O</italic>-glucuronide and pelargonidin 3-<italic>O</italic>-rutinoside (<xref rid="B121" ref-type="bibr">Ku and Mun, 2008</xref>). In their study on the black raspberry (RCS) seed enriched with a high amount of polyphenolic compounds, Lee et al. reported the antiviral activity of RCS fraction (RCS-F1) and the total extract against food-borne viral feline calicivirus-F9 (FCV-F9), murine norovirus-1 (MNV-1), and surrogates (FBVS). The highest antiviral activity was reported when both the extract and fractions were added together to infected cells with FCV-F9 or MNV-1, which resulted in a complete inhibition. The results showed that the RCS-F1 disrupted viral capsids and their expansion, and impaired the attachment to the surface protein of host cells. Moreover, one anthocyanin called cyanidin-3-glucoside (C3G) was isolated from RCS-F1 that showed inhibitory activity against the viruses. The mechanism of action of C3G is through binding to RNA polymerase of MNV-1 and expansion of viral capsids (<xref rid="B128" ref-type="bibr">Lee et al., 2016a</xref>). In BALB/c mice, black raspberry also reduced the viral titers of Inflv A and B in the lungs and improved the survival rate (<xref rid="B129" ref-type="bibr">Lee et al., 2016b</xref>), which may be related to the anthocyanins as sources of active ingredients target viruses. As Oh reported, RCS inhibited noroviruses and caliciviruses infection, probably through inhibiting their entry or attachment to the cellular receptor (<xref rid="B175" ref-type="bibr">Oh et al., 2012</xref>). In another study, RCS was found to exhibit antiviral activities against InfV A and B. The findings showed that RCS binds to hemagglutinin protein, significantly inhibits hemagglutination and disrupts viral particles (<xref rid="B129" ref-type="bibr">Lee et al., 2016b</xref>). In general, such research provided <italic>R. coreanus</italic> as a prospective plant and its cyanidin derivatives with potential use in the prevention and treatment of viral disease.</p></sec><sec id="s6_3_7"><title>
<italic>Morus alba</italic> L.</title><p>Cyanidin hexoside, cyanidin rhamnosylhexoside, cyanidin galloylhexoside, petunidin rhamnosylhexoside, pelargonidin hexoside, delphinidin hexoside, and delphinidin acetylhexoside as a part of anthocyanins, were reported in the extracts of mulberry (known as <italic>Morus alba</italic> (MA)) fruits with different distributions and contents (<xref rid="B167" ref-type="bibr">Nati&#x00107; et al., 2015</xref>). MA belongs to the Moraceae family, with antiviral activity to combat hepatitis B and C viruses (<xref rid="B90" ref-type="bibr">Jacob et al., 2007</xref>). Kim et al. studied the antiviral activities of MA and its juice (MAJ) and seed (MAS). MAJ fixed the glutathion (GSH) levels in the infected cells and showed ferric ion-reducing and DPPH radical scavenging activities. In the phenolic compound of MAJ, cyanidin-3-rutinoside had the highest amount and indicated a weak inhibition against InfV B in pre-treatment stage. The suggested mechanism of action of this extract against InfV would be a direct inhibition at the phase of attachment or internalization and intervention with the ROS-mediated cell damage caused by InfV infection. Finally, the results suggested that MAJ was more potential to be considered as a lead compound with antiviral activity against pre- and co-treatment but not post-treatment stage of InfV with no cytotoxicity against MDCK cells (<xref rid="B105" ref-type="bibr">Kim and Chung, 2018</xref>). In other research, MAS and MAJ also showed antiviral effects against foodborne viral surrogates (<xref rid="B127" ref-type="bibr">Lee et al., 2014</xref>). Nam et al. studied the anti-inflammatory properties of mulberry extract (ME) against adenovirus 36 (Ad36) in mice. The mixture of ME compound (1-deoxynojirimycin, kuromanin chloride, and resveratrol) and ME inhibited the virus replication by 50% and 70%, in contrast with the control group. Moreover, the ME reduced the pro-inflammatory cytokines, like monocyte chemoattractant protein&#x02010;1 (MCP-1) and TNF-&#x003b1;, and also decreased the concentration of macrophages and infiltrating immune cells in the fat layers of epiderm. Therefore, it can be concluded that the dietary ME might lead to prevention or treatment of obesity and inflammation caused by Ad36 (<xref rid="B164" ref-type="bibr">Na et al., 2014</xref>). Therefore, the authors asserted that MAJ might be useful in the prevention of foodborne viral infection, treatment of obesity and inflammation caused by Ad36 and may have a prosperous future in the prevention and treatment of viral disease.</p></sec><sec id="s6_3_8"><title>
<italic>Vaccinium macrocarpon</italic> Aiton</title><p>Several studies revealed the antiviral properties of cranberry (<italic>Vaccinium macrocarpon</italic>) (<xref rid="B171" ref-type="bibr">Nijveldt et al., 2001</xref>; <xref rid="B29" ref-type="bibr">C&#x000f4;t&#x000e9; et al., 2010</xref>). Cyanidin-3-galactoside, cyanidin-3-glucoside, cyanidin-3-arabinoside, peonidin-3-galactoside, peonidin-3-glucoside, and peonidin-3-arabinoside were reported as the anthocyanin content of four cultivars of cranberry by P. <xref rid="B238" ref-type="bibr">Viskelis et al. (2009)</xref>. In their study, Lipson et al. assessed the antiviral effects of cranberry juice (CJ) on unconnected viral species. The treatment of bacteriophage T2 (BT2) with CJ showed no detectable virus infection. Like BT2, almost identical data were reported for the bacteriophage T4 (BT4). The inactivation of BT4 by CJ was fast and dose dependent. Further studies determined the antiviral effect of CJ against a simian rotavirus SA-11. CJ is closely connected to the adsorption phase of the replication in virus. In addition, inhibition of hemagglutinin occurred at a 20% concentration of CJ that was treated with simian rotavirus SA-11 (<xref rid="B141" ref-type="bibr">Lipson et al., 2007</xref>). In another study, CJ inhibited InfV A and B adhesion to cells, and subsequent infectivity (<xref rid="B244" ref-type="bibr">Weiss et al., 2005</xref>). As an antiviral agent, CJ suggested being considered as an effective viral system to that of a mammalian enteric virus. The findings indicate that the inhibitory effect of CJ on InfV adhesion and infectivity may have therapeutic potential and may be a suitable natural extract for viral diseases.</p></sec><sec id="s6_3_9"><title>
<italic>Vitis vinifera</italic> L.</title><p>Delphinidin, cyanidin, petunidin, peonidin, malvidin, and their glycosides were introduced as major anthocyanin composition of fruit of <italic>Vitis vinifera</italic> (grape) (<xref rid="B28" ref-type="bibr">Cortell et al., 2007</xref>). In a research study on grape seed extract (GSE), Joshi et al. examined its antiviral effects against three viruses: feline calicivirus (FCV-F9), murine norovirus (MNV-1), and hepatitis A virus (HAV). They also studied the activity of GSE in 2% milk, apple juice (AJ), gastric juice (GJ), and water conditions at 37 &#x000b0;C. The antiviral activity of GSE was dose-dependent and enhanced with time. The GSE possessed some mild activities at the viral adsorption stage of viruses with minor activity on the replication stage. GSE also showed positive effects on foodborne viral diseases (<xref rid="B97" ref-type="bibr">Joshi et al., 2015</xref>). Previously, GSE was evaluated on the adsorption and replication phases of MNV-1, FCV-F9, and HAV prior to a viral infection was evaluated for GSE, which resulted in the decrement of viruses titer (<xref rid="B217" ref-type="bibr">Su and D&#x02019;Souza, 2011</xref>). Similarly, GSE meaningfully down-regulated the expression of CCR2,3,5 as coreceptors of HIV entry, which interfered with the binding of the viruses and their entry into the cells (<xref rid="B165" ref-type="bibr">Nair et al., 2002a</xref>). In the other study, GSE indicated antiviral effects by producing Th1-derived cytokine interferon- &#x003b3; (IFN-&#x003b3;) through peripheral mononuclear cells, proposing that the effective immunostimulatory activity of GSE might be mediated through IFN-&#x003b3; induction (<xref rid="B166" ref-type="bibr">Nair et al., 2002b</xref>). Therefore, considering the cost-effectiveness and broad-spectrum effects of GSE showed potential for use in the viral infections and also food quality and safety.</p></sec><sec id="s6_3_10"><title>
<italic>Theobroma cacao</italic> L.</title><p>Cyanidin-3-arabinoside and cyanidin-3-galactoside were found as two major anthocyanins in cocoa seeds (CS), which contained 0.02&#x02013;0.4% of defatted CS powder (<xref rid="B170" ref-type="bibr">Niemenak et al., 2006</xref>). Kamei et al. investigated the antiviral activity of CS and showed which it was dose-dependently effective against, InfV A, InfV B, and avian InfV. The extract&#x02019;s mechanism of action was the inhibition of the adsorption phase of viruses. In a mice model, CS significantly increased the survival after exposure to an intra-nasal lethal dose of InfV. On the other hand and to examine the antiviral properties of CS in the human model, the natural killer (NK) cell activity and the titers of neutralizing antibody against InfV A were evaluated. The results suggested that the NK cell activity was increased; though the improvement was more considerable in the treated group. The titers of neutralizing antibody were considerably enhanced in treated and control groups; however, the enhancements were not significantly different between the groups. Finally, CS and its derivatives improved the immune system responses and procured more potent protection against InfV disease (<xref rid="B98" ref-type="bibr">Kamei et al., 2016</xref>). In another study, the anti-HIV activity of cacao husk was evaluated. The finding showed cacao husk extract inhibited the HIV-1 cytopathic effect against MT-2 and MT-4 (HTLV-1 transformed T-cell lines), syncytium formation between HIV-infected and uninfected MOLT-4 cell line (<xref rid="B229" ref-type="bibr">Unten et al., 1991</xref>). Moreover, other research has shown the anti-inflammatory effects of cocoa produces (<xref rid="B41" ref-type="bibr">Di Giuseppe et al., 2008</xref>; <xref rid="B207" ref-type="bibr">Selmi et al., 2008</xref>). Altogether, according to the results, T. cacao is a promising plant containing anthocyanins to tackle viral infections.</p></sec><sec id="s6_3_11"><title>
<italic>Lycium barbarum</italic> L.</title><p>The anthocyanin content of <italic>Lycium barbarum</italic> (wolfberry) were reported by Zheng et al., including petunidin-3-<italic>O</italic>-galactoside-5-<italic>O</italic>-glucoside, petunidin-3-<italic>O</italic>-glucoside-5-<italic>O</italic>-glucoside, delphinidin-3-<italic>O</italic>-rutinoside(<italic>cis</italic>-<italic>p</italic>-coumaroyl)-5-<italic>O</italic>-glucoside, delphinidin-3-<italic>O</italic>-rutinoside (<italic>trans</italic>-<italic>p</italic>-coumaroyl)-5-<italic>O</italic>-glucoside, petunidin-3-<italic>O</italic>-rutinoside (caffeoyl)-5-<italic>O</italic>-glucoside, petunidin-3-<italic>O</italic>-rutinoside (<italic>cis</italic>-<italic>p</italic>-coumaroyl)-5-<italic>O</italic>-glucoside, petunidin-3-<italic>O</italic>-rutinoside (<italic>trans</italic>-<italic>p</italic>-coumaroyl acid)-5-<italic>O</italic>-glucoside, petunidin-3-<italic>O</italic>-glucoside (malonyl)-5-<italic>O</italic>-glucoside, petunidin-3-<italic>O</italic>-rutinoside (feruloyl)-5-<italic>O</italic>-glucoside, and malvidin-3-<italic>O</italic>-rutinoside (<italic>cis</italic>-<italic>p</italic>-coumaroyl)-5-<italic>O</italic>-glucoside (<xref rid="B271" ref-type="bibr">Zheng et al., 2011</xref>). Studies have shown the several health-promoting properties of wolfberry (<xref rid="B188" ref-type="bibr">Potterat, 2010</xref>). In their trial, Ren et al. studied the effect of <italic>L. barbarum</italic> on the improvement of mice immune system response. According to the results, lacto-wolfberry (LWB) supplementation reduced the pathology and symptoms of InfV infection through attenuation of inflammatory cytokines, such as TNF&#x003b1; and IL-6, in the mice that were nourished with LWB for four weeks and thereupon treated with InfV A while maintaining the same diet. However, it raised IL-2 through increasing the systemic lymphocyte T (<xref rid="B196" ref-type="bibr">Ren et al., 2012</xref>). In this regard, other reports have also consisted of the modulatory effects of wolfberry on the immune system (<xref rid="B106" ref-type="bibr">Kim et al., 2000</xref>; <xref rid="B135" ref-type="bibr">Li et al., 2011</xref>). The immunomodulating properties of wolfberry may increase the host&#x02019;s defense against viral infection; though, the scientific mark is lacking.</p></sec><sec id="s6_3_12"><title>
<italic>Aronia melanocarpa</italic> (Michx.) Elliott</title><p>Cyanidin 3-<italic>O</italic>-galactoside, cyanidin 3-<italic>O</italic>-glucoside, cyanidin 3-<italic>O</italic>-arabinoside, and cyanidin 3-<italic>O</italic>- xyloside were of the anthocyanins from fruits of chokeberry (<italic>Aronia melanocarpa</italic>) and were revealed by <xref rid="B177" ref-type="bibr">Oszmiansk and Sapis (1988)</xref>. The most-observed anthocyanins in <italic>A. melanocarpa</italic> fruit juice (AMFJ) were cyanidins, which were mainly in the form of aglycone (<xref rid="B231" ref-type="bibr">Valcheva-Kuzmanova et al., 2003</xref>). Valcheva-Kuzmanova et al. reported that AMFJ, rich in anthocyanins, decreased the activity of hemagglutination of two InfV subtypes. The OH group in location 3 was shown to be responsible for the pharmacological antiviral mechanism of <italic>A. melanocarpa</italic> anthocyanins to the highest inhibition level of HSV-1 replication (<xref rid="B247" ref-type="bibr">Wleklik et al., 1988</xref>; <xref rid="B8" ref-type="bibr">Bae et al., 2000</xref>). According to the results, the complex formation between the virion and anthocyanins influenced the adsorption stage of InfV infection (<xref rid="B231" ref-type="bibr">Valcheva-Kuzmanova et al., 2003</xref>). In another study, the anti-infV activity of chokeberry was evaluated. This plant showed cross-reactivity against InfV through anti-hemagglutinin activity by masking the hemagglutinin head in a non-specific circumstance. It is also inhibiting the viral proteins, which are impressing the maturation by blocking cellular signaling pathway (<xref rid="B181" ref-type="bibr">Park et al., 2013</xref>). So, in viral infections, promising effects might be expected from AMFJ through stimulation of the immune system.</p></sec><sec id="s6_3_13"><title>
<italic>Punica granatum</italic> L.</title><p>Pomegranate (<italic>Punica granatum</italic>) is a rich source of anthocyanins (<xref rid="B131" ref-type="bibr">Legua et al., 2016</xref>). Delphinidin-3,5-diglucoside is known as a major anthocyanin in pomegranate juice, and cyanidin-3,5-diglucoside, pelargonidin-3,5-diglucoside, delphinidin-3-glucoside, cyanidin-3-glucoside, pelargonidin-3-galactoside, and pelargonidin-3-glucoside are in the next ranks (<xref rid="B47" ref-type="bibr">Du et al., 1975</xref>). Moradi et al. examined the pomegranate peel extract (PPE) activity against adenovirus through using MTT assay with Hela cell line, and the extract was assumed to possess anti-adenovirus agents (<xref rid="B162" ref-type="bibr">Moradi et al., 2015</xref>). Neurath et al. investigated the inhibitory activity of pomegranate juice (PJ) against HIV-1 of the cells, which was expressing the CD4 and CXCR4 receptors as coreceptors. PJ acts directly through inhibiting the both HIV-1 and the virus receptor: CXCR4 as a coreceptor with the highest inhibitory effect. Actually, PJ inhibited the binding of CD4 to the gp120 of HIV-1 envelope. According to the evidence, it has been suggested that the PJ ingredients bound irreversibly or strongly to the binding site of CD4 on gp120 to inhibit the early stages of virus replication. It also possessed inhibitors of HIV-1 that were targeted by the gp120 virus envelope belonging to a class of antiretroviral drugs, the development of which is quite rare (<xref rid="B168" ref-type="bibr">Neurath et al., 2004</xref>). Altogether, the results suggest <italic>P. granatum</italic> as an inexpensive and safe anti-HIV-1 fruit with widely available sources.</p></sec><sec id="s6_3_14"><title>Lamiaceae Family</title><p>As used in traditional and complementary medicine, the Lamiaceae family are used with outstanding antiviral activity (<xref rid="B25" ref-type="bibr">Cohen et al., 1964</xref>; <xref rid="B44" ref-type="bibr">Dimitrova et al., 1993</xref>), but there is still a lack of information regarding the antiviral effects of many plants of the Lamiaceae family (<xref rid="B91" ref-type="bibr">Jassim and Naji, 2003</xref>). The Lamiaceae family, like sage, basil, and thyme, has long been assessed as a rich source of unique and diverse anthocyanins. Several anthocyanin structures were isolated, consisting of cyanidin and peonidin-based pigments, such as cyanidin 3,5-diglucoside, cyanidin 3-glucoside, cyanidin based, <italic>p</italic>-coumaryl and malonyl acids, peonidin 3,5-diglucoside, peonidin 3-(<italic>p</italic>-coumarylglucoside)-5-glucoside and peonidin (aglycon) (<xref rid="B184" ref-type="bibr">Phippen and Simon, 1998</xref>). In their research study, Nolkemper et al. studied the activity of six species of the Lamiaceae family, including thyme (<italic>Thymus vulgaris</italic>), rosemary (<italic>Rosmarinus officinalis)</italic>, prunella (<italic>Prunella vulgaris)</italic>, peppermint (<italic>Mentha x piperita)</italic>, lemon balm (<italic>Melissa officinalis)</italic>, and sage (<italic>Salvia officinalis)</italic> against HSV. The inhibitory activities of phenolic compounds against HSV type 1 (HSV-1), type 2 (HSV-2), and HSV-1 acyclovir-resistant strain (ACV<sup>res</sup>) were assayed <italic>in vitro</italic>, which indicated a high antiviral effect against three strains of HSV time-dependently. According to the results, the extracts had efficacy in anti-HSV before adsorption stage and, in contrast, had no efficacy in the replication stage (<xref rid="B173" ref-type="bibr">Nolkemper et al., 2006</xref>). Therefore, the results offer a chance to use the Lamiaceae family for therapeutic application against viral diseases like HSV.</p></sec></sec><sec id="s6_4"><title>Purified Antiviral Anthocyanin</title><p>The antiviral findings suggest that purified anthocyanin isolated from rich-anthocyanin plants may have an effective role against viral infections (<xref rid="B91" ref-type="bibr">Jassim and Naji, 2003</xref>). Swaminathan et al. reported the anti-InfV effects of cyanidin-3-sambubioside (C3S) isolated from black elderberry (<italic>Sambucus nigra</italic>) extract. From the pharmacological mechanistic point of view and according to the molecular docking of this compound, it bound with the 430-cavity adjacent to the residues of InfV neuraminidase. Since this antiviral compound bound remote from Asp 151 and Glu 119, two residues known to regulate the neuraminidase resistance, this compound was shown to have potential as a new class of antiviral drugs against the InfV without this susceptibility (<xref rid="B218" ref-type="bibr">Swaminathan et al., 2013</xref>). In their following study on C3S, Kannan et al. indicated that it possessed a high inhibitory activity against H274Y mutation. The inhibitory activity of C3S, oseltamivir and their mechanisms against H274Y mutant-type (MT) and wild-type (WT), were clarified using the quantum chemical methods, molecular dynamics, and molecular docking reasons of drug resistance. Oseltamivir was found to have less binding affinity with MT, while C3S possessed more position and affinity with the proteins of MT and WT. The evidence suggested that C3S had a stronger binding affinity with MT based on the energy of electrostatic interaction and was more potent against the oseltamivir-resistant virus strains (<xref rid="B99" ref-type="bibr">Kannan and Kolandaivel, 2018</xref>). In another study, Calland et al. attempted to discover new and novel natural compounds with potent anti-HCV activity and quantify their mode of action. Amongst the eight selected compounds, delphinidin was found to belong to the anthocyanin family and be a proper choice as a new class of flaviviridae inhibitors. The mechanism of action of this compound is that it disrupts the HCV attachment and adsorption by using the E1E2 gp of the envelope of different genotypes for HCV harboring. The time-response activity of delphinidin was also evaluated, and it was shown that its activity against HCV occurred just in the inoculation phase (<xref rid="B15" ref-type="bibr">Calland et al., 2015</xref>).</p><p>V&#x000e1;zquez-Calvo et al. studied the effect of anthocyanin, delphinidin, and cyanidin on the viral infections of flaviviruses family, including west nile virus (WNV), dengue virus (DENV), and zika virus (ZIKV). The results showed that delphinidin reduced WNV. Further assays discovered that delphinidin generally interfered with the attachment, adsorption, and entrance stages of the viral cycle and has a direct effect on the virus particles executing a virucidal activity. The same inhibitory activity of WNV variants was reported with acidic pH variation in the endosomal system for viral fusion. It was also shown that anthocyanins exhibiting antiviral activity against WNV is initiated by a virucidal activity instead of an inhibitory activity of viral fusion that was dependent on pH. Delphinidin also decreased the viral activity of DENV and ZIKV. Finally, delphinidin was reported to disrupt the viral activity of three viruses of the flaviviruses family in the cell culture (<xref rid="B234" ref-type="bibr">V&#x000e1;zquez-Calvo et al., 2017</xref>).</p><p>Swaminathan et al. assessed the activity of cyanidin, delphinidin, pelargonidin as three anthocyanins against 430-cavity of InfV neuraminidase and their binding site using molecular docking and mass spectrometry. Regardless of structural similarity, these compounds had differences not only in the position but also in the number of OH groups in the benzyl substituent connected to the chromenylium ring. The precise distinction in the binding site features was exhibited by molecular docking and mass spectrometry. Delphinidin and cyanidin, with the most number of OH substituents, bound firmly and had more inhibitory properties than pelargonidin with only one OH substituent at 4&#x000b4; position. Finally, the position and number of OH groups of anthocyanins were shown to affect their antiviral activity (<xref rid="B219" ref-type="bibr">Swaminathan et al., 2014</xref>).</p><p>Finally, according to the importance of purified antiviral anthocyanin in combating viral diseases, clarifying the exact pharmacological mechanisms of action could pave the road for the treatment of viral infections.</p></sec><sec id="s6_5"><title>Therapeutic and Clinical Antiviral Application of Anthocyanins</title><p>In traditional medicine, plants such as elderberry (<italic>Sambucus nigra</italic> L.), has been used in treating the viral disease like colds and flu from past to present (<xref rid="B199" ref-type="bibr">Roxas and Jurenka, 2007</xref>). Some independent clinical trials proved a proper effect of elderberry extract against InfV A and B infection (<xref rid="B114" ref-type="bibr">Kong, 2009</xref>). In a randomized, double-blind, placebo-controlled study, elderberry extract (EBE) demonstrated a safe and therapeutic effect in the treatment of InfV A and B (<xref rid="B263" ref-type="bibr">Zakay-Rones et al., 2004</xref>). In another randomized, double-blind placebo-controlled clinical trial, the EBE significantly reduced the common cold symptoms, duration, and severity of cold episodes in air travelers (<xref rid="B224" ref-type="bibr">Tiralongo et al., 2016</xref>). Moreover, the anti-InfV activity of EBE extracts were approved in the other studies (<xref rid="B264" ref-type="bibr">Zakay-Rones et al., 1995</xref>; <xref rid="B115" ref-type="bibr">Konlee, 1998</xref>; <xref rid="B228" ref-type="bibr">Ulbricht et al., 2014</xref>). The efficacy of immune-modulating beverage, which is rich in polyphenols and anthocyanins on common cold and the associated symptoms was also investigated. The results showed that the group taking the verum drink exhibited a faster decrease in symptoms and sooner complaint-free compared to control group. Also, several findings revealed that the physical examination was remarkably amended (<xref rid="B205" ref-type="bibr">Sch&#x000fc;tz et al., 2010</xref>). <italic>Hippopha&#x000eb; rhamnoides</italic> L. (sea buckthorn) berries indicated an immunomodulatory activity and positive effects on health (<xref rid="B253" ref-type="bibr">Yang et al., 1999</xref>; <xref rid="B96" ref-type="bibr">Johansson et al., 2000</xref>; <xref rid="B49" ref-type="bibr">Eccleston et al., 2002</xref>; <xref rid="B61" ref-type="bibr">Geetha et al., 2002</xref>; <xref rid="B254" ref-type="bibr">Yang and Kallio, 2002</xref>; <xref rid="B46" ref-type="bibr">Dorhoi et al., 2006</xref>). In a double-blind, randomized, placebo-controlled trial, the antiviral effect of sea buckthorn berries was evaluated. The results showed no differences between the number or duration and prevention of common cold in receiving sea buckthorn berries group and placebo groups, however, resulted in a decrease in serum C-reactive protein (CRP), a marker of inflammation (<xref rid="B126" ref-type="bibr">Larmo et al., 2008</xref>).</p><p>Several other studies also showed the positive effects of plants containing anthocyanins on the number, duration, and symptoms of viral disease, especially common cold and flu (the studies are shown in <xref rid="T3" ref-type="table">
<bold>Table 3</bold>
</xref>).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Human clinical trial investigations on the effects of some plant containing anthocyanins in the treatments of viral infections.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" rowspan="1" colspan="1">Study</th><th valign="top" rowspan="1" colspan="1">Treatment</th><th valign="top" rowspan="1" colspan="1">Dosage</th><th valign="top" rowspan="1" colspan="1">Results</th></tr></thead><tbody><tr><td valign="top" rowspan="1" colspan="1">(<xref rid="B114" ref-type="bibr">Kong, 2009</xref>)</td><td valign="top" rowspan="1" colspan="1">InfV</td><td valign="top" rowspan="1" colspan="1">175 mg of the proprietary elderberry extract qid for 2 days </td><td valign="top" rowspan="1" colspan="1">28% of patients were void of all symptoms, 60% showed relief from some symptoms, and had only one or two mild symptoms</td></tr><tr><td valign="top" rowspan="1" colspan="1">(<xref rid="B263" ref-type="bibr">Zakay-Rones et al., 2004</xref>)</td><td valign="top" rowspan="1" colspan="1">InfV A and B </td><td valign="top" rowspan="1" colspan="1">15 mL of elderberry or placebo syrup qid for 5 days</td><td valign="top" rowspan="1" colspan="1">Symptoms were relieved on average 4 days earlier and lessen the use of rescue medication </td></tr><tr><td valign="top" rowspan="1" colspan="1">(<xref rid="B224" ref-type="bibr">Tiralongo et al., 2016</xref>)</td><td valign="top" rowspan="1" colspan="1">Common cold </td><td valign="top" rowspan="1" colspan="1">elderberry capsules (300 mg) or placebo bid from 10 to 2 days before travel and tid from 1 day before leaving home until 4/5 days after arriving at the destination </td><td valign="top" rowspan="1" colspan="1">No difference in cold episodes, lessen in duration of cold episode days and the average symptom score. </td></tr><tr><td valign="top" rowspan="1" colspan="1">(<xref rid="B264" ref-type="bibr">Zakay-Rones et al., 1995</xref>)</td><td valign="top" rowspan="1" colspan="1">InfV</td><td valign="top" rowspan="1" colspan="1">children received bid, and adults qid for 3 days of Sambucol<sup>&#x000ae;</sup> as a standardized elderberry extract</td><td valign="top" rowspan="1" colspan="1"> Improvement of the symptoms, including fever, within 2 days. A complete cure was achieved within 2 to 3 days. </td></tr><tr><td valign="top" rowspan="1" colspan="1">(<xref rid="B205" ref-type="bibr">Sch&#x000fc;tz et al., 2010</xref>)</td><td valign="top" rowspan="1" colspan="1">Common cold</td><td valign="top" rowspan="1" colspan="1">The 250 mL of the verum drink contained green tea, grape peel grape seed, shiitake mushroom extract as well as vitamin C, bid for 10 days.</td><td valign="top" rowspan="1" colspan="1">Faster decrease in symptoms and sooner complaint free and also several findings revealed that the physical examination was remarkably amended</td></tr><tr><td valign="top" rowspan="1" colspan="1">(<xref rid="B126" ref-type="bibr">Larmo et al., 2008</xref>)</td><td valign="top" rowspan="1" colspan="1">Common cold</td><td valign="top" rowspan="1" colspan="1">The daily dose of sea buckthorn product contained 16.7 mg of flavonol glycosides</td><td valign="top" rowspan="1" colspan="1">No prevention on common cold but<break/>reduction effect on CRP, a marker of inflammation</td></tr></tbody></table><table-wrap-foot><p>InfV, Influenza viruses; Bid, Two times a day; Qid, Four times a day; CRP, C-reactive protein.</p></table-wrap-foot></table-wrap></sec><sec id="s6_6"><title>The Limitations With Anthocyanins: How to Overcome?</title><p>The daily use of anthocyanins in the USA is estimated about 200 mg/day (<xref rid="B241" ref-type="bibr">Wang and Stoner, 2008</xref>). Although anthocyanins are ordinarily consumed in the guise of a meal, there is limited information about their bioavailability and pharmacokinetic. To comprehend the effectiveness of anthocyanins, determining the features of anthocyanin at the molecular level, their absorption (serum level), as well as urine concentration of anthocyanin red pigments after oral administration, is critical (<xref rid="B144" ref-type="bibr">Lucioli, 2012</xref>). Following such intakes, the plasma concentrations of anthocyanins were found to be very low. Recent studies have revealed a rapid absorption followed by a quick metabolization and excretion of anthocyanins into urine and bile as methylated, glucuronidated or intact glycosides derivatives. Some clinical studies have shown that anthocyanins are absorbed with poor efficiency (<xref rid="B146" ref-type="bibr">Manach et al., 2005</xref>); however, an <italic>ex vivo</italic> study indicated their efficient absorption (<xref rid="B220" ref-type="bibr">Talavera et al., 2003</xref>).</p><p>In general, the <italic>in vivo</italic> bioavailability of anthocyanins was found to be about 0.26&#x02013;1.8% (<xref rid="B56" ref-type="bibr">Felgines et al., 2002</xref>; <xref rid="B55" ref-type="bibr">Felgines et al., 2003</xref>; <xref rid="B85" ref-type="bibr">Ichiyanagi et al., 2006</xref>; <xref rid="B151" ref-type="bibr">Matsumoto et al., 2006</xref>; <xref rid="B11" ref-type="bibr">Borges et al., 2007</xref>; <xref rid="B147" ref-type="bibr">Marczylo et al., 2009</xref>).</p><p>Maximum concentrations of anthocyanins are achieved after 1.5 h (plasma) and 2.5 h (urine) (<xref rid="B146" ref-type="bibr">Manach et al., 2005</xref>). The metabolites exist in the urine up until 24 h and may save the basic structure of anthocyanin (<xref rid="B101" ref-type="bibr">Kay et al., 2004</xref>). The urinary excretions of anthocyanins were estimated to be less than 0.1% in humans, while some studies reported up to 5% levels of anthocyanin excretion (<xref rid="B125" ref-type="bibr">Lapidot et al., 1998</xref>; <xref rid="B55" ref-type="bibr">Felgines et al., 2003</xref>). This demonstrates the extensive metabolism of anthocyanins in the body before their urine excretion (<xref rid="B53" ref-type="bibr">Fang, 2014</xref>). In general, the studies showed that anthocyanins are absorbed rapidly from stomach (<xref rid="B182" ref-type="bibr">Passamonti et al., 2003</xref>; <xref rid="B220" ref-type="bibr">Talavera et al., 2003</xref>) and small intestine (<xref rid="B160" ref-type="bibr">Miyazawa et al., 1999</xref>), and present in both blood and urine like intact, methylated, sulfate or glucuronide conjugated forms (<xref rid="B252" ref-type="bibr">Wu et al., 2002</xref>; <xref rid="B54" ref-type="bibr">Felgines et al., 2005</xref>). Anthocyanins are degraded rapidly by the microflora of the intestine so that they might be existing in the gastrointestinal tract (GIT). Although the degraded compounds are remarkably unstable in all circumstances, in the neutral pH, they are naturally changed into aldehydes and phenolic acids (<xref rid="B7" ref-type="bibr">Aura et al., 2005</xref>; <xref rid="B102" ref-type="bibr">Keppler and Humpf, 2005</xref>). There are different ways to enhance the stability and then the bioavailability of anthocyanins. Some studies showed that consumption of anthocyanin with foods influences the absorption and excretion phase. For instance, both rats and human, phytic acid hulls nuts components, grain and seeds (<xref rid="B40" ref-type="bibr">Dendougui and Schwedt, 2004</xref>), lead to enhance the bioavailability of blackcurrant anthocyanins (<xref rid="B152" ref-type="bibr">Matsumoto et al., 2007</xref>). Anthocyanins urinary recovery from rats was enhanced by increasing of phytic acid dose, which leads to the reduction of GIT mobility, decreases the anthocyanins passage through the GIT and finally plays a part in increasing the time for the absorption phase. Phytic acid also enhanced the levels of anthocyanin in human plasma and urine(<xref rid="B152" ref-type="bibr">Matsumoto et al., 2007</xref>). Another method to enhance the bioavailability of anthocyanins is the use of nanoformulations like nanoparticles, nanocomplexes, nanoliposomes, and nanoemulsions (<xref rid="B6" ref-type="bibr">Arroyo-Maya and McClements, 2015</xref>; <xref rid="B136" ref-type="bibr">Li et al., 2015</xref>; <xref rid="B77" ref-type="bibr">He et al., 2017</xref>; <xref rid="B20" ref-type="bibr">Chen and Stephen Inbaraj, 2019</xref>; <xref rid="B60" ref-type="bibr">Ge et al., 2019</xref>).</p></sec><sec id="s6_7"><title>Nano Formulation of Anthocyanins</title><p>Nano-medicine employs biodegradable and biocompatible nanoparticles to target administration routes, pharmacokinetics, and bioavailability of the target drug. Nanoparticles are regarded as sub-micron-sized particles with good dispersion, regular spherical shape, molecular forces, and surface chemical bonds (<xref rid="B202" ref-type="bibr">Sanvicens and Marco, 2008</xref>; <xref rid="B149" ref-type="bibr">Mart&#x000ed;nez-Ballesta et al., 2018</xref>). Nano-formulations could potentiate the existing drugs with antiviral activity through the positive modulation of pharmacokinetics and enhancement of bioavailability. Additionally, nano-medicine enhances the therapeutic window for antiviral medicines <italic>via</italic> exclusive targeting of specific sites (<xref rid="B89" ref-type="bibr">Jackman et al., 2016</xref>; <xref rid="B133" ref-type="bibr">Lembo et al., 2018</xref>).</p><p>Anthocyanins are extremely unstable hydrophilic compounds since their phenolic hydroxyl groups are easily oxidized into quinones. Moreover, they are precipitated by external factors like temperature or pH, which all affect their antiviral activities (<xref rid="B251" ref-type="bibr">Wu et al., 2018</xref>).</p><p>Encapsulating the anthocyanin into nanoparticles plays a significant role in overcoming this drawback and improving their antiviral properties (<xref rid="B3" ref-type="bibr">Amin et al., 2017</xref>; <xref rid="B2" ref-type="bibr">Ahsan et al., 2018</xref>). Protein encapsulation of procyanidins could attenuate their degradation under ultraviolet and other stressful conditions. According to Liu et al., nanocrystallization of anthocyanin potentiated the antioxidant capacity of pure proanthocyanidins under stressful conditions (<xref rid="B142" ref-type="bibr">Liu et al., 2017</xref>). These all clarify the critical role of nanocrystallization-induced improvement in the stability of anthocyanins (<xref rid="B6" ref-type="bibr">Arroyo-Maya and McClements, 2015</xref>; <xref rid="B269" ref-type="bibr">Zhang et al., 2019</xref>).</p><p>To enhance <italic>in vitro</italic> sustained-release characteristics, bioavailability and stability of anthocyanins, the nanocomplexes with chitosan hydrochloride (CHC), carboxymethyl chitosan (CMC) and &#x003b2;-Lactoglobulin (&#x003b2;-Lg) were provided. The results showed that nanocomplexes encapsulation significantly improved the stability and bioavailability of anthocyanins in simulated GIT (<xref rid="B60" ref-type="bibr">Ge et al., 2019</xref>). In another study, to improve the physicochemical stability of anthocyanins, nanoemulsion and nanoliposome were prepared. According to the results, nanoemulsion and nanoliposome enhance the anthocyanin stability and biological activity (<xref rid="B20" ref-type="bibr">Chen and Stephen Inbaraj, 2019</xref>). In this line, self-assembled nanoparticles were prepared by chitosan (CH) and chondroitin sulfate (CS) biopolymers to enhance the biological activity of black rice anthocyanin. The thermogravimetric analysis also proposed that the anthocyanin/CH/CS nanoparticles displayed high thermal stability. Significant increases in apoptosis by 12.1% and 35.1% were reported with 0.05&#x0202f;mg/ml anthocyanin and anthocyanin/CH/CS nanoparticles in the HCT-116 cell line, specifying that the nanoparticle system caused to considerable increase in apoptosis (<xref rid="B137" ref-type="bibr">Liang et al., 2019</xref>). In another study anthocyanins-loaded CHC/CMC nanocomplexes exhibited excellent stability against different temperature, different concentration of ascorbic acid, varying pH or white fluorescent light (<xref rid="B59" ref-type="bibr">Ge et al., 2018</xref>). Another investigation evaluated the bioavailability of anthocyanins-loaded nanoparticles to overcome their poor bioavailability. Based on results, pH-sensitive polymer along with the hydrophilic polymer exhibited suitable delivery system for anthocyanins. The anthocyanins delayed release profile, found in all formulations, can improve their poor bioavailability (<xref rid="B48" ref-type="bibr">Dupeyr&#x000f3;n et al., 2017</xref>). Polymer-based nanoparticles are of other approaches to enhance the bioavailability of unstable hydrophilic drugs like anthocyanins. This approach is due to the improved bioavailability and high stability. Encapsulating anthocyanins in poly lactic-co-glycolic acid (PLGA)-polyethylene glycol (PEG) nanoparticles did not ruin its natural properties and showed more potent neuroprotective properties (<xref rid="B3" ref-type="bibr">Amin et al., 2017</xref>). Altogether, the results suggest a practical approach to enhance the efficiency of anthocyanins in the form of nano-drug delivery systems.</p><p>In this regard, deployment of nanoparticles enables the controlled release of anthocyanins, enhances their biodistribution, protects them from degradation as a result of cellular metabolism and gastrointestinal digestion, and finally, allows them to target the specific sites affected by viruses (<xref rid="B149" ref-type="bibr">Mart&#x000ed;nez-Ballesta et al., 2018</xref>).</p></sec></sec><sec sec-type="conclusions" id="s7"><title>Conclusion</title><p>Natural medicine has always been considered as an excellent source against viral infections, and their discoveries would help to improve derivatives and lead-compounds to treat or even cure viral diseases. The development of novel plant-derived antiviral agents is among the top global priorities as viral infections have high mortality rates and are not yet curable.</p><p>In the present review, we highlighted the current antiviral approaches and alternative plant-derived antiviral compounds with related pharmacological mechanisms, while tackling particular attention to anthocyanins. We also focused our attention on the need to develop nanoformulation for anthocyanins in drug delivery systems to overcome the limitation with the bioavailability of anthocyanins. The potential of anthocyanin to show its antiviral effects through binding to host cells, inhibiting viral life cycle, or stimulating host immunity, strengthens the idea that anthocyanin would be an essential brick and a potential therapeutic agent to find novel antiviral lead-compounds.</p><p>Additional studies should include the investigation of other effective and novel plant-derived antiviral lead-compounds, with synergistic effects for a more favorable treatment outcome capable of enhancing immunity and reducing the cost, toxicity, and viral resistance, as well as finding their virus-specific targets and related pharmacological mechanisms of action. Synthetic campaigns could adjust these lead-compounds to find even more efficient drugs against several viral infections. Drug delivery must also be improved by new technologies using novel nano-formulation. Nonetheless, it is crucial to confirm the effects of plant-derived lead-compound in clinical trial studies.</p></sec><sec id="s8"><title>Author Contributions</title><p>Conceptualization: SF and MF. Designing the structure of the paper: SF and MF. Drafting the paper: PP, SF, SA, MF, and JE. Review and editing the paper: PP, SF, MF, and JE. Revising the paper: PP, SF, MF, and JE.</p></sec><sec sec-type="funding-information" id="s9"><title>Funding</title><p>JE gratefully acknowledges funding from CONICYT (PAI/ACADEMIA No. 79160109).</p></sec><sec id="s10"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec id="s11"><title>Abbreviations</title><p>HIV, human immunodeficiency virus; RSV, respiratory syncytial virus; NTCP, Na<sup>+</sup>/taurocholate co-transporting polypeptide; HBV, hepatitis B virus; HCV, hepatitis C virus; HDV, hepatitis D virus; InfV, Influenza virus; HSV-1/2, herpes simplex virus-1/2; NtRTIs, nucleotide reverse transcriptase inhibitors; NRTIs, nucleoside reverse transcriptase inhibitors; NNRTIs, non-nucleoside reverse transcriptase inhibitors; ORF, open reading frame; HAART, highly active antiretroviral therapy; NA, neuraminidase; NAIs, neuraminidase inhibitors; gp, glycoprotein; TLR-3 or 7, toll-like receptor-3 or 7; IFN&#x003b3;, interferon-gamma; PD-1, programmed death 1, CTLA-4, cytotoxic T-lymphocyte antigen 4; TIM-3, T-cell immunoglobulin and mucin domain-containing molecule 3; RNAi, RNA interference; siRNAs, small interfering RNAs; DDX3, Asp-Glu-Ala-Asp (DEAD)-box polypeptide 3; NS3h, non-structural protein 3 helicase; NS5B, non-structural protein 5B; VZV, varicella-zoster virus; NF-&#x0043a;B, nuclear factor-kappa B; PGC-1&#x003b1;, peroxisome proliferator-activated receptor gamma coactivator 1-alpha, EMCv, encephalomyocarditis virus; HHV-1, human herpes virus type 1; VACV-WR, vaccinia virus strains Western Reserve; SNS, <italic>Solanum nigrum</italic> seeds; TA, total anthocyanins content; RV, rabies virus, HPLC-DAD, High-performance liquid chromatography-diode array detector, CV-B1, coxsackievirus B1; PV-1 poliovirus type 1; HRSV-A2, human respiratory syncytial virus A2; FCV-F9, feline calicivirus-F9; MNV-1, murine norovirus-1; FBVS, foodborne virus surrogates; RCS, black raspberry seed; C3G, cyanidin-3-glucoside; MA, <italic>Morus alba</italic>; MAJ, <italic>Morus alba</italic> juice; MAS, <italic>Morus alba</italic> seed; Ad36, adenovirus 36; MCP-1, monocyte chemoattractant protein&#x02010;1; CJ, cranberry juice; BT2, bacteriophage T2; BT4, bacteriophage T4; GSE, grape seed extract; AJ, apple juice; GJ, gastric juice; CS, cocoa seeds; NK, natural killer cell; LWB, lacto-wolfberry; AMFJ, <italic>Aronia melanocarpa</italic> fruit juice; PJ, pomegranate juice; ACV<sup>res</sup>, HSV-1 acyclovir-resistant strain; WNV, west nile virus; DENV, dengue virus; ZIK, Zika virus; EBE, elderberry extract; CRP, c-reactive protein; Bid, two times a day; Qid, four times a day; GIT, gastrointestinal tract; CHC, chitosan hydrochloride; CMC, carboxymethyl chitosan; &#x003b2;-Lg, &#x003b2;-Lactoglobulin; CH, chitosan; CS, chondroitin sulfate; PLGA, poly lactic-co-glycolic acid; PEG, polyethylene glycol.</p></sec></body><back><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Adams</surname><given-names>J.</given-names></name><name><surname>Patel</surname><given-names>N.</given-names></name><name><surname>Mankaryous</surname><given-names>N.</given-names></name><name><surname>Tadros</surname><given-names>M.</given-names></name><name><surname>Miller</surname><given-names>C. D.</given-names></name></person-group> (<year>2010</year>). <article-title>Nonnucleoside reverse transcriptase inhibitor resistance and the role of the second-generation agents</article-title>. <source>Ann. Pharmacother.</source>
<volume>44</volume> (<issue>1</issue>), <fpage>157</fpage>&#x02013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1345/aph.1M359</pub-id>
<pub-id pub-id-type="pmid">19996323</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Ahsan</surname><given-names>S. M.</given-names></name><name><surname>Rao</surname><given-names>C. M.</given-names></name><name><surname>Ahmad</surname><given-names>M. F.</given-names></name></person-group> (<year>2018</year>). &#x0201c;<italic>Cellular and Molecular Toxicology of Nanoparticles.</italic>,&#x0201d; in <source>Nanoparticle-protein interaction: the significance and role of protein corona</source> (<publisher-loc>Cham</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>175</fpage>&#x02013;<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-72041-8_11</pub-id>
</mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amin</surname><given-names>F. U.</given-names></name><name><surname>Shah</surname><given-names>S. A.</given-names></name><name><surname>Badshah</surname><given-names>H.</given-names></name><name><surname>Khan</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>M. O.</given-names></name></person-group> (<year>2017</year>). <article-title>Anthocyanins encapsulated by PLGA @ PEG nanoparticles potentially improved its free radical scavenging capabilities <italic>via</italic> p38/JNK pathway against A&#x003b2; 1&#x02013;42-induced oxidative stress</article-title>. <source>J. Nanobiotechnol.</source>
<volume>15</volume> (<issue>1</issue>), <fpage>12</fpage>. <pub-id pub-id-type="doi">10.1186/s12951-016-0227-4</pub-id>
</mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Antoine</surname><given-names>T. E.</given-names></name><name><surname>Park</surname><given-names>P. J.</given-names></name><name><surname>Shukla</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics</article-title>. <source>Rev. Med. Virol.</source>
<volume>23</volume> (<issue>3</issue>), <fpage>194</fpage>&#x02013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1002/rmv.1740</pub-id>
<pub-id pub-id-type="pmid">23440920</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>G.</given-names></name><name><surname>Turriziani</surname><given-names>O.</given-names></name></person-group> (<year>2012</year>). <article-title>Antiviral therapy: old and current issues</article-title>. <source>Int. J. Antimicrob. Agents</source>
<volume>40</volume> (<issue>2</issue>), <fpage>95</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2012.04.005</pub-id>
<pub-id pub-id-type="pmid">22727532</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arroyo-Maya</surname><given-names>I. J.</given-names></name><name><surname>McClements</surname><given-names>D. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Biopolymer nanoparticles as potential delivery systems for anthocyanins: fabrication and properties</article-title>. <source>Food Res. Int.</source>
<volume>69</volume>, <fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodres.2014.12.005</pub-id>
</mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aura</surname><given-names>A.-M.</given-names></name><name><surname>Martin-Lopez</surname><given-names>P.</given-names></name><name><surname>O&#x02019;Leary</surname><given-names>K. A.</given-names></name><name><surname>Williamson</surname><given-names>G.</given-names></name><name><surname>Oksman-Caldentey</surname><given-names>K.-M.</given-names></name><name><surname>Poutanen</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>In vitro metabolism of anthocyanins by human gut microflora</article-title>. <source>Eur. J. Nutr.</source>
<volume>44</volume> (<issue>3</issue>), <fpage>133</fpage>&#x02013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1007/s00394-004-0502-2</pub-id>
<pub-id pub-id-type="pmid">15309431</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bae</surname><given-names>E.-A.</given-names></name><name><surname>Han</surname><given-names>M. J.</given-names></name><name><surname>Lee</surname><given-names>M.</given-names></name><name><surname>KIM</surname><given-names>D.-H.</given-names></name></person-group> (<year>2000</year>). <article-title>In vitro inhibitory effect of some flavonoids on rotavirus infectivity</article-title>. <source>Biol. Pharmaceut. Bull.</source>
<volume>23</volume> (<issue>9</issue>), <fpage>1122</fpage>&#x02013;<lpage>1124</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.23.1122</pub-id>
</mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bagchi</surname><given-names>D.</given-names></name><name><surname>Sen</surname><given-names>C.</given-names></name><name><surname>Bagchi</surname><given-names>M.</given-names></name><name><surname>Atalay</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula</article-title>. <source>Biochemistry (Mosc.)</source>
<volume>69</volume> (<issue>1</issue>), <fpage>75</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1023/B:BIRY.0000016355.19999.93</pub-id>
<pub-id pub-id-type="pmid">14972022</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Becker</surname><given-names>K.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Biller-Andorno</surname><given-names>N.</given-names></name></person-group> (<year>2006</year>). <article-title>Infectious diseases&#x02013;a global challenge</article-title>. <source>Int. J. Med. Microbiol.</source>
<volume>296</volume> (<issue>4&#x02013;5</issue>), <fpage>179</fpage>&#x02013;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijmm.2005.12.015</pub-id>
<pub-id pub-id-type="pmid">16446113</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Borges</surname><given-names>G.</given-names></name><name><surname>Roowi</surname><given-names>S.</given-names></name><name><surname>Rouanet</surname><given-names>J. M.</given-names></name><name><surname>Duthie</surname><given-names>G. G.</given-names></name><name><surname>Lean</surname><given-names>M. E.</given-names></name><name><surname>Crozier</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>The bioavailability of raspberry anthocyanins and ellagitannins in rats</article-title>. <source>Mol. Nutr. Food Res.</source>
<volume>51</volume> (<issue>6</issue>), <fpage>714</fpage>&#x02013;<lpage>725</lpage>. <pub-id pub-id-type="doi">10.1002/mnfr.200700024</pub-id>
<pub-id pub-id-type="pmid">17533654</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bowen-Forbes</surname><given-names>C. S.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Nair</surname><given-names>M. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Anthocyanin content, antioxidant, anti-inflammatory and anticancer properties of blackberry and raspberry fruits</article-title>. <source>J. Food Compost. Anal.</source>
<volume>23</volume> (<issue>6</issue>), <fpage>554</fpage>&#x02013;<lpage>560</lpage>. <pub-id pub-id-type="doi">10.1016/j.jfca.2009.08.012</pub-id>
</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Brouillard</surname><given-names>R.</given-names></name></person-group> (<year>1982</year>). <source>Chemical structure of anthocyanins</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Academic Press</publisher-name>. <pub-id pub-id-type="doi">10.1016/B978-0-12-472550-8.50005-6</pub-id>
</mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Calland</surname><given-names>N.</given-names></name><name><surname>Dubuisson</surname><given-names>J.</given-names></name><name><surname>Rouill&#x000e9;</surname><given-names>Y.</given-names></name><name><surname>S&#x000e9;ron</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Hepatitis C virus and natural compounds: a new antiviral approach</article-title>? <source>Viruses</source>
<volume>4</volume> (<issue>10</issue>), <fpage>2197</fpage>&#x02013;<lpage>2217</lpage>. <pub-id pub-id-type="doi">10.3390/v4102197</pub-id>
<pub-id pub-id-type="pmid">23202460</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Calland</surname><given-names>N.</given-names></name><name><surname>Sahuc</surname><given-names>M.-E.</given-names></name><name><surname>Belouzard</surname><given-names>S.</given-names></name><name><surname>P&#x000e8;ne</surname><given-names>V.</given-names></name><name><surname>Bonnafous</surname><given-names>P.</given-names></name><name><surname>Mesalam</surname><given-names>A. A.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Polyphenols inhibit hepatitis C virus entry by a new mechanism of action</article-title>. <source>J. Virol.</source>
<volume>89</volume> (<issue>19</issue>), <fpage>10053</fpage>&#x02013;<lpage>10063</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01473-15</pub-id>
<pub-id pub-id-type="pmid">26202241</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Castaneda-Ovando</surname><given-names>A.</given-names></name><name><surname>de Lourdes Pacheco-Hern&#x000e1;ndez</surname><given-names>M.</given-names></name><name><surname>P&#x000e1;ez-Hern&#x000e1;ndez</surname><given-names>M. E.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>J. A.</given-names></name><name><surname>Gal&#x000e1;n-Vidal</surname><given-names>C. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Chemical studies of anthocyanins: a review</article-title>. <source>Food Chem.</source>
<volume>113</volume> (<issue>4</issue>), <fpage>859</fpage>&#x02013;<lpage>871</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2008.09.001</pub-id>
</mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Champier</surname><given-names>G.</given-names></name><name><surname>Couvreux</surname><given-names>A.</given-names></name><name><surname>Hantz</surname><given-names>S.</given-names></name><name><surname>Rametti</surname><given-names>A.</given-names></name><name><surname>Mazeron</surname><given-names>M.-C.</given-names></name><name><surname>Bouaziz</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity</article-title>. <source>Antivir. Ther.</source>
<volume>13</volume>, <fpage>643</fpage>&#x02013;<lpage>654</lpage>. <pub-id pub-id-type="pmid">18771048</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>L.-Y.</given-names></name><name><surname>Tsao</surname><given-names>K.-C.</given-names></name><name><surname>Hsia</surname><given-names>S.-H.</given-names></name><name><surname>Shih</surname><given-names>S.-R.</given-names></name><name><surname>Huang</surname><given-names>C.-G.</given-names></name><name><surname>Chan</surname><given-names>W.-K.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan</article-title>. <source>JAMA</source>
<volume>291</volume> (<issue>2</issue>), <fpage>222</fpage>&#x02013;<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1001/jama.291.2.222</pub-id>
<pub-id pub-id-type="pmid">14722149</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chaponda</surname><given-names>M.</given-names></name><name><surname>Pirmohamed</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Hypersensitivity reactions to HIV therapy</article-title>. <source>Br. J. Clin. Pharmacol.</source>
<volume>71</volume> (<issue>5</issue>), <fpage>659</fpage>&#x02013;<lpage>671</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2125.2010.03784.x</pub-id>
<pub-id pub-id-type="pmid">21480946</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>B.-H.</given-names></name><name><surname>Stephen Inbaraj</surname><given-names>B.</given-names></name></person-group> (<year>2019</year>). <article-title>Nanoemulsion and nanoliposome based strategies for improving anthocyanin stability and bioavailability</article-title>. <source>Nutrients</source>
<volume>11</volume> (<issue>5</issue>), <fpage>1052</fpage>. <pub-id pub-id-type="doi">10.3390/nu11051052</pub-id>
</mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Dimitrov</surname><given-names>D. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Monoclonal antibody-based candidate therapeutics against HIV type 1</article-title>. <source>AIDS Res. Hum. Retroviruses</source>
<volume>28</volume> (<issue>5</issue>), <fpage>425</fpage>&#x02013;<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1089/aid.2011.0226</pub-id>
<pub-id pub-id-type="pmid">21827278</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="other">
<person-group person-group-type="author"><name><surname>Cheng</surname><given-names>H.-Y.</given-names></name><name><surname>Yang</surname><given-names>C.-M.</given-names></name><name><surname>Lin</surname><given-names>T.-C.</given-names></name><name><surname>Lin</surname><given-names>L.-T.</given-names></name><name><surname>Chiang</surname><given-names>L.-C.</given-names></name><name><surname>Lin</surname><given-names>C.-C.</given-names></name></person-group> (<year>2011</year>). <article-title>Excoecarianin, isolated from Phyllanthus urinaria Linnea, inhibits herpes simplex virus type 2 infection through inactivation of viral particles</article-title>. <source>Evid. Based Complement. Alternat. Med.</source>, <fpage>2011</fpage>. <pub-id pub-id-type="doi">10.1093/ecam/nep157</pub-id>
</mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chono</surname><given-names>K.</given-names></name><name><surname>Katsumata</surname><given-names>K.</given-names></name><name><surname>Kontani</surname><given-names>T.</given-names></name><name><surname>Kobayashi</surname><given-names>M.</given-names></name><name><surname>Sudo</surname><given-names>K.</given-names></name><name><surname>Yokota</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>ASP2151, a novel helicase&#x02013;primase inhibitor, possesses antiviral activity against varicella&#x02013;zoster virus and herpes simplex virus types 1 and 2</article-title>. <source>J. Antimicrob. Chemother.</source>
<volume>65</volume> (<issue>8</issue>), <fpage>1733</fpage>&#x02013;<lpage>1741</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkq198</pub-id>
<pub-id pub-id-type="pmid">20534624</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cisowska</surname><given-names>A.</given-names></name><name><surname>Wojnicz</surname><given-names>D.</given-names></name><name><surname>Hendrich</surname><given-names>A. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Anthocyanins as antimicrobial agents of natural plant origin</article-title>. <source>Nat. Prod. Commun.</source>
<volume>6</volume> (<issue>1</issue>), <fpage>149</fpage>&#x02013;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1177/1934578X1100600136</pub-id>
<pub-id pub-id-type="pmid">21366068</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cohen</surname><given-names>R. A.</given-names></name><name><surname>Kucera</surname><given-names>L. S.</given-names></name><name><surname>Herrmann</surname><given-names>E. C.</given-names><suffix>Jr.</suffix></name></person-group> (<year>1964</year>). <article-title>Antiviral Activity of Melissa officinalis (Lemon Balm) Extract</article-title>. <source>Proc. Soc. Exp. Biol. Med.</source>
<volume>117</volume> (<issue>2</issue>), <fpage>431</fpage>&#x02013;<lpage>434</lpage>. <pub-id pub-id-type="doi">10.3181/00379727-117-29600</pub-id>
<pub-id pub-id-type="pmid">14233461</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Colman</surname><given-names>P. M.</given-names></name></person-group> (<year>1994</year>). <article-title>Influenza virus neuraminidase: structure, antibodies, and inhibitors</article-title>. <source>Protein Sci.</source>
<volume>3</volume> (<issue>10</issue>), <fpage>1687</fpage>&#x02013;<lpage>1696</lpage>. <pub-id pub-id-type="doi">10.1002/pro.5560031007</pub-id>
<pub-id pub-id-type="pmid">7849585</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Colombo</surname><given-names>F.</given-names></name><name><surname>Di Lorenzo</surname><given-names>C.</given-names></name><name><surname>Regazzoni</surname><given-names>L.</given-names></name><name><surname>Fumagalli</surname><given-names>M.</given-names></name><name><surname>Sangiovanni</surname><given-names>E.</given-names></name><name><surname>Peres de Sousa</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Phenolic profiles and anti-inflammatory activities of sixteen table grape (<italic>Vitis vinifera</italic> L.) varieties</article-title>. <source>Food Funct.</source>
<volume>10</volume> (<issue>4</issue>), <fpage>1797</fpage>&#x02013;<lpage>1807</lpage>. <pub-id pub-id-type="doi">10.1039/C8FO02175A</pub-id>
<pub-id pub-id-type="pmid">30778463</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cortell</surname><given-names>J. M.</given-names></name><name><surname>Halbleib</surname><given-names>M.</given-names></name><name><surname>Gallagher</surname><given-names>A. V.</given-names></name><name><surname>Righetti</surname><given-names>T. L.</given-names></name><name><surname>Kennedy</surname><given-names>J. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Influence of vine vigor on grape (<italic>Vitis vinifera</italic> L. cv. Pinot Noir) anthocyanins. 1. Anthocyanin concentration and composition in fruit</article-title>. <source>J. Agric. Food Chem.</source>
<volume>55</volume> (<issue>16</issue>), <fpage>6575</fpage>&#x02013;<lpage>6584</lpage>. <pub-id pub-id-type="doi">10.1021/jf070195v</pub-id>
<pub-id pub-id-type="pmid">17636933</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>C&#x000f4;t&#x000e9;</surname><given-names>J.</given-names></name><name><surname>Caillet</surname><given-names>S.</given-names></name><name><surname>Doyon</surname><given-names>G.</given-names></name><name><surname>Sylvain</surname><given-names>J.-F.</given-names></name><name><surname>Lacroix</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Bioactive compounds in cranberries and their biological properties</article-title>. <source>Crit. Rev. Food Sci. Nutr.</source>
<volume>50</volume> (<issue>7</issue>), <fpage>666</fpage>&#x02013;<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1080/10408390903044107</pub-id>
<pub-id pub-id-type="pmid">20694928</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Danaher</surname><given-names>R. J.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Dai</surname><given-names>J.</given-names></name><name><surname>Mumper</surname><given-names>R. J.</given-names></name><name><surname>Miller</surname><given-names>C. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Antiviral effects of blackberry extract against herpes simplex virus type 1</article-title>. <source>Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol.</source>
<volume>112</volume> (<issue>3</issue>), <fpage>e31</fpage>&#x02013;<lpage>e35</lpage>. <pub-id pub-id-type="doi">10.1016/j.tripleo.2011.04.007</pub-id>
</mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dao</surname><given-names>T. T.</given-names></name><name><surname>Dang</surname><given-names>T. T.</given-names></name><name><surname>Nguyen</surname><given-names>P. H.</given-names></name><name><surname>Kim</surname><given-names>E.</given-names></name><name><surname>Thuong</surname><given-names>P. T.</given-names></name><name><surname>Oh</surname><given-names>W. K.</given-names></name></person-group> (<year>2012</year>). <article-title>Xanthones from Polygala karensium inhibit neuraminidases from influenza A viruses</article-title>. <source>Bioorg. Med. Chem. Lett.</source>
<volume>22</volume> (<issue>11</issue>), <fpage>3688</fpage>&#x02013;<lpage>3692</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2012.04.028</pub-id>
<pub-id pub-id-type="pmid">22552195</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dao</surname><given-names>T. T.</given-names></name><name><surname>Nguyen</surname><given-names>P. H.</given-names></name><name><surname>Lee</surname><given-names>H. S.</given-names></name><name><surname>Kim</surname><given-names>E.</given-names></name><name><surname>Park</surname><given-names>J.</given-names></name><name><surname>Lim</surname><given-names>S. I.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata</article-title>. <source>Bioorg. Med. Chem. Lett.</source>
<volume>21</volume> (<issue>1</issue>), <fpage>294</fpage>&#x02013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2010.11.016</pub-id>
<pub-id pub-id-type="pmid">21123068</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davies</surname><given-names>W.</given-names></name><name><surname>Grunert</surname><given-names>R.</given-names></name><name><surname>Haff</surname><given-names>R.</given-names></name><name><surname>McGahen</surname><given-names>J.</given-names></name><name><surname>Neumayer</surname><given-names>E.</given-names></name><name><surname>Paulshock</surname><given-names>M.</given-names></name><etal/></person-group> (<year>1964</year>). <article-title>Antiviral activity of 1-adamantanamine (amantadine)</article-title>. <source>Science</source>
<volume>144</volume> (<issue>3620</issue>), <fpage>862</fpage>&#x02013;<lpage>863</lpage>. <pub-id pub-id-type="doi">10.1126/science.144.3620.862</pub-id>
<pub-id pub-id-type="pmid">14151624</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de B&#x000e9;thune</surname><given-names>M.-P.</given-names></name></person-group> (<year>2010</year>). <article-title>Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989&#x02013;2009)</article-title>. <source>Antivir. Res.</source>
<volume>85</volume> (<issue>1</issue>), <fpage>75</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2009.09.008</pub-id>
<pub-id pub-id-type="pmid">19781578</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Britoa</surname><given-names>E. S.</given-names></name><name><surname>de Araujob</surname><given-names>M. C. P.</given-names></name><name><surname>Lin</surname><given-names>L.-Z.</given-names></name><name><surname>Harnly</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Determination of the flavonoid components of cashew apple (Anacardium occidentale) by LC-DAD-ESI/MS</article-title>. <source>Food Chem.</source>
<volume>105</volume>, <fpage>1112</fpage>&#x02013;<lpage>1118</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2007.02.009</pub-id>
<pub-id pub-id-type="pmid">25544795</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Clercq</surname><given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Antiviral agents active against influenza A viruses</article-title>. <source>Nat. Rev. Drug Discov.</source>
<volume>5</volume> (<issue>12</issue>), <fpage>1015</fpage>. <pub-id pub-id-type="doi">10.1038/nrd2175</pub-id>
<pub-id pub-id-type="pmid">17139286</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Clercq</surname><given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>The history of antiretrovirals: key discoveries over the past 25 years</article-title>. <source>Rev. Med. Virol.</source>
<volume>19</volume> (<issue>5</issue>), <fpage>287</fpage>&#x02013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1002/rmv.624</pub-id>
<pub-id pub-id-type="pmid">19714702</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Clercq</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>Current treatment of hepatitis B virus infections</article-title>. <source>Rev. Med. Virol.</source>
<volume>25</volume> (<issue>6</issue>), <fpage>354</fpage>&#x02013;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1002/rmv.1849</pub-id>
<pub-id pub-id-type="pmid">26205627</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Logu</surname><given-names>A.</given-names></name><name><surname>Loy</surname><given-names>G.</given-names></name><name><surname>Pellerano</surname><given-names>M. L.</given-names></name><name><surname>Bonsignore</surname><given-names>L.</given-names></name><name><surname>Schivo</surname><given-names>M. L.</given-names></name></person-group> (<year>2000</year>). <article-title>Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil</article-title>. <source>Antivir. Res.</source>
<volume>48</volume> (<issue>3</issue>), <fpage>177</fpage>&#x02013;<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-3542(00)00127-3</pub-id>
<pub-id pub-id-type="pmid">11164504</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dendougui</surname><given-names>F.</given-names></name><name><surname>Schwedt</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>In vitro analysis of binding capacities of calcium to phytic acid in different food samples</article-title>. <source>Eur. Food Res. Technol.</source>
<volume>219</volume> (<issue>4</issue>), <fpage>409</fpage>&#x02013;<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1007/s00217-004-0912-7</pub-id>
</mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Di Giuseppe</surname><given-names>R.</given-names></name><name><surname>Di Castelnuovo</surname><given-names>A.</given-names></name><name><surname>Centritto</surname><given-names>F.</given-names></name><name><surname>Zito</surname><given-names>F.</given-names></name><name><surname>De Curtis</surname><given-names>A.</given-names></name><name><surname>Costanzo</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Regular consumption of dark chocolate is associated with low serum concentrations of C-reactive protein in a healthy Italian population</article-title>. <source>J. Nutr.</source>
<volume>138</volume> (<issue>10</issue>), <fpage>1939</fpage>&#x02013;<lpage>1945</lpage>. <pub-id pub-id-type="doi">10.1093/jn/138.10.1939</pub-id>
<pub-id pub-id-type="pmid">18806104</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Di Sotto</surname><given-names>A.</given-names></name><name><surname>Di Giacomo</surname><given-names>S.</given-names></name><name><surname>Amatore</surname><given-names>D.</given-names></name><name><surname>Locatelli</surname><given-names>M.</given-names></name><name><surname>Vitalone</surname><given-names>A.</given-names></name><name><surname>Toniolo</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>A polyphenol rich extract from <italic>Solanum melongena</italic> L. DR2 peel exhibits antioxidant properties and anti-herpes simplex virus type 1 activity <italic>in vitro</italic></article-title>. <source>Molecules</source>
<volume>23</volume> (<issue>8</issue>), <fpage>2066</fpage>. <pub-id pub-id-type="doi">10.3390/molecules23082066</pub-id>
</mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Diaz-Mula</surname><given-names>H. M.</given-names></name><name><surname>Tomas-Barberan</surname><given-names>F. A.</given-names></name><name><surname>Garcia-Villalba</surname><given-names>R.</given-names></name></person-group> (<year>2019</year>). <article-title>Pomegranate fruit and juice (cv Mollar), rich in ellagitannins and anthocyanins, also provide a significant content of a wide range of proanthocyanidins</article-title>. <source>J. Agric. Food Chem.</source>
<volume>67</volume> (<issue>33</issue>), <fpage>9160</fpage>&#x02013;<lpage>9167</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.8b07155</pub-id>
<pub-id pub-id-type="pmid">30768267</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dimitrova</surname><given-names>Z.</given-names></name><name><surname>Dimov</surname><given-names>B.</given-names></name><name><surname>Manolova</surname><given-names>N.</given-names></name><name><surname>Pancheva</surname><given-names>S.</given-names></name><name><surname>Ilieva</surname><given-names>D.</given-names></name><name><surname>Shishkov</surname><given-names>S.</given-names></name></person-group> (<year>1993</year>). <article-title>Antiherpes effect of <italic>Melissa officinalis</italic> L. extracts</article-title>. <source>Acta Microbiol. Bulg.</source>
<volume>29</volume>, <fpage>65</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="pmid">8390134</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Diretto</surname><given-names>G.</given-names></name><name><surname>Jin</surname><given-names>X.</given-names></name><name><surname>Capell</surname><given-names>T.</given-names></name><name><surname>Zhu</surname><given-names>C.</given-names></name><name><surname>Gomez-Gomez</surname><given-names>L.</given-names></name></person-group> (<year>2019</year>). <article-title>Differential accumulation of pelargonidin glycosides in petals at three different developmental stages of the orange-flowered gentian (<italic>Gentiana lutea</italic> L. var. aurantiaca)</article-title>. <source>PLoS One</source>
<volume>14</volume> (<issue>2</issue>), <elocation-id>e0212062</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0212062</pub-id>
<pub-id pub-id-type="pmid">30742659</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A.</given-names></name><name><surname>Dobrean</surname><given-names>V.</given-names></name><name><surname>Z&#x00103;han</surname><given-names>M.</given-names></name><name><surname>Virag</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Modulatory effects of several herbal extracts on avian peripheral blood cell immune responses</article-title>. <source>Phytother. Res.</source>
<volume>20</volume> (<issue>5</issue>), <fpage>352</fpage>&#x02013;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.1859</pub-id>
<pub-id pub-id-type="pmid">16619362</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Du</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Francis</surname><given-names>F.</given-names></name></person-group> (<year>1975</year>). <article-title>Anthocyanins of pomegranate, Punica granatum</article-title>. <source>J. Food Sci.</source>
<volume>40</volume> (<issue>2</issue>), <fpage>417</fpage>&#x02013;<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2621.1975.tb02217.x</pub-id>
</mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dupeyr&#x000f3;n</surname><given-names>D.</given-names></name><name><surname>Kawakami</surname><given-names>M.</given-names></name><name><surname>Rieumont</surname><given-names>J.</given-names></name><name><surname>Carlos Carvalho</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Formulation and characterization of anthocyanins-loaded nanoparticles</article-title>. <source>Curr. Drug Deliv.</source>
<volume>14</volume> (<issue>1</issue>), <fpage>54</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.2174/1567201813666160915102151</pub-id>
<pub-id pub-id-type="pmid">27633261</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eccleston</surname><given-names>C.</given-names></name><name><surname>Baoru</surname><given-names>Y.</given-names></name><name><surname>Tahvonen</surname><given-names>R.</given-names></name><name><surname>Kallio</surname><given-names>H.</given-names></name><name><surname>Rimbach</surname><given-names>G. H.</given-names></name><name><surname>Minihane</surname><given-names>A. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Effects of an antioxidant-rich juice (sea buckthorn) on risk factors for coronary heart disease in humans</article-title>. <source>J. Nutr. Biochem.</source>
<volume>13</volume> (<issue>6</issue>), <fpage>346</fpage>&#x02013;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1016/S0955-2863(02)00179-1</pub-id>
<pub-id pub-id-type="pmid">12088800</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ehrhardt</surname><given-names>C.</given-names></name><name><surname>Dudek</surname><given-names>S. E.</given-names></name><name><surname>Holzberg</surname><given-names>M.</given-names></name><name><surname>Urban</surname><given-names>S.</given-names></name><name><surname>Hrincius</surname><given-names>E. R.</given-names></name><name><surname>Haasbach</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>A plant extract of Ribes nigrum folium possesses anti-influenza virus activity <italic>in vitro</italic> and <italic>in vivo</italic> by preventing virus entry to host cells</article-title>. <source>PloS One</source>
<volume>8</volume> (<issue>5</issue>), <elocation-id>e63657</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0063657</pub-id>
<pub-id pub-id-type="pmid">23717460</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elion</surname><given-names>G.</given-names></name></person-group> (<year>1993</year>). <article-title>Acyclovir: discovery, mechanism of action, and selectivity</article-title>. <source>J. Med. Virol.</source>
<volume>41</volume> (<issue>S1</issue>), <fpage>2</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.1890410503</pub-id>
</mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eron</surname><given-names>J.J.</given-names><suffix>Jr</suffix></name></person-group> (<year>2000</year>). <article-title>HIV-1 protease inhibitors</article-title>. <source>Clin. Infect. Dis.</source>
<volume>30</volume> (<issue>Supplement_2</issue>), <fpage>S160</fpage>&#x02013;<lpage>S170</lpage>. <pub-id pub-id-type="doi">10.1086/313853</pub-id>
<pub-id pub-id-type="pmid">10860901</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fang</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Bioavailability of anthocyanins</article-title>. <source>Drug Metab. Rev.</source>
<volume>46</volume> (<issue>4</issue>), <fpage>508</fpage>&#x02013;<lpage>520</lpage>. <pub-id pub-id-type="doi">10.3109/03602532.2014.978080</pub-id>
<pub-id pub-id-type="pmid">25347327</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Felgines</surname><given-names>C.</given-names></name><name><surname>Talavera</surname><given-names>S.</given-names></name><name><surname>Texier</surname><given-names>O.</given-names></name><name><surname>Gil-Izquierdo</surname><given-names>A.</given-names></name><name><surname>Lamaison</surname><given-names>J.-L.</given-names></name><name><surname>Remesy</surname><given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Blackberry anthocyanins are mainly recovered from urine as methylated and glucuronidated conjugates in humans</article-title>. <source>J. Agric. Food Chem.</source>
<volume>53</volume> (<issue>20</issue>), <fpage>7721</fpage>&#x02013;<lpage>7727</lpage>. <pub-id pub-id-type="doi">10.1021/jf051092k</pub-id>
<pub-id pub-id-type="pmid">16190623</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Felgines</surname><given-names>C.</given-names></name><name><surname>Talave&#x000b4;ra</surname><given-names>S.v.</given-names></name><name><surname>Gonthier</surname><given-names>M.-P.</given-names></name><name><surname>Texier</surname><given-names>O.</given-names></name><name><surname>Scalbert</surname><given-names>A.</given-names></name><name><surname>Lamaison</surname><given-names>J.-L.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Strawberry anthocyanins are recovered in urine as glucuro-and sulfoconjugates in humans</article-title>. <source>J. Nutr.</source>
<volume>133</volume> (<issue>5</issue>), <fpage>1296</fpage>&#x02013;<lpage>1301</lpage>. <pub-id pub-id-type="doi">10.1093/jn/133.5.1296</pub-id>
<pub-id pub-id-type="pmid">12730413</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Felgines</surname><given-names>C.</given-names></name><name><surname>Texier</surname><given-names>O.</given-names></name><name><surname>Besson</surname><given-names>C.</given-names></name><name><surname>Fraisse</surname><given-names>D.</given-names></name><name><surname>Lamaison</surname><given-names>J.-L.</given-names></name><name><surname>Re&#x000b4;me&#x000b4;sy</surname><given-names>C.</given-names></name></person-group> (<year>2002</year>). <article-title>Blackberry anthocyanins are slightly bioavailable in rats</article-title>. <source>J. Nutr.</source>
<volume>132</volume> (<issue>6</issue>), <fpage>1249</fpage>&#x02013;<lpage>1253</lpage>. <pub-id pub-id-type="doi">10.1093/jn/132.6.1249</pub-id>
<pub-id pub-id-type="pmid">12042441</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fumakia</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Gu</surname><given-names>J.</given-names></name><name><surname>Ho</surname><given-names>E. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Protein/peptide-based entry/fusion inhibitors as anti-HIV therapies: challenges and future direction</article-title>. <source>Rev. Med. Virol.</source>
<volume>26</volume> (<issue>1</issue>), <fpage>4</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1002/rmv.1853</pub-id>
<pub-id pub-id-type="pmid">26308574</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Garcia-Viguera</surname><given-names>C.</given-names></name><name><surname>Zafrilla</surname><given-names>P.</given-names></name><name><surname>Tom&#x000e1;s-Barber&#x000e1;n</surname><given-names>F. A.</given-names></name></person-group> (<year>1998</year>). <article-title>The use of acetone as an extraction solvent for anthocyanins from strawberry fruit</article-title>. <source>Phytochem. Anal.</source>
<volume>9</volume> (<issue>6</issue>), <fpage>274</fpage>&#x02013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1099-1565(199811/12)9:6&#x0003c;274::AID-PCA416&#x0003e;3.0.CO;2-G</pub-id>
</mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ge</surname><given-names>J.</given-names></name><name><surname>Yue</surname><given-names>P.</given-names></name><name><surname>Chi</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name></person-group> (<year>2018</year>). <article-title>Formation and stability of anthocyanins-loaded nanocomplexes prepared with chitosan hydrochloride and carboxymethyl chitosan</article-title>. <source>Food Hydrocoll.</source>
<volume>74</volume>, <fpage>23</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodhyd.2017.07.029</pub-id>
</mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ge</surname><given-names>J.</given-names></name><name><surname>Yue</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Chi</surname><given-names>J.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Nanocomplexes composed of chitosan derivatives and &#x003b2;-Lactoglobulin as a carrier for anthocyanins: preparation, stability and bioavailability <italic>in vitro</italic></article-title>. <source>Food Res. Int.</source>
<volume>116</volume>, <fpage>336</fpage>&#x02013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodres.2018.08.045</pub-id>
<pub-id pub-id-type="pmid">30716954</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Geetha</surname><given-names>S.</given-names></name><name><surname>Ram</surname><given-names>M. S.</given-names></name><name><surname>Singh</surname><given-names>V.</given-names></name><name><surname>Ilavazhagan</surname><given-names>G.</given-names></name><name><surname>Sawhney</surname><given-names>R.</given-names></name></person-group> (<year>2002</year>). <article-title>Anti-oxidant and immunomodulatory properties of seabuckthorn (Hippophae rhamnoides)&#x02014;an <italic>in vitro</italic> study</article-title>. <source>J. Ethnopharmacol.</source>
<volume>79</volume> (<issue>3</issue>), <fpage>373</fpage>&#x02013;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-8741(01)00406-8</pub-id>
<pub-id pub-id-type="pmid">11849845</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>Anthocyanins and anthocyanin-rich extracts in biology and medicine: biochemical, cellular, and medicinal properties</article-title>. <source>Curr. Topics Nutraceut. Res.</source>
<volume>3</volume>, <fpage>113</fpage>&#x02013;<lpage>124</lpage>. </mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gogineni</surname><given-names>V.</given-names></name><name><surname>Schinazi</surname><given-names>R. F.</given-names></name><name><surname>Hamann</surname><given-names>M. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Role of marine natural products in the genesis of antiviral agents</article-title>. <source>Chem. Rev.</source>
<volume>115</volume> (<issue>18</issue>), <fpage>9655</fpage>&#x02013;<lpage>9706</lpage>. <pub-id pub-id-type="doi">10.1021/cr4006318</pub-id>
<pub-id pub-id-type="pmid">26317854</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Goto</surname><given-names>T.</given-names></name></person-group> (<year>1987</year>). &#x0201c;<article-title>Fortschritte der Chemie organischer Naturstoffe/Progress in the Chemistry of Organic Natural Products</article-title>.,&#x0201d; in <source>Structure, stability and color variation of natural anthocyanins</source> (<publisher-loc>Vienna</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>113</fpage>&#x02013;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-7091-8906-1_3</pub-id>
</mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gramza-Micha&#x00142;owska</surname><given-names>A.</given-names></name><name><surname>Sidor</surname><given-names>A.</given-names></name><name><surname>Kulczy&#x00144;ski</surname><given-names>B.</given-names></name></person-group> (<year>2017</year>). <article-title>Berries as a potential anti-influenza factor&#x02013;A review</article-title>. <source>J. Funct. Foods</source>
<volume>37</volume>, <fpage>116</fpage>&#x02013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.jff.2017.07.050</pub-id>
</mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grinsztejn</surname><given-names>B.</given-names></name><name><surname>Nguyen</surname><given-names>B.-Y.</given-names></name><name><surname>Katlama</surname><given-names>C.</given-names></name><name><surname>Gatell</surname><given-names>J. M.</given-names></name><name><surname>Lazzarin</surname><given-names>A.</given-names></name><name><surname>Vittecoq</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial</article-title>. <source>Lancet</source>
<volume>369</volume> (<issue>9569</issue>), <fpage>1261</fpage>&#x02013;<lpage>1269</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(07)60597-2</pub-id>
<pub-id pub-id-type="pmid">17434401</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guan</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name></person-group> (<year>2005</year>). <article-title>Resistance to anti-influenza agents</article-title>. <source>Lancet</source>
<volume>366</volume> (<issue>9492</issue>), <fpage>1139</fpage>&#x02013;<lpage>1140</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(05)67340-0</pub-id>
<pub-id pub-id-type="pmid">16198748</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gubareva</surname><given-names>L. V.</given-names></name><name><surname>Kaiser</surname><given-names>L.</given-names></name><name><surname>Hayden</surname><given-names>F. G.</given-names></name></person-group> (<year>2000</year>). <article-title>Influenza virus neuraminidase inhibitors</article-title>. <source>Lancet</source>
<volume>355</volume> (<issue>9206</issue>), <fpage>827</fpage>&#x02013;<lpage>835</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(99)11433-8</pub-id>
<pub-id pub-id-type="pmid">10711940</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hakim</surname><given-names>M. S.</given-names></name><name><surname>Spaan</surname><given-names>M.</given-names></name><name><surname>Janssen</surname><given-names>H. L.</given-names></name><name><surname>Boonstra</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Inhibitory receptor molecules in chronic hepatitis B and C infections: novel targets for immunotherapy</article-title>? <source>Rev. Med. Virol.</source>
<volume>24</volume> (<issue>2</issue>), <fpage>125</fpage>&#x02013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1002/rmv.1779</pub-id>
<pub-id pub-id-type="pmid">24757728</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>H.-k.</given-names></name><name><surname>Vrueh, de</surname></name><name><surname>Rhie</surname><given-names>J. K.</given-names></name><name><surname>Covitz</surname><given-names>K.-M. Y.</given-names></name><name><surname>Smith</surname><given-names>P. L.</given-names></name><name><surname>Lee</surname><given-names>C.-P.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>5&#x02032;-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter</article-title>. <source>Pharmaceut. Res.</source>
<volume>15</volume> (<issue>8</issue>), <fpage>1154</fpage>&#x02013;<lpage>1159</lpage>. <pub-id pub-id-type="doi">10.1023/A:1011919319810</pub-id>
</mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hao</surname><given-names>B.-J.</given-names></name><name><surname>Wu</surname><given-names>Y.-H.</given-names></name><name><surname>Wang</surname><given-names>J.-G.</given-names></name><name><surname>Hu</surname><given-names>S.-Q.</given-names></name><name><surname>Keil</surname><given-names>D. J.</given-names></name><name><surname>Hu</surname><given-names>H.-J.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Hepatoprotective and antiviral properties of isochlorogenic acid A from Laggera alata against hepatitis B virus infection</article-title>. <source>J. Ethnopharmacol.</source>
<volume>144</volume> (<issue>1</issue>), <fpage>190</fpage>&#x02013;<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2012.09.003</pub-id>
<pub-id pub-id-type="pmid">22982394</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harborne</surname><given-names>J. B.</given-names></name></person-group> (<year>1967</year>). <article-title>Comparative biochemistry of the flavonoids-IV.: correlations between chemistry, pollen morphology and systematics in the family plumbaginaceae</article-title>. <source>Phytochemistry</source>
<volume>6</volume> (<issue>10</issue>), <fpage>1415</fpage>&#x02013;<lpage>1428</lpage>. <pub-id pub-id-type="doi">10.1016/S0031-9422(00)82884-8</pub-id>
</mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hassan</surname><given-names>S. T.</given-names></name><name><surname>&#x00160;udomov&#x000e1;</surname><given-names>M.</given-names></name><name><surname>Berchov&#x000e1;-B&#x000ed;mov&#x000e1;</surname><given-names>K.</given-names></name><name><surname>&#x00160;mejkal</surname><given-names>K.</given-names></name><name><surname>Echeverr&#x000ed;a</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Psoromic acid, a lichen-derived molecule, inhibits the replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA polymerase: shedding light on antiherpetic properties</article-title>. <source>Molecules</source>
<volume>24</volume> (<issue>16</issue>), <fpage>2912</fpage>. <pub-id pub-id-type="doi">10.3390/molecules24162912</pub-id>
</mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>K.</given-names></name><name><surname>Mori</surname><given-names>M.</given-names></name><name><surname>Knox</surname><given-names>Y. M.</given-names></name><name><surname>Suzutan</surname><given-names>T.</given-names></name><name><surname>Ogasawara</surname><given-names>M.</given-names></name><name><surname>Yoshida</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Anti influenza virus activity of a red-fleshed potato anthocyanin</article-title>. <source>Food Sci. Technol. Res.</source>
<volume>9</volume> (<issue>3</issue>), <fpage>242</fpage>&#x02013;<lpage>244</lpage>. <pub-id pub-id-type="doi">10.3136/fstr.9.242</pub-id>
</mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hayden</surname><given-names>F. G.</given-names></name><name><surname>Osterhaus</surname><given-names>A. D.</given-names></name><name><surname>Treanor</surname><given-names>J. J.</given-names></name><name><surname>Fleming</surname><given-names>D. M.</given-names></name><name><surname>Aoki</surname><given-names>F. Y.</given-names></name><name><surname>Nicholson</surname><given-names>K. G.</given-names></name><etal/></person-group> (<year>1997</year>). <article-title>Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections</article-title>. <source>N. Engl. J. Med.</source>
<volume>337</volume> (<issue>13</issue>), <fpage>874</fpage>&#x02013;<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199709253371302</pub-id>
<pub-id pub-id-type="pmid">9302301</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hazuda</surname><given-names>D. J.</given-names></name><name><surname>Felock</surname><given-names>P.</given-names></name><name><surname>Witmer</surname><given-names>M.</given-names></name><name><surname>Wolfe</surname><given-names>A.</given-names></name><name><surname>Stillmock</surname><given-names>K.</given-names></name><name><surname>Grobler</surname><given-names>J. A.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells</article-title>. <source>Science</source>
<volume>287</volume> (<issue>5453</issue>), <fpage>646</fpage>&#x02013;<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1126/science.287.5453.646</pub-id>
<pub-id pub-id-type="pmid">10649997</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>B.</given-names></name><name><surname>Ge</surname><given-names>J.</given-names></name><name><surname>Yue</surname><given-names>P.</given-names></name><name><surname>Yue</surname><given-names>X.</given-names></name><name><surname>Fu</surname><given-names>R.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Loading of anthocyanins on chitosan nanoparticles influences anthocyanin degradation in gastrointestinal fluids and stability in a beverage</article-title>. <source>Food Chem.</source>
<volume>221</volume>, <fpage>1671</fpage>&#x02013;<lpage>1677</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2016.10.120</pub-id>
<pub-id pub-id-type="pmid">27979145</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holt</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Friedman</surname><given-names>G.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Taupin</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 <italic>in vivo</italic></article-title>. <source>Nat. Biotechnol.</source>
<volume>28</volume> (<issue>8</issue>), <fpage>839</fpage>. <pub-id pub-id-type="doi">10.1038/nbt.1663</pub-id>
<pub-id pub-id-type="pmid">20601939</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holton</surname><given-names>T. A.</given-names></name><name><surname>Cornish</surname><given-names>E. C.</given-names></name></person-group> (<year>1995</year>). <article-title>Genetics and biochemistry of anthocyanin biosynthesis</article-title>. <source>Plant Cell</source>
<volume>7</volume> (<issue>7</issue>), <fpage>1071</fpage>. <pub-id pub-id-type="doi">10.2307/3870058</pub-id>
<pub-id pub-id-type="pmid">12242398</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Houttuynoids</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>anti-herpes simplex virus active flavonoids with novel skeletons from Houttuynia cordata/SD Chen H. Gao, QC Zhu [et al.]</article-title>. <source>Org. Lett.</source> (<issue>14</issue>), <fpage>7</fpage>. <pub-id pub-id-type="doi">10.1021/ol300017m</pub-id>
</mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Robinson</surname><given-names>J. L.</given-names></name></person-group> (<year>2010</year>). <article-title>Treatment of respiratory syncytial virus with palivizumab: a systematic review</article-title>. <source>World J. Pediatr.</source>
<volume>6</volume> (<issue>4</issue>), <fpage>296</fpage>&#x02013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1007/s12519-010-0230-z</pub-id>
<pub-id pub-id-type="pmid">21080142</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Ye</surname><given-names>W.</given-names></name><name><surname>Ooi</surname><given-names>V. E.</given-names></name><name><surname>Chung</surname><given-names>H. Y.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Antiviral biflavonoids from Radix wikstroemiae (Liaogewanggen)</article-title>. <source>Chin. Med.</source>
<volume>5</volume> (<issue>1</issue>), <fpage>23</fpage>. <pub-id pub-id-type="doi">10.1186/1749-8546-5-23</pub-id>
<pub-id pub-id-type="pmid">20565950</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hussein</surname><given-names>G.</given-names></name><name><surname>Miyashiro</surname><given-names>H.</given-names></name><name><surname>Nakamura</surname><given-names>N.</given-names></name><name><surname>Hattori</surname><given-names>M.</given-names></name><name><surname>Kakiuchi</surname><given-names>N.</given-names></name><name><surname>Shimotohno</surname><given-names>K.</given-names></name></person-group> (<year>2000</year>). <article-title>Inhibitory effects of Sudanese medicinal plant extracts on hepatitis C virus (HCV) protease</article-title>. <source>Phytother. Res.</source>
<volume>14</volume> (<issue>7</issue>), <fpage>510</fpage>&#x02013;<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1002/1099-1573(200011)14:7&#x0003c;510::AID-PTR646&#x0003e;3.0.CO;2-B</pub-id>
<pub-id pub-id-type="pmid">11054840</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huthoff</surname><given-names>H.</given-names></name><name><surname>Towers</surname><given-names>G. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Restriction of retroviral replication by APOBEC3G/F and TRIM5&#x003b1;</article-title>. <source>Trends Microbiol.</source>
<volume>16</volume> (<issue>12</issue>), <fpage>612</fpage>&#x02013;<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2008.08.013</pub-id>
<pub-id pub-id-type="pmid">18976920</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ichiyanagi</surname><given-names>T.</given-names></name><name><surname>Shida</surname><given-names>Y.</given-names></name><name><surname>Rahman</surname><given-names>M. M.</given-names></name><name><surname>Hatano</surname><given-names>Y.</given-names></name><name><surname>Konishi</surname><given-names>T.</given-names></name></person-group> (<year>2006</year>). <article-title>Bioavailability and tissue distribution of anthocyanins in bilberry (Vaccinium myrtillus L.) extract in rats</article-title>. <source>J. Agric. Food Chem.</source>
<volume>54</volume> (<issue>18</issue>), <fpage>6578</fpage>&#x02013;<lpage>6587</lpage>. <pub-id pub-id-type="doi">10.1021/jf0602370</pub-id>
<pub-id pub-id-type="pmid">16939312</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ikuta</surname><given-names>K.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name><name><surname>Kaneko</surname><given-names>H.</given-names></name><name><surname>Mori</surname><given-names>S.</given-names></name><name><surname>Ohashi</surname><given-names>K.</given-names></name><name><surname>Suzutani</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Anti-viral and anti-bacterial activities of an extract of blackcurrants (Ribes nigrum L.)</article-title>. <source>Microbiol. Immunol.</source>
<volume>56</volume> (<issue>12</issue>), <fpage>805</fpage>&#x02013;<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1111/j.1348-0421.2012.00510.x</pub-id>
<pub-id pub-id-type="pmid">22985050</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ikuta</surname><given-names>K.</given-names></name><name><surname>Mizuta</surname><given-names>K.</given-names></name><name><surname>Suzutani</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Anti-influenza virus activity of two extracts of the blackcurrant (<italic>Ribes nigrum</italic> L.) from New Zealand and Poland</article-title>. <source>Fukushima J. Med. Sci.</source>
<volume>59</volume> (<issue>1</issue>), <fpage>35</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.5387/fms.59.35</pub-id>
<pub-id pub-id-type="pmid">23842512</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iwashina</surname><given-names>T.</given-names></name></person-group> (<year>2000</year>). <article-title>The structure and distribution of the flavonoids in plants</article-title>. <source>J. Plant Res.</source>
<volume>113</volume> (<issue>3</issue>), <fpage>287</fpage>&#x02013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1007/PL00013940</pub-id>
</mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jackman</surname><given-names>J. A.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Cho</surname><given-names>N. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Nanomedicine for infectious disease applications: innovation towards broad-spectrum treatment of viral infections</article-title>. <source>Small</source>
<volume>12</volume> (<issue>9</issue>), <fpage>1133</fpage>&#x02013;<lpage>1139</lpage>. <pub-id pub-id-type="doi">10.1002/smll.201500854</pub-id>
<pub-id pub-id-type="pmid">26551316</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jacob</surname><given-names>J. R.</given-names></name><name><surname>Mansfield</surname><given-names>K.</given-names></name><name><surname>You</surname><given-names>J. E.</given-names></name><name><surname>Tennant</surname><given-names>B. C.</given-names></name><name><surname>Kim</surname><given-names>Y. H.</given-names></name></person-group> (<year>2007</year>). <article-title>Natural iminosugar derivatives of 1-deoxynojirimycin inhibit glycosylation of hepatitis viral envelope proteins</article-title>. <source>J. Microbiol.</source>
<volume>45</volume> (<issue>5</issue>), <fpage>431</fpage>&#x02013;<lpage>440</lpage>. <pub-id pub-id-type="pmid">17978803</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jassim</surname><given-names>S. A.</given-names></name><name><surname>Naji</surname><given-names>M. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Novel antiviral agents: a medicinal plant perspective</article-title>. <source>J. Appl. Microbiol.</source>
<volume>95</volume> (<issue>3</issue>), <fpage>412</fpage>&#x02013;<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2672.2003.02026.x</pub-id>
<pub-id pub-id-type="pmid">12911688</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Javed</surname><given-names>T.</given-names></name><name><surname>Ashfaq</surname><given-names>U. A.</given-names></name><name><surname>Riaz</surname><given-names>S.</given-names></name><name><surname>Rehman</surname><given-names>S.</given-names></name><name><surname>Riazuddin</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus</article-title>. <source>Virol. J.</source>
<volume>8</volume> (<issue>1</issue>), <fpage>26</fpage>. <pub-id pub-id-type="doi">10.1186/1743-422X-8-26</pub-id>
<pub-id pub-id-type="pmid">21247464</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jayaprakasam</surname><given-names>B.</given-names></name><name><surname>Vareed</surname><given-names>S. K.</given-names></name><name><surname>Olson</surname><given-names>L. K.</given-names></name><name><surname>Nair</surname><given-names>M. G.</given-names></name></person-group> (<year>2005</year>). <article-title>Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits</article-title>. <source>J. Agric. Food Chem.</source>
<volume>53</volume> (<issue>1</issue>), <fpage>28</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1021/jf049018+</pub-id>
<pub-id pub-id-type="pmid">15631504</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jeong</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>Y. M.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>J. Y.</given-names></name><name><surname>Park</surname><given-names>J.-Y.</given-names></name><name><surname>Park</surname><given-names>S.-J.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Homoisoflavonoids from Caesalpinia sappan displaying viral neuraminidases inhibition</article-title>. <source>Biol. Pharmaceut. Bull.</source>
<volume>35</volume> (<issue>5</issue>), <fpage>786</fpage>&#x02013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.35.786</pub-id>
</mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Z.-Y.</given-names></name><name><surname>Liu</surname><given-names>W.-F.</given-names></name><name><surname>Zhang</surname><given-names>X.-M.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>Y.-B.</given-names></name><name><surname>Chen</surname><given-names>J.-J.</given-names></name></person-group> (<year>2013</year>). <article-title>Anti-HBV active constituents from Piper longum</article-title>. <source>Bioorg. Med. Chem. Lett.</source>
<volume>23</volume> (<issue>7</issue>), <fpage>2123</fpage>&#x02013;<lpage>2127</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2013.01.118</pub-id>
<pub-id pub-id-type="pmid">23434420</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johansson</surname><given-names>A. K.</given-names></name><name><surname>Korte</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Stanley</surname><given-names>J. C.</given-names></name><name><surname>Kallio</surname><given-names>H. P.</given-names></name></person-group> (<year>2000</year>). <article-title>Sea buckthorn berry oil inhibits platelet aggregation</article-title>. <source>J. Nutr. Biochem.</source>
<volume>11</volume> (<issue>10</issue>), <fpage>491</fpage>&#x02013;<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1016/S0955-2863(00)00105-4</pub-id>
<pub-id pub-id-type="pmid">11120446</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Joshi</surname><given-names>S. S.</given-names></name><name><surname>Su</surname><given-names>X.</given-names></name><name><surname>D&#x02019;Souza</surname><given-names>D. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Antiviral effects of grape seed extract against feline calicivirus, murine norovirus, and hepatitis A virus in model food systems and under gastric conditions</article-title>. <source>Food Microbiol.</source>
<volume>52</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.fm.2015.05.011</pub-id>
<pub-id pub-id-type="pmid">26338111</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kamei</surname><given-names>M.</given-names></name><name><surname>Nishimura</surname><given-names>H.</given-names></name><name><surname>Takahashi</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Inokuchi</surname><given-names>K.</given-names></name><name><surname>Mato</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Anti-influenza virus effects of cocoa</article-title>. <source>J. Sci. Food Agric.</source>
<volume>96</volume> (<issue>4</issue>), <fpage>1150</fpage>&#x02013;<lpage>1158</lpage>. <pub-id pub-id-type="doi">10.1002/jsfa.7197</pub-id>
<pub-id pub-id-type="pmid">25847473</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kannan</surname><given-names>S.</given-names></name><name><surname>Kolandaivel</surname><given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus</article-title>. <source>J. Biomol. Struct. Dyn.</source>
<volume>36</volume> (<issue>16</issue>), <fpage>4255</fpage>&#x02013;<lpage>4269</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2017.1413422</pub-id>
<pub-id pub-id-type="pmid">29199545</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kawai</surname><given-names>A.</given-names></name><name><surname>Fujita</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Small red bean (azuki) sheds biologically active substances as a prerequisite step for germination, one of which displays the antiviral activity against the rabies virus infectivity and infections in culture</article-title>. <source>Microbiol. Immunol.</source>
<volume>51</volume> (<issue>11</issue>), <fpage>1071</fpage>&#x02013;<lpage>1079</lpage>. <pub-id pub-id-type="doi">10.1111/j.1348-0421.2007.tb04002.x</pub-id>
<pub-id pub-id-type="pmid">18037784</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kay</surname><given-names>C. D.</given-names></name><name><surname>Mazza</surname><given-names>G.</given-names></name><name><surname>Holub</surname><given-names>B. J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Anthocyanin metabolites in human urine and serum</article-title>. <source>Br. J. Nutr.</source>
<volume>91</volume> (<issue>6</issue>), <fpage>933</fpage>&#x02013;<lpage>942</lpage>. <pub-id pub-id-type="doi">10.1079/BJN20041126</pub-id>
<pub-id pub-id-type="pmid">15228048</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Keppler</surname><given-names>K.</given-names></name><name><surname>Humpf</surname><given-names>H.-U.</given-names></name></person-group> (<year>2005</year>). <article-title>Metabolism of anthocyanins and their phenolic degradation products by the intestinal microflora</article-title>. <source>Bioorg. Med. Chem.</source>
<volume>13</volume> (<issue>17</issue>), <fpage>5195</fpage>&#x02013;<lpage>5205</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2005.05.003</pub-id>
<pub-id pub-id-type="pmid">15963727</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khan</surname><given-names>M. T. H.</given-names></name><name><surname>Ather</surname><given-names>A.</given-names></name><name><surname>Thompson</surname><given-names>K. D.</given-names></name><name><surname>Gambari</surname><given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>Extracts and molecules from medicinal plants against herpes simplex viruses</article-title>. <source>Antivir. Res.</source>
<volume>67</volume> (<issue>2</issue>), <fpage>107</fpage>&#x02013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2005.05.002</pub-id>
<pub-id pub-id-type="pmid">16040137</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khan</surname><given-names>R.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Ali</surname><given-names>A.</given-names></name><name><surname>Idrees</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>The interplay between viruses and TRIM family proteins</article-title>. <source>Rev. Med. Virol.</source>
<volume>29</volume> (<issue>2</issue>), <elocation-id>e2028</elocation-id>. <pub-id pub-id-type="doi">10.1002/rmv.2028</pub-id>
<pub-id pub-id-type="pmid">30609250</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Chung</surname><given-names>M. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Antiviral activities of mulberry (Morus alba) juice and seed against influenza viruses</article-title>. <source>Evid. Based Complement. Alternat. Med.</source>
<volume>2018</volume>, <fpage>2606583</fpage>. <pub-id pub-id-type="doi">10.1155/2018/2606583</pub-id>
<pub-id pub-id-type="pmid">30515232</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. W.</given-names></name><name><surname>Chew</surname><given-names>B. P.</given-names></name><name><surname>Wong</surname><given-names>T. S.</given-names></name><name><surname>Park</surname><given-names>J. S.</given-names></name><name><surname>Weng</surname><given-names>B. B.</given-names></name><name><surname>Byrne</surname><given-names>K. M.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Modulation of humoral and cell-mediated immune responses by dietary lutein in cats</article-title>. <source>Vet. Immunol. Immunopathol.</source>
<volume>73</volume> (<issue>3&#x02013;4</issue>), <fpage>331</fpage>&#x02013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-2427(00)00152-5</pub-id>
<pub-id pub-id-type="pmid">10713345</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kindberg</surname><given-names>E.</given-names></name><name><surname>Mickien&#x00117;</surname><given-names>A.</given-names></name><name><surname>Ax</surname><given-names>C.</given-names></name><name><surname>&#x000c5;kerlind</surname><given-names>B.</given-names></name><name><surname>Vene</surname><given-names>S.</given-names></name><name><surname>Lindquist</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis</article-title>. <source>J. Infect. Dis.</source>
<volume>197</volume> (<issue>2</issue>), <fpage>266</fpage>&#x02013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1086/524709</pub-id>
<pub-id pub-id-type="pmid">18179389</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kitamura</surname><given-names>K.</given-names></name><name><surname>Honda</surname><given-names>M.</given-names></name><name><surname>Yoshizaki</surname><given-names>H.</given-names></name><name><surname>Yamamoto</surname><given-names>S.</given-names></name><name><surname>Nakane</surname><given-names>H.</given-names></name><name><surname>Fukushima</surname><given-names>M.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>Baicalin, an inhibitor of HIV-1 production <italic>in vitro</italic></article-title>. <source>Antivir. Res.</source>
<volume>37</volume> (<issue>2</issue>), <fpage>131</fpage>&#x02013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-3542(97)00069-7</pub-id>
<pub-id pub-id-type="pmid">9588845</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kitazato</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Kobayashi</surname><given-names>N.</given-names></name></person-group> (<year>2007</year>). <article-title>Viral infectious disease and natural products with antiviral activity</article-title>. <source>Drug Discov. Ther.</source>
<volume>1</volume> (<issue>1</issue>), <fpage>14</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="pmid">22504360</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kleymann</surname><given-names>G.</given-names></name><name><surname>Fischer</surname><given-names>R.</given-names></name><name><surname>Betz</surname><given-names>U. A.</given-names></name><name><surname>Hendrix</surname><given-names>M.</given-names></name><name><surname>Bender</surname><given-names>W.</given-names></name><name><surname>Schneider</surname><given-names>U.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease</article-title>. <source>Nat. Med.</source>
<volume>8</volume> (<issue>4</issue>), <fpage>392</fpage>. <pub-id pub-id-type="doi">10.1038/nm0402-392</pub-id>
<pub-id pub-id-type="pmid">11927946</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knox</surname><given-names>Y.</given-names></name><name><surname>Hayashi</surname><given-names>K.</given-names></name><name><surname>Suzutani</surname><given-names>T.</given-names></name><name><surname>Ogasawara</surname><given-names>M.</given-names></name><name><surname>Yoshida</surname><given-names>I.</given-names></name><name><surname>Shiina</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Activity of anthocyanins from fruit extract of Ribes nigrum L. against influenza A and B viruses</article-title>. <source>Acta Virol.</source>
<volume>45</volume> (<issue>4</issue>), <fpage>209</fpage>&#x02013;<lpage>215</lpage>. <pub-id pub-id-type="pmid">11885927</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knox</surname><given-names>Y. M.</given-names></name><name><surname>Suzutani</surname><given-names>T.</given-names></name><name><surname>Yosida</surname><given-names>I.</given-names></name><name><surname>Azuma</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Anti-influenza virus activity of crude extract of Ribes nigrum L</article-title>. <source>Phytother. Res.</source>
<volume>17</volume> (<issue>2</issue>), <fpage>120</fpage>&#x02013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.1053</pub-id>
<pub-id pub-id-type="pmid">12601672</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koehn</surname><given-names>F. E.</given-names></name><name><surname>Carter</surname><given-names>G. T.</given-names></name></person-group> (<year>2005</year>). <article-title>The evolving role of natural products in drug discovery</article-title>. <source>Nat. Rev. Drug Discov.</source>
<volume>4</volume> (<issue>3</issue>), <fpage>206</fpage>. <pub-id pub-id-type="doi">10.1038/nrd1657</pub-id>
<pub-id pub-id-type="pmid">15729362</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>F.-k.</given-names></name></person-group> (<year>2009</year>). <article-title>Pilot clinical study on a proprietary elderberry extract: efficacy in addressing influenza symptoms</article-title>. <source>Online J. Pharmacol. Pharmacokinet.</source>
<volume>5</volume>, <fpage>32</fpage>&#x02013;<lpage>43</lpage>.</mixed-citation></ref><ref id="B115"><mixed-citation publication-type="other">
<person-group person-group-type="author"><name><surname>Konlee</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>A new triple combination therapy</article-title>. <source>Posit. Health News</source> (<issue>17</issue>), <fpage>12</fpage>. </mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Konowalchuk</surname><given-names>J.</given-names></name><name><surname>Speirs</surname><given-names>J. I.</given-names></name></person-group> (<year>1976</year>). <article-title>Antiviral activity of fruit extracts</article-title>. <source>J. Food Sci.</source>
<volume>41</volume> (<issue>5</issue>), <fpage>1013</fpage>&#x02013;<lpage>1017</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2621.1976.tb14379.x</pub-id>
</mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kouda-Bonafos</surname><given-names>M.</given-names></name><name><surname>Czyzewska</surname><given-names>E.</given-names></name><name><surname>Nacro</surname><given-names>M.</given-names></name><name><surname>Oehlschlager</surname><given-names>A.</given-names></name></person-group> (<year>1994</year>). <article-title>Isolation of apigeninidin from leaf sheaths of Sorghum caudatum</article-title>. <source>J. Chem. Ecol.</source>
<volume>20</volume> (<issue>8</issue>), <fpage>2123</fpage>&#x02013;<lpage>2125</lpage>. <pub-id pub-id-type="doi">10.1007/BF02066248</pub-id>
<pub-id pub-id-type="pmid">24242734</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koumbi</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Current and future antiviral drug therapies of hepatitis B chronic infection</article-title>. <source>World J. Hepatol.</source>
<volume>7</volume> (<issue>8</issue>), <fpage>1030</fpage>. <pub-id pub-id-type="doi">10.4254/wjh.v7.i8.1030</pub-id>
<pub-id pub-id-type="pmid">26052392</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krawitz</surname><given-names>C.</given-names></name><name><surname>Mraheil</surname><given-names>M. A.</given-names></name><name><surname>Stein</surname><given-names>M.</given-names></name><name><surname>Imirzalioglu</surname><given-names>C.</given-names></name><name><surname>Domann</surname><given-names>E.</given-names></name><name><surname>Pleschka</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses</article-title>. <source>BMC Complement. Altern. Med.</source>
<volume>11</volume> (<issue>1</issue>), <fpage>16</fpage>. <pub-id pub-id-type="doi">10.1186/1472-6882-11-16</pub-id>
<pub-id pub-id-type="pmid">21352539</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kropeit</surname><given-names>D.</given-names></name><name><surname>McCormick</surname><given-names>D.</given-names></name><name><surname>Erb-Zohar</surname><given-names>K.</given-names></name><name><surname>Moiseev</surname><given-names>V. S.</given-names></name><name><surname>Kobalava</surname><given-names>Z. D.</given-names></name><name><surname>Stobernack</surname><given-names>H. P.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Pharmacokinetics and safety of the anti-human cytomegalovirus drug letermovir in subjects with hepatic impairment</article-title>. <source>Br. J. Clin. Pharmacol.</source>
<volume>83</volume> (<issue>12</issue>), <fpage>2678</fpage>&#x02013;<lpage>2686</lpage>. <pub-id pub-id-type="doi">10.1111/bcp.13376</pub-id>
<pub-id pub-id-type="pmid">28722153</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ku</surname><given-names>C.</given-names></name><name><surname>Mun</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Optimization of the extraction of anthocyanin from Bokbunja (<italic>Rubus coreanus</italic> Miq.) marc produced during traditional wine processing and characterization of the extracts</article-title>. <source>Bioresour. Technol.</source>
<volume>99</volume> (<issue>17</issue>), <fpage>8325</fpage>&#x02013;<lpage>8330</lpage>. <pub-id pub-id-type="doi">10.1016/j.biortech.2008.03.013</pub-id>
<pub-id pub-id-type="pmid">18456493</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kudo</surname><given-names>E.</given-names></name><name><surname>Taura</surname><given-names>M.</given-names></name><name><surname>Matsuda</surname><given-names>K.</given-names></name><name><surname>Shimamoto</surname><given-names>M.</given-names></name><name><surname>Kariya</surname><given-names>R.</given-names></name><name><surname>Goto</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells</article-title>. <source>Bioorg. Med. Chem. Lett.</source>
<volume>23</volume> (<issue>3</issue>), <fpage>606</fpage>&#x02013;<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2012.12.034</pub-id>
<pub-id pub-id-type="pmid">23290051</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kulkarni</surname><given-names>S.</given-names></name><name><surname>Sanghai</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Screening Of Antiviral Compounds From Plants-A Review</article-title>. <source>J. Pharm. Res.</source>
<volume>8</volume> (<issue>8</issue>), <fpage>1050</fpage>&#x02013;<lpage>1058</lpage>. </mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lanari</surname><given-names>M.</given-names></name><name><surname>Silvestri</surname><given-names>M.</given-names></name><name><surname>Rossi</surname><given-names>G. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Palivizumab prophylaxis in &#x02018;late preterm&#x02019;newborns</article-title>. <source>J. Matern.Fetal Neonatal Med.</source>
<volume>23</volume> (<issue>sup3</issue>), <fpage>53</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.3109/14767058.2010.506757</pub-id>
<pub-id pub-id-type="pmid">20695756</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lapidot</surname><given-names>T.</given-names></name><name><surname>Harel</surname><given-names>S.</given-names></name><name><surname>Granit</surname><given-names>R.</given-names></name><name><surname>Kanner</surname><given-names>J.</given-names></name></person-group> (<year>1998</year>). <article-title>Bioavailability of red wine anthocyanins as detected in human urine</article-title>. <source>J. Agric. Food Chem.</source>
<volume>46</volume> (<issue>10</issue>), <fpage>4297</fpage>&#x02013;<lpage>4302</lpage>. <pub-id pub-id-type="doi">10.1021/jf980007o</pub-id>
</mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Larmo</surname><given-names>P.</given-names></name><name><surname>Alin</surname><given-names>J.</given-names></name><name><surname>Salminen</surname><given-names>E.</given-names></name><name><surname>Kallio</surname><given-names>H.</given-names></name><name><surname>Tahvonen</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>Effects of sea buckthorn berries on infections and inflammation: a double-blind, randomized, placebo-controlled trial</article-title>. <source>Eur. J. Clin. Nutr.</source>
<volume>62</volume> (<issue>9</issue>), <fpage>1123</fpage>. <pub-id pub-id-type="doi">10.1038/sj.ejcn.1602831</pub-id>
<pub-id pub-id-type="pmid">17593932</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Bae</surname><given-names>S. Y.</given-names></name><name><surname>Oh</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>K. H.</given-names></name><name><surname>Chung</surname><given-names>M. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Antiviral effects of mulberry (Morus alba) juice and its fractions on foodborne viral surrogates</article-title>. <source>Foodborne Pathog. Dis.</source>
<volume>11</volume> (<issue>3</issue>), <fpage>224</fpage>&#x02013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1089/fpd.2013.1633</pub-id>
<pub-id pub-id-type="pmid">24350883</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Bae</surname><given-names>S. Y.</given-names></name><name><surname>Oh</surname><given-names>M.</given-names></name><name><surname>Seok</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Chung</surname><given-names>Y. B.</given-names></name><etal/></person-group> (<year>2016</year>a). <article-title>Antiviral effects of black raspberry (<italic>Rubus coreanus</italic>) seed extract and its polyphenolic compounds on norovirus surrogates</article-title>. <source>Biosci. Biotechnol. Biochem.</source>
<volume>80</volume> (<issue>6</issue>), <fpage>1196</fpage>&#x02013;<lpage>1204</lpage>. <pub-id pub-id-type="doi">10.1080/09168451.2016.1151337</pub-id>
<pub-id pub-id-type="pmid">26983677</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Oh</surname><given-names>M.</given-names></name><name><surname>Seok</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>D.</given-names></name><name><surname>Bae</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2016</year>b). <article-title>Antiviral effects of black raspberry (<italic>Rubus coreanus</italic>) seed and its gallic acid against influenza virus infection</article-title>. <source>Viruses</source>
<volume>8</volume> (<issue>6</issue>), <fpage>157</fpage>. <pub-id pub-id-type="doi">10.3390/v8060157</pub-id>
</mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>J. S.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Lee</surname><given-names>Y. S.</given-names></name></person-group> (<year>2003</year>). <article-title>A new anti-HIV flavonoid glucuronide from Chrysanthemum morifolium</article-title>. <source>Planta Med.</source>
<volume>69</volume> (<issue>09</issue>), <fpage>859</fpage>&#x02013;<lpage>861</lpage>. <pub-id pub-id-type="doi">10.1055/s-2003-43207</pub-id>
<pub-id pub-id-type="pmid">14598216</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Legua</surname><given-names>P.</given-names></name><name><surname>Forner-Giner</surname><given-names>M.&#x000c1;.</given-names></name><name><surname>Nuncio-J&#x000e1;uregui</surname><given-names>N.</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>F.</given-names></name></person-group> (<year>2016</year>). <article-title>Polyphenolic compounds, anthocyanins and antioxidant activity of nineteen pomegranate fruits: a rich source of bioactive compounds</article-title>. <source>J. Funct. Foods</source>
<volume>23</volume>, <fpage>628</fpage>&#x02013;<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1016/j.jff.2016.01.043</pub-id>
</mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Leichtweis</surname><given-names>M. G.</given-names></name><name><surname>Pereira</surname><given-names>C.</given-names></name><name><surname>Prieto</surname><given-names>M. A.</given-names></name><name><surname>Barreiro</surname><given-names>M. F.</given-names></name><name><surname>Baraldi</surname><given-names>I. J.</given-names></name><name><surname>Barros</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Ultrasound as a rapid and low-cost extraction procedure to obtain anthocyanin-based colorants from <italic>prunus spinosa</italic> L. fruit epicarp: comparative study with conventional heat-based extraction</article-title>. <source>Molecules</source>
<volume>24</volume> (<issue>3</issue>), <fpage>573</fpage>&#x02013;<lpage>590</lpage>. <pub-id pub-id-type="doi">10.3390/molecules24030573</pub-id>
</mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lembo</surname><given-names>D.</given-names></name><name><surname>Donalisio</surname><given-names>M.</given-names></name><name><surname>Civra</surname><given-names>A.</given-names></name><name><surname>Argenziano</surname><given-names>M.</given-names></name><name><surname>Cavalli</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections</article-title>. <source>Expert Opin. Drug Deliv.</source>
<volume>15</volume> (<issue>1</issue>), <fpage>93</fpage>&#x02013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1080/17425247.2017.1360863</pub-id>
<pub-id pub-id-type="pmid">28749739</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>B. Q.</given-names></name><name><surname>Fu</surname><given-names>T.</given-names></name><name><surname>Dongyan</surname><given-names>Y.</given-names></name><name><surname>Mikovits</surname><given-names>J. A.</given-names></name><name><surname>Ruscetti</surname><given-names>F. W.</given-names></name><name><surname>Wang</surname><given-names>J. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>276</volume> (<issue>2</issue>), <fpage>534</fpage>&#x02013;<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.2000.3485</pub-id>
<pub-id pub-id-type="pmid">11027509</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>S.-Y.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Yeung</surname><given-names>C.-M.</given-names></name><name><surname>Yu</surname><given-names>W.-Y.</given-names></name><name><surname>Chang</surname><given-names>R. C.-C.</given-names></name><name><surname>So</surname><given-names>K.-F.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Lycium barbarum polysaccharides reduce neuronal damage, blood-retinal barrier disruption and oxidative stress in retinal ischemia/reperfusion injury</article-title>. <source>PloS One</source>
<volume>6</volume> (<issue>1</issue>), <elocation-id>e16380</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0016380</pub-id>
<pub-id pub-id-type="pmid">21298100</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Gu</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>A review: using nanoparticles to enhance absorption and bioavailability of phenolic phytochemicals</article-title>. <source>Food Hydrocoll.</source>
<volume>43</volume>, <fpage>153</fpage>&#x02013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodhyd.2014.05.010</pub-id>
</mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liang</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Jing</surname><given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Black rice anthocyanins embedded in self-assembled chitosan/chondroitin sulfate nanoparticles enhance apoptosis in HCT-116 cells</article-title>. <source>Food Chem.</source>
<volume>301</volume>, <fpage>125280</fpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2019.125280</pub-id>
<pub-id pub-id-type="pmid">31377624</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lila</surname><given-names>M. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Anthocyanins and human health: an <italic>in vitro</italic> investigative approach</article-title>. <source>BioMed. Res. Int.</source>
<volume>2004</volume> (<issue>5</issue>), <fpage>306</fpage>&#x02013;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1155/S111072430440401X</pub-id>
</mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lim</surname><given-names>J. K.</given-names></name><name><surname>Murphy</surname><given-names>P. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Chemokine control of West Nile virus infection</article-title>. <source>Exp. Cell Res.</source>
<volume>317</volume> (<issue>5</issue>), <fpage>569</fpage>&#x02013;<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2011.01.009</pub-id>
<pub-id pub-id-type="pmid">21376172</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>L.-T.</given-names></name><name><surname>Chen</surname><given-names>T.-Y.</given-names></name><name><surname>Lin</surname><given-names>S.-C.</given-names></name><name><surname>Chung</surname><given-names>C.-Y.</given-names></name><name><surname>Lin</surname><given-names>T.-C.</given-names></name><name><surname>Wang</surname><given-names>G.-H.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry</article-title>. <source>BMC Microbiology</source>
<volume>13</volume> (<issue>1</issue>), <fpage>187</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2180-13-187</pub-id>
<pub-id pub-id-type="pmid">23924316</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lipson</surname><given-names>S.</given-names></name><name><surname>Sethi</surname><given-names>L.</given-names></name><name><surname>Cohen</surname><given-names>P.</given-names></name><name><surname>Gordon</surname><given-names>R.</given-names></name><name><surname>Tan</surname><given-names>I.</given-names></name><name><surname>Burdowski</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Antiviral effects on bacteriophages and rotavirus by cranberry juice</article-title>. <source>Phytomedicine</source>
<volume>14</volume> (<issue>1</issue>), <fpage>23</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2006.11.009</pub-id>
<pub-id pub-id-type="pmid">17140784</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Xiong</surname><given-names>L.</given-names></name><name><surname>Sun</surname><given-names>Q.</given-names></name></person-group> (<year>2017</year>). <article-title>Fabrication and characterization of biocompatible hybrid nanoparticles from spontaneous co-assembly of casein/gliadin and proanthocyanidin</article-title>. <source>Food Hydrocoll.</source>
<volume>73</volume>, <fpage>74</fpage>&#x02013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodhyd.2017.06.036</pub-id>
</mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Zhu</surname><given-names>M.</given-names></name><name><surname>Shi</surname><given-names>R.</given-names></name><name><surname>Yang</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials</article-title>. <source>Am. J. Chin. Med.</source>
<volume>31</volume> (<issue>03</issue>), <fpage>337</fpage>&#x02013;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1142/S0192415X03001107</pub-id>
<pub-id pub-id-type="pmid">12943166</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Lucioli</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). "<article-title>Anthocyanins: mechanism of action and therapeutic efficacy</article-title>" in <source>Medicinal Plants as Antioxidant Agents: Understand-ing Their Mechanism of Action and Therapeutic Efficacy</source>
<person-group person-group-type="editor"><name><surname>Capasso</surname><given-names>A.</given-names></name></person-group>, Ed., <fpage>27</fpage>&#x02013;<lpage>57</lpage>, <publisher-name>Research Signpost</publisher-name>, <publisher-loc>Kerala, India</publisher-loc>.</mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ma</surname><given-names>L.-Y.</given-names></name><name><surname>Ma</surname><given-names>S.-C.</given-names></name><name><surname>Wei</surname><given-names>F.</given-names></name><name><surname>Lin</surname><given-names>R.-C.</given-names></name><name><surname>But</surname><given-names>P. P.-H.</given-names></name><name><surname>Lee</surname><given-names>S. H.-S.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Uncinoside A and B, two new antiviral chromone glycosides from Selaginella uncinata</article-title>. <source>Chem. Pharmaceut. Bull.</source>
<volume>51</volume> (<issue>11</issue>), <fpage>1264</fpage>&#x02013;<lpage>1267</lpage>. <pub-id pub-id-type="doi">10.1248/cpb.51.1264</pub-id>
</mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Manach</surname><given-names>C.</given-names></name><name><surname>Williamson</surname><given-names>G.</given-names></name><name><surname>Morand</surname><given-names>C.</given-names></name><name><surname>Scalbert</surname><given-names>A.</given-names></name><name><surname>R&#x000e9;m&#x000e9;sy</surname><given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies</article-title>. <source>Am. J. Clin. Nutr.</source>
<volume>81</volume> (<issue>1</issue>), <fpage>230S</fpage>&#x02013;<lpage>242S</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/81.1.230S</pub-id>
<pub-id pub-id-type="pmid">15640486</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marczylo</surname><given-names>T. H.</given-names></name><name><surname>Cooke</surname><given-names>D.</given-names></name><name><surname>Brown</surname><given-names>K.</given-names></name><name><surname>Steward</surname><given-names>W. P.</given-names></name><name><surname>Gescher</surname><given-names>A. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice</article-title>. <source>Cancer Chemother Pharmacol.</source>
<volume>64</volume> (<issue>6</issue>), <fpage>1261</fpage>&#x02013;<lpage>1268</lpage>. <pub-id pub-id-type="doi">10.1007/s00280-009-0996-7</pub-id>
<pub-id pub-id-type="pmid">19363608</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martin</surname><given-names>K.</given-names></name><name><surname>Heleniust</surname><given-names>A.</given-names></name></person-group> (<year>1991</year>). <article-title>Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import</article-title>. <source>Cell</source>
<volume>67</volume> (<issue>1</issue>), <fpage>117</fpage>&#x02013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(91)90576-K</pub-id>
<pub-id pub-id-type="pmid">1913813</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mart&#x000ed;nez-Ballesta</surname><given-names>M.</given-names></name><name><surname>Gil-Izquierdo</surname><given-names>&#x000c1;.</given-names></name><name><surname>Garc&#x000ed;a-Viguera</surname><given-names>C.</given-names></name><name><surname>Dom&#x000ed;nguez-Perles</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Nanoparticles and controlled delivery for bioactive compounds: outlining challenges for new &#x0201c;Smart-foods&#x0201d;</article-title>. <source>Foods</source>
<volume>7</volume> (<issue>5</issue>), <fpage>72</fpage>. <pub-id pub-id-type="doi">10.3390/foods7050072</pub-id>
</mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Martins</surname><given-names>N.</given-names></name><name><surname>Imler</surname><given-names>J.-L.</given-names></name><name><surname>Meignin</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Discovery of novel targets for antivirals: learning from flies</article-title>. <source>Curr. Opin. Virol.</source>
<volume>20</volume>, <fpage>64</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.coviro.2016.09.005</pub-id>
<pub-id pub-id-type="pmid">27657660</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>H.</given-names></name><name><surname>Ichiyanagi</surname><given-names>T.</given-names></name><name><surname>Iida</surname><given-names>H.</given-names></name><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>Tsuda</surname><given-names>T.</given-names></name><name><surname>Hirayama</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Ingested delphinidin-3-rutinoside is primarily excreted to urine as the intact form and to bile as the methylated form in rats</article-title>. <source>J. Agric. Food Chem.</source>
<volume>54</volume> (<issue>2</issue>), <fpage>578</fpage>&#x02013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1021/jf052411a</pub-id>
<pub-id pub-id-type="pmid">16417324</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>H.</given-names></name><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>Yonekura</surname><given-names>K.</given-names></name><name><surname>Tsuda</surname><given-names>T.</given-names></name><name><surname>Ichiyanagi</surname><given-names>T.</given-names></name><name><surname>Hirayama</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Enhanced absorption of anthocyanins after oral administration of phytic acid in rats and humans</article-title>. <source>J. Agric. Food Chem.</source>
<volume>55</volume> (<issue>6</issue>), <fpage>2489</fpage>&#x02013;<lpage>2496</lpage>. <pub-id pub-id-type="doi">10.1021/jf063199t</pub-id>
<pub-id pub-id-type="pmid">17319688</pub-id></mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McVoy</surname><given-names>M. A.</given-names></name><name><surname>Nixon</surname><given-names>D. E.</given-names></name></person-group> (<year>2005</year>). <article-title>Impact of 2-Bromo-5, 6-Dichloro-1-&#x003b2;-D-Ribofuranosyl benzimidazole riboside and inhibitors of DNA, RNA, and protein synthesis on human cytomegalovirus genome maturation</article-title>. <source>J. Virol.</source>
<volume>79</volume> (<issue>17</issue>), <fpage>11115</fpage>&#x02013;<lpage>11127</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.79.17.11115-11127.2005</pub-id>
<pub-id pub-id-type="pmid">16103162</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Melendez</surname><given-names>D. P.</given-names></name><name><surname>Razonable</surname><given-names>R. R.</given-names></name></person-group> (<year>2015</year>). <article-title>Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus</article-title>. <source>Infect. Drug Resist.</source>
<volume>8</volume>, <fpage>269</fpage>. <pub-id pub-id-type="doi">10.2147/IDR.S79131</pub-id>
<pub-id pub-id-type="pmid">26345608</pub-id></mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miki</surname><given-names>K.</given-names></name><name><surname>Nagai</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name><name><surname>Tsujimura</surname><given-names>R.</given-names></name><name><surname>Koyama</surname><given-names>K.</given-names></name><name><surname>Kinoshita</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Anti-influenza virus activity of biflavonoids</article-title>. <source>Bioorg. Med. Chem. Lett.</source>
<volume>17</volume> (<issue>3</issue>), <fpage>772</fpage>&#x02013;<lpage>775</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2006.10.075</pub-id>
<pub-id pub-id-type="pmid">17110111</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miller</surname><given-names>R. L.</given-names></name><name><surname>Meng</surname><given-names>T.-C.</given-names></name><name><surname>Tomai</surname><given-names>M. A.</given-names></name></person-group> (<year>2008</year>). <article-title>The antiviral activity of Toll-like receptor 7 and 7/8 agonists</article-title>. <source>Drug News Perspect.</source>
<volume>21</volume> (<issue>2</issue>), <fpage>69</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1358/dnp.2008.21.2.1188193</pub-id>
<pub-id pub-id-type="pmid">18389099</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miller</surname><given-names>W. H.</given-names></name><name><surname>Miller</surname><given-names>R. L.</given-names></name></person-group> (<year>1982</year>). <article-title>Phosphorylation of acyclovir diphosphate by cellular enzymes</article-title>. <source>Biochem. Pharmacol.</source>
<volume>31</volume> (<issue>23</issue>), <fpage>3879</fpage>&#x02013;<lpage>3884</lpage>. <pub-id pub-id-type="doi">10.1016/0006-2952(82)90305-7</pub-id>
<pub-id pub-id-type="pmid">7159465</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Min</surname><given-names>B. S.</given-names></name><name><surname>Hattori</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>H. K.</given-names></name><name><surname>Kim</surname><given-names>Y. H.</given-names></name></person-group> (<year>1999</year>a). <article-title>Inhibitory constituents against HIV-1 protease fromAgastache rugosa</article-title>. <source>Arch. Pharm. Res.</source>
<volume>22</volume> (<issue>1</issue>), <fpage>75</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1007/BF02976440</pub-id>
<pub-id pub-id-type="pmid">10071964</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Min</surname><given-names>B. S.</given-names></name><name><surname>Jung</surname><given-names>H. J.</given-names></name><name><surname>Lee</surname><given-names>J. S.</given-names></name><name><surname>Kim</surname><given-names>Y. H.</given-names></name><name><surname>Bok</surname><given-names>S. H.</given-names></name><name><surname>Ma</surname><given-names>C. M.</given-names></name><etal/></person-group> (<year>1999</year>b). <article-title>Inhibitory effect of triterpenes from Crataegus pinatifida on HIV-I protease</article-title>. <source>Planta Med.</source>
<volume>65</volume> (<issue>04</issue>), <fpage>374</fpage>&#x02013;<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1055/s-2006-960792</pub-id>
<pub-id pub-id-type="pmid">10364847</pub-id></mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miyazawa</surname><given-names>T.</given-names></name><name><surname>Nakagawa</surname><given-names>K.</given-names></name><name><surname>Kudo</surname><given-names>M.</given-names></name><name><surname>Muraishi</surname><given-names>K.</given-names></name><name><surname>Someya</surname><given-names>K.</given-names></name></person-group> (<year>1999</year>). <article-title>Direct intestinal absorption of red fruit anthocyanins, cyanidin-3-glucoside and cyanidin-3, 5-diglucoside, into rats and humans</article-title>. <source>J. Agric. Food Chem.</source>
<volume>47</volume> (<issue>3</issue>), <fpage>1083</fpage>&#x02013;<lpage>1091</lpage>. <pub-id pub-id-type="doi">10.1021/jf9809582</pub-id>
<pub-id pub-id-type="pmid">10552420</pub-id></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Montaner</surname><given-names>J. S.</given-names></name><name><surname>Wood</surname><given-names>E.</given-names></name><name><surname>Kerr</surname><given-names>T.</given-names></name><name><surname>Lima</surname><given-names>V.</given-names></name><name><surname>Barrios</surname><given-names>R.</given-names></name><name><surname>Shannon</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Expanded highly active antiretroviral therapy coverage among HIV-positive drug users to improve individual and public health outcomes</article-title>. <source>J. Acquir. Immune. Defic. Syndr.</source>
<volume>55</volume>
<issue>Suppl 1</issue>, <fpage>S5</fpage>&#x02013;<lpage>S9</lpage>. <pub-id pub-id-type="doi">10.1097/QAI.0b013e3181f9c1f0</pub-id>
<pub-id pub-id-type="pmid">21045601</pub-id></mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moradi</surname><given-names>M.-T.</given-names></name><name><surname>Karimi</surname><given-names>A.</given-names></name><name><surname>Alidadi</surname><given-names>S.</given-names></name><name><surname>Saedi-Marghmaleki</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>In vitro Anti-adenovirus activity of pomegranate (Punica granatum L.) peel extract</article-title>. <source>Adv. Herb. Med.</source>
<volume>1</volume> (<issue>4</issue>), <fpage>1</fpage>&#x02013;<lpage>8</lpage>. </mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morishima</surname><given-names>C.</given-names></name><name><surname>Shuhart</surname><given-names>M. C.</given-names></name><name><surname>Wang</surname><given-names>C. C.</given-names></name><name><surname>Paschal</surname><given-names>D. M.</given-names></name><name><surname>Apodaca</surname><given-names>M. C.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Silymarin inhibits <italic>in vitro</italic> T-cell proliferation and cytokine production in hepatitis C virus infection</article-title>. <source>Gastroenterology</source>
<volume>138</volume> (<issue>2</issue>), <fpage>671</fpage>&#x02013;<lpage>681</lpage>. e672. <pub-id pub-id-type="doi">10.1053/j.gastro.2009.09.021</pub-id>
<pub-id pub-id-type="pmid">19782083</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Na</surname><given-names>H. N.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Jeon</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>H. B.</given-names></name><name><surname>Nam</surname><given-names>J. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Reduction of adenovirus 36-induced obesity and inflammation by mulberry extract</article-title>. <source>Microbiol. Immunol.</source>
<volume>58</volume> (<issue>5</issue>), <fpage>303</fpage>&#x02013;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1111/1348-0421.12146</pub-id>
<pub-id pub-id-type="pmid">24580367</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nair</surname><given-names>M. P.</given-names></name><name><surname>Kandaswami</surname><given-names>C.</given-names></name><name><surname>Mahajan</surname><given-names>S.</given-names></name><name><surname>Nair</surname><given-names>H. N.</given-names></name><name><surname>Chawda</surname><given-names>R.</given-names></name><name><surname>Shanahan</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2002</year>a). <article-title>Grape seed extract proanthocyanidins downregulate HIV-1 entry coreceptors, CCR2b, CCR3 and CCR5 gene expression by normal peripheral blood mononuclear cells</article-title>. <source>Biol. Res.</source>
<volume>35</volume> (<issue>3&#x02013;4</issue>), <fpage>421</fpage>&#x02013;<lpage>431</lpage>. <pub-id pub-id-type="doi">10.4067/S0716-97602002000300016</pub-id>
<pub-id pub-id-type="pmid">12462994</pub-id></mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nair</surname><given-names>N.</given-names></name><name><surname>Mahajan</surname><given-names>S.</given-names></name><name><surname>Chawda</surname><given-names>R.</given-names></name><name><surname>Kandaswami</surname><given-names>C.</given-names></name><name><surname>Shanahan</surname><given-names>T. C.</given-names></name><name><surname>Schwartz</surname><given-names>S. A.</given-names></name></person-group> (<year>2002</year>b). <article-title>Grape seed extract activates Th1 cells <italic>in vitro</italic></article-title>. <source>Clin. Diagn. Lab. Immunol.</source>
<volume>9</volume> (<issue>2</issue>), <fpage>470</fpage>&#x02013;<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1128/CDLI.9.2.470-476.2002</pub-id>
<pub-id pub-id-type="pmid">11874895</pub-id></mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nati&#x00107;</surname><given-names>M. M.</given-names></name><name><surname>Dabi&#x00107;</surname><given-names>D.&#x0010c;.</given-names></name><name><surname>Papetti</surname><given-names>A.</given-names></name><name><surname>Ak&#x00161;i&#x00107;</surname><given-names>M. M. F.</given-names></name><name><surname>Ognjanov</surname><given-names>V.</given-names></name><name><surname>Ljubojevi&#x00107;</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Analysis and characterisation of phytochemicals in mulberry (Morus alba L.) fruits grown in Vojvodina, North Serbia</article-title>. <source>Food Chem.</source>
<volume>171</volume>, <fpage>128</fpage>&#x02013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2014.08.101</pub-id>
<pub-id pub-id-type="pmid">25308652</pub-id></mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Neurath</surname><given-names>A. R.</given-names></name><name><surname>Strick</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>Y.-Y.</given-names></name><name><surname>Debnath</surname><given-names>A. K.</given-names></name></person-group> (<year>2004</year>). <article-title>Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide</article-title>. <source>BMC Infect. Dis.</source>
<volume>4</volume> (<issue>1</issue>), <fpage>41</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-4-41</pub-id>
<pub-id pub-id-type="pmid">15485580</pub-id></mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Newman</surname><given-names>D. J.</given-names></name><name><surname>Cragg</surname><given-names>G. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Natural products as sources of new drugs over the last 25 years</article-title>. <source>J. Nat. Prod.</source>
<volume>70</volume> (<issue>3</issue>), <fpage>461</fpage>&#x02013;<lpage>477</lpage>. <pub-id pub-id-type="doi">10.1021/np068054v</pub-id>
<pub-id pub-id-type="pmid">17309302</pub-id></mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Niemenak</surname><given-names>N.</given-names></name><name><surname>Rohsius</surname><given-names>C.</given-names></name><name><surname>Elwers</surname><given-names>S.</given-names></name><name><surname>Ndoumou</surname><given-names>D. O.</given-names></name><name><surname>Lieberei</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Comparative study of different cocoa (<italic>Theobroma cacao</italic> L.) clones in terms of their phenolics and anthocyanins contents</article-title>. <source>J. Food Compost. Anal.</source>
<volume>19</volume> (<issue>6-7</issue>), <fpage>612</fpage>&#x02013;<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1016/j.jfca.2005.02.006</pub-id>
</mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nijveldt</surname><given-names>R. J.</given-names></name><name><surname>Van Nood</surname><given-names>E.</given-names></name><name><surname>Van Hoorn</surname><given-names>D. E.</given-names></name><name><surname>Boelens</surname><given-names>P. G.</given-names></name><name><surname>Van Norren</surname><given-names>K.</given-names></name><name><surname>Van Leeuwen</surname><given-names>P. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Flavonoids: a review of probable mechanisms of action and potential applications</article-title>. <source>Am. J. Clin. Nutr.</source>
<volume>74</volume> (<issue>4</issue>), <fpage>418</fpage>&#x02013;<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/74.4.418</pub-id>
<pub-id pub-id-type="pmid">11566638</pub-id></mixed-citation></ref><ref id="B172"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nikolaeva-Glomb</surname><given-names>L.</given-names></name><name><surname>Mukova</surname><given-names>L.</given-names></name><name><surname>Nikolova</surname><given-names>N.</given-names></name><name><surname>Badjakov</surname><given-names>I.</given-names></name><name><surname>Dincheva</surname><given-names>I.</given-names></name><name><surname>Kondakova</surname><given-names>V.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title><italic>In vitro</italic> antiviral activity of a series of wild berry fruit extracts against representatives of Picorna-, Orthomyxo-and Paramyxoviridae</article-title>. <source>Nat. Prod. Commun.</source>
<volume>9</volume> (<issue>1</issue>), <fpage>51</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1177/1934578X1400900116</pub-id>
<pub-id pub-id-type="pmid">24660461</pub-id></mixed-citation></ref><ref id="B173"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nolkemper</surname><given-names>S.</given-names></name><name><surname>Reichling</surname><given-names>J.</given-names></name><name><surname>Stintzing</surname><given-names>F. C.</given-names></name><name><surname>Carle</surname><given-names>R.</given-names></name><name><surname>Schnitzler</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 <italic>in vitro</italic></article-title>. <source>Planta Med.</source>
<volume>72</volume> (<issue>15</issue>), <fpage>1378</fpage>&#x02013;<lpage>1382</lpage>. <pub-id pub-id-type="doi">10.1055/s-2006-951719</pub-id>
<pub-id pub-id-type="pmid">17091431</pub-id></mixed-citation></ref><ref id="B174"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>N&#x000f8;rbaek</surname><given-names>R.</given-names></name><name><surname>Christensen</surname><given-names>L. P.</given-names></name><name><surname>Bojesen</surname><given-names>G.</given-names></name><name><surname>Brandt</surname><given-names>K.</given-names></name></person-group> (<year>1996</year>). <article-title>Anthocyanins in Chilean species of Alstroemeria</article-title>. <source>Phytochemistry</source>
<volume>42</volume> (<issue>1</issue>), <fpage>97</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/0031-9422(95)00859-4</pub-id>
</mixed-citation></ref><ref id="B175"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oh</surname><given-names>M.</given-names></name><name><surname>Bae</surname><given-names>S. Y.</given-names></name><name><surname>Lee</surname><given-names>J.-H.</given-names></name><name><surname>Cho</surname><given-names>K. J.</given-names></name><name><surname>Kim</surname><given-names>K. H.</given-names></name><name><surname>Chung</surname><given-names>M. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Antiviral effects of black raspberry (<italic>Rubus coreanus</italic>) juice on foodborne viral surrogates</article-title>. <source>Foodborne Pathog. Dis.</source>
<volume>9</volume> (<issue>10</issue>), <fpage>915</fpage>&#x02013;<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1089/fpd.2012.1174</pub-id>
<pub-id pub-id-type="pmid">22924523</pub-id></mixed-citation></ref><ref id="B176"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Opar</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). "<article-title>New HIV drug classes on the horizon</article-title>." <source>Nat. Rev. Drug Discovery</source>, <volume>6</volume> (<issue>4</issue>), <fpage>258</fpage>&#x02013;<lpage>259</lpage>.<pub-id pub-id-type="pmid">17457997</pub-id></mixed-citation></ref><ref id="B177"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oszmianski</surname><given-names>J.</given-names></name><name><surname>Sapis</surname><given-names>J. C.</given-names></name></person-group> (<year>1988</year>). <article-title>Anthocyanins in fruits of Aronia melanocarpa (chokeberry)</article-title>. <source>J. Food Sci.</source>
<volume>53</volume> (<issue>4</issue>), <fpage>1241</fpage>&#x02013;<lpage>1242</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2621.1988.tb13577.x</pub-id>
</mixed-citation></ref><ref id="B178"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>&#x000d6;z&#x000e7;elik</surname><given-names>B.</given-names></name><name><surname>Kartal</surname><given-names>M.</given-names></name><name><surname>Orhan</surname><given-names>I.</given-names></name></person-group> (<year>2011</year>). <article-title>Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids</article-title>. <source>Pharmaceut. Biol.</source>
<volume>49</volume> (<issue>4</issue>), <fpage>396</fpage>&#x02013;<lpage>402</lpage>. <pub-id pub-id-type="doi">10.3109/13880209.2010.519390</pub-id>
</mixed-citation></ref><ref id="B179"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pantaleo</surname><given-names>G.</given-names></name></person-group> (<year>1997</year>). <article-title>How immune-based interventions can change HIV therapy</article-title>. <source>Nat. Med.</source>
<volume>3</volume> (<issue>5</issue>), <fpage>483</fpage>. <pub-id pub-id-type="doi">10.1038/nm0597-483</pub-id>
<pub-id pub-id-type="pmid">9142107</pub-id></mixed-citation></ref><ref id="B180"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pantaleo</surname><given-names>G.</given-names></name><name><surname>Perrin</surname><given-names>L.</given-names></name></person-group> (<year>1998</year>). <article-title>Can HIV be eradicated</article-title>? <source>AIDS (London, England)</source>
<volume>12</volume>, <fpage>S175</fpage>&#x02013;<lpage>S180</lpage>.</mixed-citation></ref><ref id="B181"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>J. I.</given-names></name><name><surname>Lee</surname><given-names>I.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Hwang</surname><given-names>M.-W.</given-names></name><name><surname>Bae</surname><given-names>J.-Y.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>440</volume> (<issue>1</issue>), <fpage>14</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2013.08.090</pub-id>
<pub-id pub-id-type="pmid">24012672</pub-id></mixed-citation></ref><ref id="B182"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Passamonti</surname><given-names>S.</given-names></name><name><surname>Vrhovsek</surname><given-names>U.</given-names></name><name><surname>Vanzo</surname><given-names>A.</given-names></name><name><surname>Mattivi</surname><given-names>F.</given-names></name></person-group> (<year>2003</year>). <article-title>The stomach as a site for anthocyanins absorption from food</article-title>. <source>FEBS Lett.</source>
<volume>544</volume> (<issue>1&#x02013;3</issue>), <fpage>210</fpage>&#x02013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(03)00504-0</pub-id>
<pub-id pub-id-type="pmid">12782318</pub-id></mixed-citation></ref><ref id="B183"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Perrin</surname><given-names>L.</given-names></name><name><surname>Telenti</surname><given-names>A.</given-names></name></person-group> (<year>1998</year>). <article-title>HIV treatment failure: testing for HIV resistance in clinical practice</article-title>. <source>Science</source>
<volume>280</volume> (<issue>5371</issue>), <fpage>1871</fpage>&#x02013;<lpage>1873</lpage>. <pub-id pub-id-type="doi">10.1126/science.280.5371.1871</pub-id>
<pub-id pub-id-type="pmid">9669946</pub-id></mixed-citation></ref><ref id="B184"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Phippen</surname><given-names>W. B.</given-names></name><name><surname>Simon</surname><given-names>J. E.</given-names></name></person-group> (<year>1998</year>). <article-title>Anthocyanins in basil (<italic>Ocimum basilicum</italic> L.)</article-title>. <source>J. Agric. Food Chem.</source>
<volume>46</volume> (<issue>5</issue>), <fpage>1734</fpage>&#x02013;<lpage>1738</lpage>. <pub-id pub-id-type="doi">10.1021/jf970887r</pub-id>
</mixed-citation></ref><ref id="B185"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pinto</surname><given-names>L. H.</given-names></name><name><surname>Holsinger</surname><given-names>L. J.</given-names></name><name><surname>Lamb</surname><given-names>R. A.</given-names></name></person-group> (<year>1992</year>). <article-title>Influenza virus M2 protein has ion channel activity</article-title>. <source>Cell</source>
<volume>69</volume> (<issue>3</issue>), <fpage>517</fpage>&#x02013;<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(92)90452-I</pub-id>
<pub-id pub-id-type="pmid">1374685</pub-id></mixed-citation></ref><ref id="B186"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pojer</surname><given-names>E.</given-names></name><name><surname>Mattivi</surname><given-names>F.</given-names></name><name><surname>Johnson</surname><given-names>D.</given-names></name><name><surname>Stockley</surname><given-names>C. S.</given-names></name></person-group> (<year>2013</year>). <article-title>The case for anthocyanin consumption to promote human health: a review</article-title>. <source>Compr. Rev. Food Sci. Food Saf.</source>
<volume>12</volume> (<issue>5</issue>), <fpage>483</fpage>&#x02013;<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1111/1541-4337.12024</pub-id>
</mixed-citation></ref><ref id="B187"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pommier</surname><given-names>Y.</given-names></name><name><surname>Johnson</surname><given-names>A. A.</given-names></name><name><surname>Marchand</surname><given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Integrase inhibitors to treat HIV/AIDS</article-title>. <source>Nat. Rev. Drug Discov.</source>
<volume>4</volume> (<issue>3</issue>), <fpage>236</fpage>. <pub-id pub-id-type="doi">10.1038/nrd1660</pub-id>
<pub-id pub-id-type="pmid">15729361</pub-id></mixed-citation></ref><ref id="B188"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Potterat</surname><given-names>O.</given-names></name></person-group> (<year>2010</year>). <article-title>Goji (<italic>Lycium barbarum</italic> and L. chinense): phytochemistry, pharmacology and safety in the perspective of traditional uses and recent popularity</article-title>. <source>Planta Med.</source>
<volume>76</volume> (<issue>01</issue>), <fpage>7</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1055/s-0029-1186218</pub-id>
<pub-id pub-id-type="pmid">19844860</pub-id></mixed-citation></ref><ref id="B189"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Premanathan</surname><given-names>M.</given-names></name><name><surname>Arakaki</surname><given-names>R.</given-names></name><name><surname>Izumi</surname><given-names>H.</given-names></name><name><surname>Kathiresan</surname><given-names>K.</given-names></name><name><surname>Nakano</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>N.</given-names></name><etal/></person-group> (<year>1999</year>). <article-title>Antiviral properties of a mangrove plant, Rhizophora apiculata Blume, against human immunodeficiency virus</article-title>. <source>Antivir. Res.</source>
<volume>44</volume> (<issue>2</issue>), <fpage>113</fpage>&#x02013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-3542(99)00058-3</pub-id>
<pub-id pub-id-type="pmid">10669261</pub-id></mixed-citation></ref><ref id="B190"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qin</surname><given-names>Y.</given-names></name><name><surname>Xia</surname><given-names>M.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Hao</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Mou</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Anthocyanin supplementation improves serum LDL-and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects</article-title>. <source>Am. J. Clin. Nutr.</source>
<volume>90</volume> (<issue>3</issue>), <fpage>485</fpage>&#x02013;<lpage>492</lpage>. <pub-id pub-id-type="doi">10.3945/ajcn.2009.27814</pub-id>
<pub-id pub-id-type="pmid">19640950</pub-id></mixed-citation></ref><ref id="B191"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rahman</surname><given-names>S. H.</given-names></name><name><surname>Maeder</surname><given-names>M. L.</given-names></name><name><surname>Joung</surname><given-names>J. K.</given-names></name><name><surname>Cathomen</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Zinc-finger nucleases for somatic gene therapy: the next frontier</article-title>. <source>Hum. Gene Ther.</source>
<volume>22</volume> (<issue>8</issue>), <fpage>925</fpage>&#x02013;<lpage>933</lpage>. <pub-id pub-id-type="doi">10.1089/hum.2011.087</pub-id>
<pub-id pub-id-type="pmid">21631241</pub-id></mixed-citation></ref><ref id="B192"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rechtman</surname><given-names>M. M.</given-names></name><name><surname>Har-Noy</surname><given-names>O.</given-names></name><name><surname>Bar-Yishay</surname><given-names>I.</given-names></name><name><surname>Fishman</surname><given-names>S.</given-names></name><name><surname>Adamovich</surname><given-names>Y.</given-names></name><name><surname>Shaul</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Curcumin inhibits hepatitis B virus <italic>via</italic> down-regulation of the metabolic coactivator PGC-1&#x003b1;</article-title>. <source>FEBS Lett.</source>
<volume>584</volume> (<issue>11</issue>), <fpage>2485</fpage>&#x02013;<lpage>2490</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2010.04.067</pub-id>
<pub-id pub-id-type="pmid">20434445</pub-id></mixed-citation></ref><ref id="B193"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reddivari</surname><given-names>L.</given-names></name><name><surname>Vanamala</surname><given-names>J.</given-names></name><name><surname>Chintharlapalli</surname><given-names>S.</given-names></name><name><surname>Safe</surname><given-names>S. H.</given-names></name><name><surname>Miller</surname><given-names>J. C.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2007</year>). <article-title>Anthocyanin fraction from potato extracts is cytotoxic to prostate cancer cells through activation of caspase-dependent and caspase-independent pathways</article-title>. <source>Carcinogenesis</source>
<volume>28</volume> (<issue>10</issue>), <fpage>2227</fpage>&#x02013;<lpage>2235</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgm117</pub-id>
<pub-id pub-id-type="pmid">17522067</pub-id></mixed-citation></ref><ref id="B194"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reeves</surname><given-names>P. M.</given-names></name><name><surname>Bommarius</surname><given-names>B.</given-names></name><name><surname>Lebeis</surname><given-names>S.</given-names></name><name><surname>McNulty</surname><given-names>S.</given-names></name><name><surname>Christensen</surname><given-names>J.</given-names></name><name><surname>Swimm</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases</article-title>. <source>Nat. Med.</source>
<volume>11</volume> (<issue>7</issue>), <fpage>731</fpage>. <pub-id pub-id-type="doi">10.1038/nm1265</pub-id>
<pub-id pub-id-type="pmid">15980865</pub-id></mixed-citation></ref><ref id="B195"><mixed-citation publication-type="other">
<person-group person-group-type="author"><name><surname>Rein</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Copigmentation reactions and color stability of berry anthocyanins</article-title>.</mixed-citation></ref><ref id="B196"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ren</surname><given-names>Z.</given-names></name><name><surname>Na</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Rozati</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Dietary supplementation with lacto-wolfberry enhances the immune response and reduces pathogenesis to influenza infection in mice</article-title>. <source>J. Nutr.</source>
<volume>142</volume> (<issue>8</issue>), <fpage>1596</fpage>&#x02013;<lpage>1602</lpage>. <pub-id pub-id-type="doi">10.3945/jn.112.159467</pub-id>
<pub-id pub-id-type="pmid">22739381</pub-id></mixed-citation></ref><ref id="B197"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Revuelta-Herrero</surname><given-names>J. L.</given-names></name><name><surname>Chamorro-de-Vega</surname><given-names>E.</given-names></name><name><surname>Rodr&#x000ed;guez-Gonz&#x000e1;lez</surname><given-names>C. G.</given-names></name><name><surname>Alonso</surname><given-names>R.</given-names></name><name><surname>Herranz-Alonso</surname><given-names>A.</given-names></name><name><surname>Sanjurjo-S&#x000e1;ez</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Effectiveness, safety, and costs of a treatment switch to dolutegravir plus rilpivirine dual therapy in treatment-experienced HIV patients</article-title>. <source>Ann. Pharmacother.</source>
<volume>52</volume> (<issue>1</issue>), <fpage>11</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1177/1060028017728294</pub-id>
<pub-id pub-id-type="pmid">28836468</pub-id></mixed-citation></ref><ref id="B198"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rodriguez-Saona</surname><given-names>L. E.</given-names></name><name><surname>Giusti</surname><given-names>M. M.</given-names></name><name><surname>Wrolstad</surname><given-names>R. E.</given-names></name></person-group> (<year>1998</year>). <article-title>Anthocyanin pigment composition of red-fleshed potatoes</article-title>. <source>J. Food Sci.</source>
<volume>63</volume> (<issue>3</issue>), <fpage>458</fpage>&#x02013;<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2621.1998.tb15764.x</pub-id>
</mixed-citation></ref><ref id="B199"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roxas</surname><given-names>M.</given-names></name><name><surname>Jurenka</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations</article-title>. <source>Altern. Med. Rev.</source>
<volume>12</volume> (<issue>1</issue>), <fpage>25</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="pmid">17397266</pub-id></mixed-citation></ref><ref id="B200"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rukachaisirikul</surname><given-names>V.</given-names></name><name><surname>Pailee</surname><given-names>P.</given-names></name><name><surname>Hiranrat</surname><given-names>A.</given-names></name><name><surname>Tuchinda</surname><given-names>P.</given-names></name><name><surname>Yoosook</surname><given-names>C.</given-names></name><name><surname>Kasisit</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Anti-HIV-1 protostane triterpenes and digeranylbenzophenone from trunk bark and stems of Garcinia speciosa</article-title>. <source>Planta Med.</source>
<volume>69</volume> (<issue>12</issue>), <fpage>1141</fpage>&#x02013;<lpage>1146</lpage>. <pub-id pub-id-type="doi">10.1055/s-2003-818006</pub-id>
<pub-id pub-id-type="pmid">14750032</pub-id></mixed-citation></ref><ref id="B201"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saito</surname><given-names>N.</given-names></name><name><surname>Yokoi</surname><given-names>M.</given-names></name><name><surname>Yamaji</surname><given-names>M.</given-names></name><name><surname>Honda</surname><given-names>T.</given-names></name></person-group> (<year>1985</year>). <article-title>Anthocyanidin glycosides from the flowers of Alstroemeria</article-title>. <source>Phytochemistry</source>
<volume>24</volume> (<issue>9</issue>), <fpage>2125</fpage>&#x02013;<lpage>2126</lpage>. <pub-id pub-id-type="doi">10.1016/S0031-9422(00)83139-8</pub-id>
</mixed-citation></ref><ref id="B202"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sanvicens</surname><given-names>N.</given-names></name><name><surname>Marco</surname><given-names>M. P.</given-names></name></person-group> (<year>2008</year>). <article-title>Multifunctional nanoparticles&#x02013;properties and prospects for their use in human medicine</article-title>. <source>Trends Biotechnol.</source>
<volume>26</volume> (<issue>8</issue>), <fpage>425</fpage>&#x02013;<lpage>433</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2008.04.005</pub-id>
<pub-id pub-id-type="pmid">18514941</pub-id></mixed-citation></ref><ref id="B203"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schiller</surname><given-names>D. S.</given-names></name><name><surname>Youssef-Bessler</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Etravirine: a second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIV</article-title>. <source>Clin. Therapeut.</source>
<volume>31</volume> (<issue>4</issue>), <fpage>692</fpage>&#x02013;<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinthera.2009.04.020</pub-id>
</mixed-citation></ref><ref id="B204"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schneider</surname><given-names>W. M.</given-names></name><name><surname>Chevillotte</surname><given-names>M. D.</given-names></name><name><surname>Rice</surname><given-names>C. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Interferon-stimulated genes: a complex web of host defenses</article-title>. <source>Annu. Rev. Immunol.</source>
<volume>32</volume>, <fpage>513</fpage>&#x02013;<lpage>545</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120231</pub-id>
<pub-id pub-id-type="pmid">24555472</pub-id></mixed-citation></ref><ref id="B205"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sch&#x000fc;tz</surname><given-names>K.</given-names></name><name><surname>Sa&#x000df;</surname><given-names>M.</given-names></name><name><surname>Graubaum</surname><given-names>H.-J.</given-names></name><name><surname>Gr&#x000fc;nwald</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Immune-modulating efficacy of a polyphenol-rich beverage on symptoms associated with the common cold: a double-blind, randomised, placebo-controlled, multi-centric clinical study</article-title>. <source>Br. J. Nutr.</source>
<volume>104</volume> (<issue>8</issue>), <fpage>1156</fpage>&#x02013;<lpage>1164</lpage>. <pub-id pub-id-type="doi">10.1017/S0007114510002047</pub-id>
<pub-id pub-id-type="pmid">20487584</pub-id></mixed-citation></ref><ref id="B206"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sekizawa</surname><given-names>H.</given-names></name><name><surname>Ikuta</surname><given-names>K.</given-names></name><name><surname>Mizuta</surname><given-names>K.</given-names></name><name><surname>Takechi</surname><given-names>S.</given-names></name><name><surname>Suzutani</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Relationship between polyphenol content and anti-influenza viral effects of berries</article-title>. <source>J. Sci. Food Agric.</source>
<volume>93</volume> (<issue>9</issue>), <fpage>2239</fpage>&#x02013;<lpage>2241</lpage>. <pub-id pub-id-type="doi">10.1002/jsfa.6031</pub-id>
<pub-id pub-id-type="pmid">23355221</pub-id></mixed-citation></ref><ref id="B207"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Selmi</surname><given-names>C.</given-names></name><name><surname>Cocchi</surname><given-names>C. A.</given-names></name><name><surname>Lanfredini</surname><given-names>M.</given-names></name><name><surname>Keen</surname><given-names>C. L.</given-names></name><name><surname>Gershwin</surname><given-names>M. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Chocolate at heart: The anti-inflammatory impact of cocoa flavanols</article-title>. <source>Mol. Nutr. Food Res.</source>
<volume>52</volume> (<issue>11</issue>), <fpage>1340</fpage>&#x02013;<lpage>1348</lpage>. <pub-id pub-id-type="doi">10.1002/mnfr.200700435</pub-id>
<pub-id pub-id-type="pmid">18991246</pub-id></mixed-citation></ref><ref id="B208"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Serkedjieva</surname><given-names>J.</given-names></name><name><surname>Velcheva</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title><italic>In vitro</italic> anti-influenza virus activity of the pavine alkaloid (-)-thalimonine isolated from <italic>Thalictrum simplex</italic> L</article-title>. <source>Antivir. Chem. Chemother.</source>
<volume>14</volume> (<issue>2</issue>), <fpage>75</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1177/095632020301400202</pub-id>
<pub-id pub-id-type="pmid">12856918</pub-id></mixed-citation></ref><ref id="B209"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sim&#x000f5;es</surname><given-names>C.</given-names></name><name><surname>de Castro</surname><given-names>T. C.</given-names></name><name><surname>da Silva Cordeiro</surname><given-names>L.</given-names></name><name><surname>Albarello</surname><given-names>N.</given-names></name><name><surname>Mansur</surname><given-names>E.</given-names></name><name><surname>Romanos</surname><given-names>M. T. V.</given-names></name></person-group> (<year>2010</year>). <article-title>Antiviral activity of Cleome rosea extracts from field-grown plants and tissue culture-derived materials against acyclovir-resistant Herpes simplex viruses type 1 (ACVr-HSV-1) and type 2 (ACVr-HSV-2)</article-title>. <source>World J. Microbiol. Biotechnol.</source>
<volume>26</volume> (<issue>1</issue>), <fpage>93</fpage>. <pub-id pub-id-type="doi">10.1007/s11274-009-0147-7</pub-id>
</mixed-citation></ref><ref id="B210"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sim&#x000f5;es</surname><given-names>C. M. O.</given-names></name><name><surname>Reginatto</surname><given-names>F. H.</given-names></name><name><surname>Calvete</surname><given-names>E.</given-names></name><name><surname>Blum Silva</surname><given-names>C. H.</given-names></name><name><surname>Carvalho</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Anti HSV-1 activity of five strawberry cultivars</article-title>. <source>Lat. Am. J. Pharm.</source>
<volume>31</volume> (<issue>1</issue>), <fpage>133</fpage>&#x02013;<lpage>137</lpage>.</mixed-citation></ref><ref id="B211"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Simon</surname><given-names>V.</given-names></name><name><surname>Ho</surname><given-names>D. D.</given-names></name><name><surname>Karim</surname><given-names>Q. A.</given-names></name></person-group> (<year>2006</year>). <article-title>HIV/AIDS epidemiology, pathogenesis, prevention, and treatment</article-title>. <source>Lancet</source>
<volume>368</volume> (<issue>9534</issue>), <fpage>489</fpage>&#x02013;<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(06)69157-5</pub-id>
<pub-id pub-id-type="pmid">16890836</pub-id></mixed-citation></ref><ref id="B212"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Slimestad</surname><given-names>R.</given-names></name><name><surname>Solheim</surname><given-names>H.</given-names></name></person-group> (<year>2002</year>). <article-title>Anthocyanins from black currants (Ribes nigrum L.)</article-title>. <source>J. Agric. Food Chem.</source>
<volume>50</volume> (<issue>11</issue>), <fpage>3228</fpage>&#x02013;<lpage>3231</lpage>. <pub-id pub-id-type="doi">10.1021/jf011581u</pub-id>
<pub-id pub-id-type="pmid">12009991</pub-id></mixed-citation></ref><ref id="B213"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smeriglio</surname><given-names>A.</given-names></name><name><surname>Barreca</surname><given-names>D.</given-names></name><name><surname>Bellocco</surname><given-names>E.</given-names></name><name><surname>Trombetta</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>Chemistry, pharmacology and health benefits of anthocyanins</article-title>. <source>Phytother. Res.</source>
<volume>30</volume> (<issue>8</issue>), <fpage>1265</fpage>&#x02013;<lpage>1286</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.5642</pub-id>
<pub-id pub-id-type="pmid">27221033</pub-id></mixed-citation></ref><ref id="B214"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sodagari</surname><given-names>H. R.</given-names></name><name><surname>Farzaei</surname><given-names>M. H.</given-names></name><name><surname>Bahramsoltani</surname><given-names>R.</given-names></name><name><surname>Abdolghaffari</surname><given-names>A. H.</given-names></name><name><surname>Mahmoudi</surname><given-names>M.</given-names></name><name><surname>Rezaei</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>Dietary anthocyanins as a complementary medicinal approach for management of inflammatory bowel disease</article-title>. <source>Expert Rev. Gastroenterol. Hepatol.</source>
<volume>9</volume> (<issue>6</issue>), <fpage>807</fpage>&#x02013;<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1586/17474124.2015.1002086</pub-id>
<pub-id pub-id-type="pmid">25586636</pub-id></mixed-citation></ref><ref id="B215"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sokmen</surname><given-names>M.</given-names></name><name><surname>Angelova</surname><given-names>M.</given-names></name><name><surname>Krumova</surname><given-names>E.</given-names></name><name><surname>Pashova</surname><given-names>S.</given-names></name><name><surname>Ivancheva</surname><given-names>S.</given-names></name><name><surname>Sokmen</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>In vitro antioxidant activity of polyphenol extracts with antiviral properties from <italic>Geranium sanguineum</italic> L</article-title>. <source>Life Sci.</source>
<volume>76</volume> (<issue>25</issue>), <fpage>2981</fpage>&#x02013;<lpage>2993</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2004.11.020</pub-id>
<pub-id pub-id-type="pmid">15820508</pub-id></mixed-citation></ref><ref id="B216"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Soriano</surname><given-names>V.</given-names></name><name><surname>Perno</surname><given-names>C.-F.</given-names></name><name><surname>Kaiser</surname><given-names>R.</given-names></name><name><surname>Calvez</surname><given-names>V.</given-names></name><name><surname>Gatell</surname><given-names>J. M.</given-names></name><name><surname>Di Perri</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>When and how to use maraviroc in HIV-infected patients</article-title>. <source>Aids</source>
<volume>23</volume> (<issue>18</issue>), <fpage>2377</fpage>&#x02013;<lpage>2385</lpage>. <pub-id pub-id-type="doi">10.1097/QAD.0b013e328332d32d</pub-id>
<pub-id pub-id-type="pmid">19834318</pub-id></mixed-citation></ref><ref id="B217"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Su</surname><given-names>X.</given-names></name><name><surname>D&#x02019;Souza</surname><given-names>D. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Grape seed extract for control of human enteric viruses</article-title>. <source>Appl. Environ. Microbiol.</source>
<volume>77</volume> (<issue>12</issue>), <fpage>3982</fpage>&#x02013;<lpage>3987</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00193-11</pub-id>
<pub-id pub-id-type="pmid">21498749</pub-id></mixed-citation></ref><ref id="B218"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Swaminathan</surname><given-names>K.</given-names></name><name><surname>Dyason</surname><given-names>J. C.</given-names></name><name><surname>Maggioni</surname><given-names>A.</given-names></name><name><surname>von Itzstein</surname><given-names>M.</given-names></name><name><surname>Downard</surname><given-names>K. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry</article-title>. <source>Anal. Bioanal. Chem.</source>
<volume>405</volume> (<issue>20</issue>), <fpage>6563</fpage>&#x02013;<lpage>6572</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-013-7068-x</pub-id>
<pub-id pub-id-type="pmid">23748498</pub-id></mixed-citation></ref><ref id="B219"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Swaminathan</surname><given-names>K.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>P.</given-names></name><name><surname>Downard</surname><given-names>K. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Substituent effects on the binding of natural product anthocyanidin inhibitors to influenza neuraminidase with mass spectrometry</article-title>. <source>Anal. Chim. acta</source>
<volume>828</volume>, <fpage>61</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.aca.2014.04.021</pub-id>
<pub-id pub-id-type="pmid">24845816</pub-id></mixed-citation></ref><ref id="B220"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Talavera</surname><given-names>S.</given-names></name><name><surname>Felgines</surname><given-names>C.</given-names></name><name><surname>Texier</surname><given-names>O.</given-names></name><name><surname>Besson</surname><given-names>C.</given-names></name><name><surname>Lamaison</surname><given-names>J.-L.</given-names></name><name><surname>Re&#x000b4;me&#x000b4;sy</surname><given-names>C.</given-names></name></person-group> (<year>2003</year>). <article-title>Anthocyanins are efficiently absorbed from the stomach in anesthetized rats</article-title>. <source>J. Nutr.</source>
<volume>133</volume> (<issue>12</issue>), <fpage>4178</fpage>&#x02013;<lpage>4182</lpage>. <pub-id pub-id-type="doi">10.1093/jn/133.12.4178</pub-id>
<pub-id pub-id-type="pmid">14652368</pub-id></mixed-citation></ref><ref id="B221"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tatsuzawa</surname><given-names>F.</given-names></name><name><surname>Saito</surname><given-names>N.</given-names></name><name><surname>Murata</surname><given-names>N.</given-names></name><name><surname>Shinoda</surname><given-names>K.</given-names></name><name><surname>Shigihara</surname><given-names>A.</given-names></name><name><surname>Honda</surname><given-names>T.</given-names></name></person-group> (<year>2003</year>). <article-title>6-Hydroxypelargonidin glycosides in the orange&#x02013;red flowers of Alstroemeria</article-title>. <source>Phytochemistry</source>
<volume>62</volume> (<issue>8</issue>), <fpage>1239</fpage>&#x02013;<lpage>1242</lpage>. <pub-id pub-id-type="doi">10.1016/S0031-9422(02)00683-0</pub-id>
<pub-id pub-id-type="pmid">12648544</pub-id></mixed-citation></ref><ref id="B222"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Telenti</surname><given-names>A.</given-names></name><name><surname>Paolo Rizzardi</surname><given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>Limits to potent antiretroviral therapy</article-title>. <source>Rev. Med. Virol.</source>
<volume>10</volume> (<issue>6</issue>), <fpage>385</fpage>&#x02013;<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1002/1099-1654(200011/12)10:6&#x0003c;385::AID-RMV296&#x0003e;3.0.CO;2-1</pub-id>
<pub-id pub-id-type="pmid">11114077</pub-id></mixed-citation></ref><ref id="B223"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tilton</surname><given-names>J. C.</given-names></name><name><surname>Doms</surname><given-names>R. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Entry inhibitors in the treatment of HIV-1 infection</article-title>. <source>Antivir. Res.</source>
<volume>85</volume> (<issue>1</issue>), <fpage>91</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2009.07.022</pub-id>
<pub-id pub-id-type="pmid">19683546</pub-id></mixed-citation></ref><ref id="B224"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tiralongo</surname><given-names>E.</given-names></name><name><surname>Wee</surname><given-names>S.</given-names></name><name><surname>Lea</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Elderberry supplementation reduces cold duration and symptoms in air-travellers: a randomized, double-blind placebo-controlled clinical trial</article-title>. <source>Nutrients</source>
<volume>8</volume> (<issue>4</issue>), <fpage>182</fpage>. <pub-id pub-id-type="doi">10.3390/nu8040182</pub-id>
<pub-id pub-id-type="pmid">27023596</pub-id></mixed-citation></ref><ref id="B225"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tozzi</surname><given-names>V.</given-names></name></person-group> (<year>2010</year>). <article-title>Pharmacogenetics of antiretrovirals</article-title>. <source>Antivir. Res.</source>
<volume>85</volume> (<issue>1</issue>), <fpage>190</fpage>&#x02013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2009.09.001</pub-id>
<pub-id pub-id-type="pmid">19744523</pub-id></mixed-citation></ref><ref id="B226"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tsuda</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Dietary anthocyanin-rich plants: biochemical basis and recent progress in health benefits studies</article-title>. <source>Mol. Nutr. Food Res.</source>
<volume>56</volume> (<issue>1</issue>), <fpage>159</fpage>&#x02013;<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1002/mnfr.201100526</pub-id>
<pub-id pub-id-type="pmid">22102523</pub-id></mixed-citation></ref><ref id="B227"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Uhl</surname><given-names>P.</given-names></name><name><surname>Fricker</surname><given-names>G.</given-names></name><name><surname>Haberkorn</surname><given-names>U.</given-names></name><name><surname>Mier</surname><given-names>W.</given-names></name></person-group> (<year>2014</year>). <article-title>Current status in the therapy of liver diseases</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>15</volume> (<issue>5</issue>), <fpage>7500</fpage>&#x02013;<lpage>7512</lpage>. <pub-id pub-id-type="doi">10.3390/ijms15057500</pub-id>
<pub-id pub-id-type="pmid">24786290</pub-id></mixed-citation></ref><ref id="B228"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ulbricht</surname><given-names>C.</given-names></name><name><surname>Basch</surname><given-names>E.</given-names></name><name><surname>Cheung</surname><given-names>L.</given-names></name><name><surname>Goldberg</surname><given-names>H.</given-names></name><name><surname>Hammerness</surname><given-names>P.</given-names></name><name><surname>Isaac</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>An evidence-based systematic review of elderberry and elderflower (Sambucus nigra) by the natural standard research collaboration</article-title>. <source>J. Diet. Suppl.</source>
<volume>11</volume> (<issue>1</issue>), <fpage>80</fpage>&#x02013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.3109/19390211.2013.859852</pub-id>
<pub-id pub-id-type="pmid">24409980</pub-id></mixed-citation></ref><ref id="B229"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Unten</surname><given-names>S.</given-names></name><name><surname>Ushijima</surname><given-names>H.</given-names></name><name><surname>Shimizu</surname><given-names>H.</given-names></name><name><surname>Tsuchie</surname><given-names>H.</given-names></name><name><surname>Kitamura</surname><given-names>T.</given-names></name><name><surname>Moritome</surname><given-names>N.</given-names></name><etal/></person-group> (<year>1991</year>). <article-title>Effect of cacao husk extract on human immunodeficiency virus infection</article-title>. <source>Lett. Appl. Microbiol.</source>
<volume>13</volume> (<issue>6</issue>), <fpage>251</fpage>&#x02013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1111/j.1472-765X.1991.tb00621.x</pub-id>
<pub-id pub-id-type="pmid">1367748</pub-id></mixed-citation></ref><ref id="B230"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Valadares</surname><given-names>Y. M.</given-names></name><name><surname>Brand&#x000e3;o</surname><given-names>G. C.</given-names></name><name><surname>Kroon</surname><given-names>E. G.</given-names></name><name><surname>Souza Filho</surname><given-names>J. D.</given-names></name><name><surname>Oliveira</surname><given-names>A. B.</given-names></name><name><surname>Braga</surname><given-names>F. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Antiviral activity of Solanum paniculatum extract and constituents</article-title>. <source>Z. Naturforsch. C.</source>
<volume>64</volume> (<issue>11&#x02013;12</issue>), <fpage>813</fpage>&#x02013;<lpage>818</lpage>. <pub-id pub-id-type="doi">10.1515/znc-2009-11-1210</pub-id>
<pub-id pub-id-type="pmid">20158151</pub-id></mixed-citation></ref><ref id="B231"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Valcheva-Kuzmanova</surname><given-names>S.</given-names></name><name><surname>Russev</surname><given-names>V.</given-names></name><name><surname>Bojkova</surname><given-names>K.</given-names></name><name><surname>Belcheva</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Study of natural Aronia melanocarpa fruit juice for antibacterial and antiviral activity</article-title>. <source>Scr. Sci. Med.</source>
<volume>35</volume>, <fpage>21</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.14748/ssm.v35i0.1948</pub-id>
</mixed-citation></ref><ref id="B232"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Valiente-Echeverr&#x000ed;a</surname><given-names>F.</given-names></name><name><surname>Hermoso</surname><given-names>M. A.</given-names></name><name><surname>Soto-Rifo</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>RNA helicase DDX3: at the crossroad of viral replication and antiviral immunity</article-title>. <source>Rev. Med. Virol.</source>
<volume>25</volume> (<issue>5</issue>), <fpage>286</fpage>&#x02013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1002/rmv.1845</pub-id>
<pub-id pub-id-type="pmid">26174373</pub-id></mixed-citation></ref><ref id="B233"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vassilaki</surname><given-names>N.</given-names></name><name><surname>Friebe</surname><given-names>P.</given-names></name><name><surname>Meuleman</surname><given-names>P.</given-names></name><name><surname>Kallis</surname><given-names>S.</given-names></name><name><surname>Kaul</surname><given-names>A.</given-names></name><name><surname>Paranhos-Baccal&#x000e0;</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Role of the hepatitis C virus core+ 1 open reading frame and core cis-acting RNA elements in viral RNA translation and replication</article-title>. <source>J. Virol.</source>
<volume>82</volume> (<issue>23</issue>), <fpage>11503</fpage>&#x02013;<lpage>11515</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01640-08</pub-id>
<pub-id pub-id-type="pmid">18799568</pub-id></mixed-citation></ref><ref id="B234"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>V&#x000e1;zquez-Calvo</surname><given-names>&#x000c1;.</given-names></name><name><surname>Jim&#x000e9;nez de Oya</surname><given-names>N.</given-names></name><name><surname>Mart&#x000ed;n-Acebes</surname><given-names>M. A.</given-names></name><name><surname>Garcia-Moruno</surname><given-names>E.</given-names></name><name><surname>Saiz</surname><given-names>J.-C.</given-names></name></person-group> (<year>2017</year>). <article-title>Antiviral properties of the natural polyphenols delphinidin and epigallocatechin gallate against the flaviviruses West Nile virus, Zika virus, and dengue virus</article-title>. <source>Front. Microbiol.</source>
<volume>8</volume>, <fpage>1314</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.01314</pub-id>
<pub-id pub-id-type="pmid">28744282</pub-id></mixed-citation></ref><ref id="B235"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Veberic</surname><given-names>R.</given-names></name><name><surname>Slatnar</surname><given-names>A.</given-names></name><name><surname>Bizjak</surname><given-names>J.</given-names></name><name><surname>Stampar</surname><given-names>F.</given-names></name><name><surname>Mikulic-Petkovsek</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Anthocyanin composition of different wild and cultivated berry species</article-title>. <source>LWT-Food Sci. Technol.</source>
<volume>60</volume> (<issue>1</issue>), <fpage>509</fpage>&#x02013;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1016/j.lwt.2014.08.033</pub-id>
</mixed-citation></ref><ref id="B236"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Veckenstedt</surname><given-names>A.</given-names></name><name><surname>B&#x000e9;l&#x000e1;di</surname><given-names>I.</given-names></name><name><surname>Mucsi</surname><given-names>I.</given-names></name></person-group> (<year>1978</year>). <article-title>Effect of treatment with certain flavonoids on Mengo virus-induced encephalitis in mice</article-title>. <source>Arch. Virol.</source>
<volume>57</volume> (<issue>3</issue>), <fpage>255</fpage>&#x02013;<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1007/BF01315089</pub-id>
<pub-id pub-id-type="pmid">209770</pub-id></mixed-citation></ref><ref id="B237"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vishnu</surname><given-names>V. R.</given-names></name><name><surname>Renjith</surname><given-names>R. S.</given-names></name><name><surname>Mukherjee</surname><given-names>A.</given-names></name><name><surname>Anil</surname><given-names>S. R.</given-names></name><name><surname>Sreekumar</surname><given-names>J.</given-names></name><name><surname>Jyothi</surname><given-names>A. N.</given-names></name></person-group> (<year>2019</year>). <article-title>Comparative study on the chemical structure and <italic>in vitro</italic> antiproliferative activity of anthocyanins in purple root tubers and leaves of sweet potato (Ipomoea batatas)</article-title>. <source>J. Agric. Food Chem.</source>
<volume>67</volume> (<issue>9</issue>), <fpage>2467</fpage>&#x02013;<lpage>2475</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.8b05473</pub-id>
<pub-id pub-id-type="pmid">30741542</pub-id></mixed-citation></ref><ref id="B238"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Viskelis</surname><given-names>P.</given-names></name><name><surname>Rubinskien&#x00117;</surname><given-names>M.</given-names></name><name><surname>Jasutien&#x00117;</surname><given-names>I.</given-names></name><name><surname>&#x00160;arkinas</surname><given-names>A.</given-names></name><name><surname>Daubaras</surname><given-names>R.</given-names></name><name><surname>&#x0010c;esonien&#x00117;</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>Anthocyanins, antioxidative, and antimicrobial properties of American cranberry (Vaccinium macrocarpon Ait.) and their press cakes</article-title>. <source>J. Food Sci.</source>
<volume>74</volume> (<issue>2</issue>), <fpage>C157</fpage>&#x02013;<lpage>C161</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-3841.2009.01066.x</pub-id>
<pub-id pub-id-type="pmid">19323730</pub-id></mixed-citation></ref><ref id="B239"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vlietinck</surname><given-names>A. J.</given-names></name><name><surname>Berghe</surname><given-names>D. A. V.</given-names></name></person-group> (<year>1991</year>). <article-title>Can ethnopharmacology contribute to the development of antiviral drugs</article-title>? <source>J. Ethnopharmacol.</source>
<volume>32</volume> (<issue>1&#x02013;3</issue>), <fpage>141</fpage>&#x02013;<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/0378-8741(91)90112-Q</pub-id>
<pub-id pub-id-type="pmid">1652667</pub-id></mixed-citation></ref><ref id="B240"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Nair</surname><given-names>M. G.</given-names></name><name><surname>Strasburg</surname><given-names>G. M.</given-names></name><name><surname>Chang</surname><given-names>Y.-C.</given-names></name><name><surname>Booren</surname><given-names>A. M.</given-names></name><name><surname>Gray</surname><given-names>J. I.</given-names></name><etal/></person-group> (<year>1999</year>). <article-title>Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries</article-title>. <source>J. Nat. Prod.</source>
<volume>62</volume> (<issue>2</issue>), <fpage>294</fpage>&#x02013;<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1021/np980501m</pub-id>
<pub-id pub-id-type="pmid">10075763</pub-id></mixed-citation></ref><ref id="B241"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.-S.</given-names></name><name><surname>Stoner</surname><given-names>G. D.</given-names></name></person-group> (<year>2008</year>). <article-title>Anthocyanins and their role in cancer prevention</article-title>. <source>Cancer Lett.</source>
<volume>269</volume> (<issue>2</issue>), <fpage>281</fpage>&#x02013;<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2008.05.020</pub-id>
<pub-id pub-id-type="pmid">18571839</pub-id></mixed-citation></ref><ref id="B242"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Jia</surname><given-names>W.</given-names></name><name><surname>Zhao</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group> (<year>2006</year>). <article-title>Anti-influenza agents from plants and traditional Chinese medicine</article-title>. <source>Phytother. Res.</source>
<volume>20</volume> (<issue>5</issue>), <fpage>335</fpage>&#x02013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.1892</pub-id>
<pub-id pub-id-type="pmid">16619359</pub-id></mixed-citation></ref><ref id="B243"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.-L.</given-names></name><name><surname>Huang</surname><given-names>X.-J.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Flavone C-glycosides from the leaves of Lophatherum gracile and their <italic>in vitro</italic> antiviral activity</article-title>. <source>Planta Med.</source>
<volume>78</volume> (<issue>01</issue>), <fpage>46</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1055/s-0031-1280128</pub-id>
<pub-id pub-id-type="pmid">21870321</pub-id></mixed-citation></ref><ref id="B244"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weiss</surname><given-names>E.</given-names></name><name><surname>Houri-Haddad</surname><given-names>Y.</given-names></name><name><surname>Greenbaum</surname><given-names>E.</given-names></name><name><surname>Hochman</surname><given-names>N.</given-names></name><name><surname>Ofek</surname><given-names>I.</given-names></name><name><surname>Zakay-Rones</surname><given-names>Z.</given-names></name></person-group> (<year>2005</year>). <article-title>Cranberry juice constituents affect influenza virus adhesion and infectivity</article-title>. <source>Antivir. Res.</source>
<volume>66</volume> (<issue>1</issue>), <fpage>9</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2004.12.011</pub-id>
<pub-id pub-id-type="pmid">15781126</pub-id></mixed-citation></ref><ref id="B245"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Welliver</surname><given-names>R. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Pharmacotherapy of respiratory syncytial virus infection</article-title>. <source>Curr. Opin. Pharmacol.</source>
<volume>10</volume> (<issue>3</issue>), <fpage>289</fpage>&#x02013;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2010.04.013</pub-id>
<pub-id pub-id-type="pmid">20493773</pub-id></mixed-citation></ref><ref id="B246"><mixed-citation publication-type="other">
<person-group person-group-type="author"><name><surname>Willig</surname><given-names>J. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Analysis of antiviral and chemoprotective effects of strawberry anthocyanins</article-title>.</mixed-citation></ref><ref id="B247"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wleklik</surname><given-names>M.</given-names></name><name><surname>Luczak</surname><given-names>M.</given-names></name><name><surname>Panasiak</surname><given-names>W.</given-names></name><name><surname>Kobus</surname><given-names>M.</given-names></name><name><surname>Lammer-Zarawska</surname><given-names>E.</given-names></name></person-group> (<year>1988</year>). <article-title>Structural basis for antiviral activity of flavonoids-naturally occurring compounds</article-title>. <source>Acta Virol.</source>
<volume>32</volume> (<issue>6</issue>), <fpage>522</fpage>&#x02013;<lpage>525</lpage>.<pub-id pub-id-type="pmid">2906224</pub-id></mixed-citation></ref><ref id="B248"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wongwichai</surname><given-names>T.</given-names></name><name><surname>Teeyakasem</surname><given-names>P.</given-names></name><name><surname>Pruksakorn</surname><given-names>D.</given-names></name><name><surname>Kongtawelert</surname><given-names>P.</given-names></name><name><surname>Pothacharoen</surname><given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Anthocyanins and metabolites from purple rice inhibit IL-1beta-induced matrix metalloproteinases expression in human articular chondrocytes through the NF-kappaB and ERK/MAPK pathway</article-title>. <source>Biomed. Pharmacother.</source>
<volume>112</volume>, <fpage>108610</fpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2019.108610</pub-id>
<pub-id pub-id-type="pmid">30797145</pub-id></mixed-citation></ref><ref id="B249"><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Wouters</surname><given-names>J.</given-names></name><name><surname>Berghe</surname><given-names>I. V.</given-names></name><name><surname>Devia</surname><given-names>B.</given-names></name></person-group> (<year>2005</year>). <article-title>Understanding historic dyeing technology: a multifaceted approach, in Scientific analysis of ancient and historic textiles: informing preservation, display and interpretation</article-title> (eds. R. <person-group person-group-type="editor"><name><surname>Wyeth</surname><given-names>Janawayand P.</given-names></name></person-group>), <fpage>187</fpage>&#x02013;<lpage>193</lpage>, <publisher-name>Archetype</publisher-name>, <publisher-loc>London</publisher-loc>.</mixed-citation></ref><ref id="B250"><mixed-citation publication-type="other">
<person-group person-group-type="author"><name><surname>Wright</surname><given-names>A. E.</given-names></name><name><surname>Cross</surname><given-names>S. S.</given-names></name><name><surname>Burres</surname><given-names>N. S.</given-names></name><name><surname>Koehn</surname><given-names>F.</given-names></name></person-group> (<year>1993</year>). <source>Novel antiviral and anti-leukemia terpene hydroquinones and methods of use</source>. US5204367A, United States, Google Patents. </mixed-citation></ref><ref id="B251"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>H.-Y.</given-names></name><name><surname>Yang</surname><given-names>K.-M.</given-names></name><name><surname>Chiang</surname><given-names>P.-Y.</given-names></name></person-group> (<year>2018</year>). <article-title>Roselle anthocyanins: antioxidant properties and stability to heat and pH</article-title>. <source>Molecules</source>
<volume>23</volume> (<issue>6</issue>), <fpage>1357</fpage>. <pub-id pub-id-type="doi">10.3390/molecules23061357</pub-id>
</mixed-citation></ref><ref id="B252"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Cao</surname><given-names>G.</given-names></name><name><surname>Prior</surname><given-names>R. L.</given-names></name></person-group> (<year>2002</year>). <article-title>Absorption and metabolism of anthocyanins in elderly women after consumption of elderberry or blueberry</article-title>. <source>J. Nutr.</source>
<volume>132</volume> (<issue>7</issue>), <fpage>1865</fpage>&#x02013;<lpage>1871</lpage>. <pub-id pub-id-type="doi">10.1093/jn/132.7.1865</pub-id>
<pub-id pub-id-type="pmid">12097661</pub-id></mixed-citation></ref><ref id="B253"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Kalimo</surname><given-names>K. O.</given-names></name><name><surname>Mattila</surname><given-names>L. M.</given-names></name><name><surname>Kallio</surname><given-names>S. E.</given-names></name><name><surname>Katajisto</surname><given-names>J. K.</given-names></name><name><surname>Peltola</surname><given-names>O. J.</given-names></name><etal/></person-group> (<year>1999</year>). <article-title>Effects of dietary supplementation with sea buckthorn (<italic>Hippophae rhamnoides</italic>) seed and pulp oils on atopic dermatitis</article-title>. <source>J. Nutr. Biochem.</source>
<volume>10</volume> (<issue>11</issue>), <fpage>622</fpage>&#x02013;<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1016/S0955-2863(99)00049-2</pub-id>
<pub-id pub-id-type="pmid">15539258</pub-id></mixed-citation></ref><ref id="B254"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>B.</given-names></name><name><surname>Kallio</surname><given-names>H.</given-names></name></person-group> (<year>2002</year>). <article-title>Composition and physiological effects of sea buckthorn (Hippophae) lipids</article-title>. <source>Trends Food Sci. Technol.</source>
<volume>13</volume> (<issue>5</issue>), <fpage>160</fpage>&#x02013;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1016/S0924-2244(02)00136-X</pub-id>
</mixed-citation></ref><ref id="B255"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>C.-M.</given-names></name><name><surname>Cheng</surname><given-names>H.-Y.</given-names></name><name><surname>Lin</surname><given-names>T.-C.</given-names></name><name><surname>Chiang</surname><given-names>L.-C.</given-names></name><name><surname>Lin</surname><given-names>C.-C.</given-names></name></person-group> (<year>2007</year>a). <article-title>The <italic>in vitro</italic> activity of geraniin and 1, 3, 4, 6-tetra-O-galloyl-&#x003b2;-d-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection</article-title>. <source>J. Ethnopharmacol.</source>
<volume>110</volume> (<issue>3</issue>), <fpage>555</fpage>&#x02013;<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2006.09.039</pub-id>
<pub-id pub-id-type="pmid">17113739</pub-id></mixed-citation></ref><ref id="B256"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>C. M.</given-names></name><name><surname>Cheng</surname><given-names>H. Y.</given-names></name><name><surname>Lin</surname><given-names>T. C.</given-names></name><name><surname>Chiang</surname><given-names>L. C.</given-names></name><name><surname>Lin</surname><given-names>C. C.</given-names></name></person-group> (<year>2007</year>b). <article-title>Hippomanin a from acetone extract of Phyllanthus urinaria inhibited HSV-2 but not HSV-1 infection <italic>in vitro</italic></article-title>. <source>Phytother. Res.</source>
<volume>21</volume> (<issue>12</issue>), <fpage>1182</fpage>&#x02013;<lpage>1186</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.2232</pub-id>
<pub-id pub-id-type="pmid">17661333</pub-id></mixed-citation></ref><ref id="B257"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>S.-K.</given-names></name><name><surname>Kim</surname><given-names>M.</given-names></name><name><surname>Reche</surname><given-names>P. A.</given-names></name><name><surname>Morehead</surname><given-names>T. J.</given-names></name><name><surname>Damon</surname><given-names>I. K.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction</article-title>. <source>J. Clin. Invest.</source>
<volume>115</volume> (<issue>2</issue>), <fpage>379</fpage>&#x02013;<lpage>387</lpage>. <pub-id pub-id-type="doi">10.1172/JCI200523220</pub-id>
<pub-id pub-id-type="pmid">15690085</pub-id></mixed-citation></ref><ref id="B258"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>N.</given-names></name><name><surname>Sun</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>Identification and analysis of novel inhibitors against NS3 helicase and NS5B RNA-dependent RNA polymerase from hepatitis C virus 1b (Con1)</article-title>. <source>Front. Microbiol.</source>
<volume>8</volume>, <fpage>2153</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.02153</pub-id>
<pub-id pub-id-type="pmid">29209282</pub-id></mixed-citation></ref><ref id="B259"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yeung</surname><given-names>A. W. K.</given-names></name><name><surname>Aggarwal</surname><given-names>B. B.</given-names></name><name><surname>Barreca</surname><given-names>D.</given-names></name><name><surname>Battino</surname><given-names>M.</given-names></name><name><surname>Belwal</surname><given-names>T.</given-names></name><name><surname>Berindan-Neagoe</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Dietary natural products and their potential to influence health and disease</article-title>. <source>Anim. Sci. Pap. Rep.</source>
<volume>36</volume>, <fpage>345</fpage>&#x02013;<lpage>358</lpage>. </mixed-citation></ref><ref id="B260"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>K.</given-names></name><name><surname>Sato</surname><given-names>Y.</given-names></name><name><surname>Okuno</surname><given-names>R.</given-names></name><name><surname>Kameda</surname><given-names>K.</given-names></name><name><surname>Isobe</surname><given-names>M.</given-names></name><name><surname>Kondo</surname><given-names>T.</given-names></name></person-group> (<year>1996</year>). <article-title>Structural analysis and measurement of anthocyanins from colored seed coats of Vigna, Phaseolus, and Glycine legumes</article-title>. <source>Biosci. Biotechnol. Biochem.</source>
<volume>60</volume> (<issue>4</issue>), <fpage>589</fpage>&#x02013;<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.60.589</pub-id>
</mixed-citation></ref><ref id="B261"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Morris-Natschke</surname><given-names>S. L.</given-names></name><name><surname>Lee</surname><given-names>K. H.</given-names></name></person-group> (<year>2007</year>). <article-title>New developments in natural products-based anti-AIDS research</article-title>. <source>Med. Res. Rev.</source>
<volume>27</volume> (<issue>1</issue>), <fpage>108</fpage>&#x02013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1002/med.20075</pub-id>
<pub-id pub-id-type="pmid">16888749</pub-id></mixed-citation></ref><ref id="B262"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yuan</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Crain</surname><given-names>K.</given-names></name><name><surname>Fearns</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>K. A.</given-names></name><name><surname>Hua</surname><given-names>K. L.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4+ T cell resistance and enrichment</article-title>. <source>Mol. Ther.</source>
<volume>20</volume> (<issue>4</issue>), <fpage>849</fpage>&#x02013;<lpage>859</lpage>. <pub-id pub-id-type="doi">10.1038/mt.2011.310</pub-id>
<pub-id pub-id-type="pmid">22273578</pub-id></mixed-citation></ref><ref id="B263"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zakay-Rones</surname><given-names>Z.</given-names></name><name><surname>Thom</surname><given-names>E.</given-names></name><name><surname>Wollan</surname><given-names>T.</given-names></name><name><surname>Wadstein</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections</article-title>. <source>J. Int. Med. Res.</source>
<volume>32</volume> (<issue>2</issue>), <fpage>132</fpage>&#x02013;<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1177/147323000403200205</pub-id>
<pub-id pub-id-type="pmid">15080016</pub-id></mixed-citation></ref><ref id="B264"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zakay-Rones</surname><given-names>Z.</given-names></name><name><surname>Varsano</surname><given-names>N.</given-names></name><name><surname>Zlotnik</surname><given-names>M.</given-names></name><name><surname>Manor</surname><given-names>O.</given-names></name><name><surname>Regev</surname><given-names>L.</given-names></name><name><surname>Schlesinger</surname><given-names>M.</given-names></name><etal/></person-group> (<year>1995</year>). <article-title>Inhibition of several strains of influenza virus <italic>in vitro</italic> and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama</article-title>. <source>J. Alternat. Complement. Med.</source>
<volume>1</volume> (<issue>4</issue>), <fpage>361</fpage>&#x02013;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1089/acm.1995.1.361</pub-id>
</mixed-citation></ref><ref id="B265"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zang</surname><given-names>N.</given-names></name><name><surname>Xie</surname><given-names>X.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Peng</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice</article-title>. <source>J. Virol.</source>
<volume>85</volume> (<issue>24</issue>), <fpage>13061</fpage>&#x02013;<lpage>13068</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.05869-11</pub-id>
<pub-id pub-id-type="pmid">21937650</pub-id></mixed-citation></ref><ref id="B266"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zeller</surname><given-names>S. J.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>RNA-based gene therapy for the treatment and prevention of HIV: from bench to bedside</article-title>. <source>Yale J. Biol. Med.</source>
<volume>84</volume> (<issue>3</issue>), <fpage>301</fpage>. <pub-id pub-id-type="pmid">21966049</pub-id></mixed-citation></ref><ref id="B267"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zeng</surname><given-names>F.-L.</given-names></name><name><surname>Xiang</surname><given-names>Y.-F.</given-names></name><name><surname>Liang</surname><given-names>Z.-R.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>D.-e.</given-names></name><name><surname>Zhu</surname><given-names>S.-N.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Anti-hepatitis B virus effects of dehydrocheilanthifoline from Corydalis saxicola</article-title>. <source>Am. J. Chin. Med.</source>
<volume>41</volume> (<issue>01</issue>), <fpage>119</fpage>&#x02013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1142/S0192415X13500092</pub-id>
<pub-id pub-id-type="pmid">23336511</pub-id></mixed-citation></ref><ref id="B268"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.-J.</given-names></name><name><surname>Tan</surname><given-names>G. T.</given-names></name><name><surname>Hoang</surname><given-names>V. D.</given-names></name><name><surname>Hung</surname><given-names>N. V.</given-names></name><name><surname>Cuong</surname><given-names>N. M.</given-names></name><name><surname>Soejarto</surname><given-names>D. D.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Natural Anti-HIV Agents. Part IV. Anti-HIV Constituents from Vatica c inerea</article-title>. <source>J. Nat. Prod.</source>
<volume>66</volume> (<issue>2</issue>), <fpage>263</fpage>&#x02013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1021/np020379y</pub-id>
<pub-id pub-id-type="pmid">12608862</pub-id></mixed-citation></ref><ref id="B269"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Huo</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Dai</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group> (<year>2019</year>). <article-title>Nanocrystallization of Anthocyanin Extract from Red-Fleshed Apple&#x02032; QN-5&#x02032; Improved Its Antioxidant Effect through Enhanced Stability and Activity under Stressful Conditions</article-title>. <source>Molecules</source>
<volume>24</volume> (<issue>7</issue>), <fpage>1421</fpage>. <pub-id pub-id-type="doi">10.3390/molecules24071421</pub-id>
</mixed-citation></ref><ref id="B270"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C. L.</given-names></name><name><surname>Guo</surname><given-names>H. C.</given-names></name><name><surname>Dong</surname><given-names>Z. Y.</given-names></name><name><surname>Zhao</surname><given-names>Q.</given-names></name></person-group> (<year>2009</year>). <article-title>Pharmacological and nutritional activities of potato anthocyanins</article-title>. <source>Afr. J. Pharm. Pharmacol.</source>
<volume>3</volume> (<issue>10</issue>), <fpage>463</fpage>&#x02013;<lpage>468</lpage>.</mixed-citation></ref><ref id="B271"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J.</given-names></name><name><surname>Ding</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>G.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Anthocyanins composition and antioxidant activity of wild Lycium ruthenicum Murr. from Qinghai-Tibet Plateau</article-title>. <source>Food Chem.</source>
<volume>126</volume> (<issue>3</issue>), <fpage>859</fpage>&#x02013;<lpage>865</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2010.11.052</pub-id>
</mixed-citation></ref></ref-list></back></article>